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ABSTRACT OF THE DISSERTATION 
THE CYCLODEXTRIN-PERFLUORINATED SURFACTANT HOST-GUEST 
COMPLEX: FUNDAMENTAL STUDIES FOR POTENTIAL ENVIRONMENTAL 
REMEDIATION AND THERAPEUTIC APPLICATIONS 
by 
Mary Joelle Errico 
Florida International University, 2018 
Miami, Florida 
Professor Kevin E. O’Shea, Major Professor 
Perfluoroalkyl substances (PFASs) are contaminants of emerging concern, and 
have been detected in drinking water, wildlife, humans, and the environment. 
Cyclodextrins (CDs), cyclic sugars composed of glucose monomers, are proposed as a 
potential remediation strategy. CDs can form host-guest complexes with hydrophobic 
molecules; this complexation could be capitalized on for PFAS removal and 
sequestration. These dissertation projects aim to study the fundamental host-guest 
interactions between a variety of PFASs and CDs for eventual applications in 
environmental and biological remediation. 1D and 2D Nuclear magnetic resonance 
(NMR) spectroscopic methods were employed to determine the strength, dynamics, and 
structure of the CD:PFAS host-guest complexes. Legacy and emerging PFASs were 
studied with the three native CDs (α-, β-, and γ-CDs) as well as β-CD derivatives. β-CD 
and its derivatives exhibit the strongest complexation with all studied PFASs, with 
association constants of 10
2
-10
5
 M
-1
, depending on PFAS chain length, functional groups, 
and branching. The host-guest complex was not significantly disturbed under different 
ix 
 
environmental conditions, such as changing pH, ionic strength, and in the presence of 
humic acid. A competition study between perfluorooctanoic acid (PFOA), β-CD, and 
human serum albumin (HSA), the most abundant protein in blood serum, was then 
conducted using NMR, circular dichroism, and fluorescence spectroscopies. Excess β-CD 
was able to totally reverse all PFOA binding to HSA. Finally, the host-guest complex was 
studied within a biological organism to test its viability as a remediation strategy. The 
attenuation of the toxicity of PFOA in zebrafish embryos, a model organism for 
toxicology studies, was tested with β-CD. Excess β-CD increased the LC50 (lethal 
concentration for 50 % of the population) of PFOA compared to PFOA in the absence of 
β-CD (p < 0.0001). These dissertation projects suggest that the encapsulation of PFASs 
by CDs has potential in PFAS remediation strategies. 
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Introduction 
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1.1 Perfluorinated Surfactants 
 Perfluorinated surfactants, or perfluoroalkyl substances (PFASs), are emerging 
contaminants of concern and problematic persistent organic pollutants. Their extreme 
persistence in the environment has posed many challenges to their remediation.  
 
1.1.1 Structure and Function 
 The unique properties of PFASs arise from their molecular structure. PFASs 
generally are surfactant-like in nature, with a hydrophobic tail and a hydrophilic head 
group (Prevedourous et al. 2006, Jensen and Leffers 2008, Buck et al. 2011, Wang et al. 
2017). The hydrophobic tail is either per- or poly-fluorinated, and head groups include 
carboxylates, sulfonates, sulfonamides, and phosphonates, among others (Wang et al. 
2017). Their dual nature renders them both hydrophobic and lipophobic (Prevedourous et 
al. 2006, Jensen and Leffers 2008, Buck et al. 2011, Wang et al. 2017). The pKa of the 
polar head groups are less than that of the corresponding hydrogenated surfactants; for 
example, hydrogenated carboxylic acids have a pKa of about 4, whereas perfluorinated 
carboxylic acids have a pKa ~ 0, meaning PFASs have a negative charge in most 
environmentally relevant pH (Goss 2008). The numerous carbon-fluorine bonds in the 
perfluorinated backbone, furthermore, give the structure extreme chemical and thermal 
stability (Prevedourous et al. 2006, Jensen and Leffers 2008, Buck et al. 2011, Wang et 
al. 2017). Finally, they are relatively soluble in water, depending on chain length of the 
perfluorinated backbone (with longer chain PFASs less soluble than shorter chain) 
(Prevedourous et al. 2006, Cousins et al. 2011, Wang et al. 2017). Chain length is 
typically between four and twelve carbons. Historically, the most widely produced and 
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used PFASs have eight carbons in their backbone, including perfluorooctanoic acid 
(PFOA) and perfluorooctanesulfonic acid (PFOS), shown in Figure 1.1 (Prevedouros et 
al. 2006, Wang et al. 2017). 
 
 
Figure 1.1: Structures of two legacy PFASs. Above: Perfluorooctanoic acid (PFOA); 
Below: Perfluorooctanesulfonic acid (PFOS). 
 
 The molecular structure gives PFASs properties desirable to various industries. 
PFASs have been traditionally used in three applications. The first application is as 
processing aids in fluoropolymer (including PTFE, DuPont/Chemours brand name 
Teflon) synthesis (Prevedourous et al. 2006). PFASs aid solvation of tetrafluoroethylene 
monomers and PTFE itself so that emulsion polymerization can occur. The second 
application is as surfactants in aqueous film-forming foams (AFFF) (Prevedouros et al. 
2006, Barzen-Hanson et al. 2017, Wang et al. 2017). AFFF are used to stop hydrocarbon 
fires, by coating the surface of the hydrocarbon with PFASs to prevent oxygen from 
reacting with the hydrocarbon. AFFF have been extensively used by the military, 
especially in air craft hangers and air craft carriers, though they are also used in 
commercial airports (Barzen-Hanson et al. 2017). The third application of PFASs is in 
various consumer products with water-, grease-, or stain-repellant properties 
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(Prevedouros et al. 2006, D’Hollander et al. 2010, Schaider et al. 2017). Examples 
include food packaging (especially fast food, microwave popcorn bags, and pizza boxes), 
stain removers, and water-proof clothing (Prevedouros et al. 2006, D’Hollander et al. 
2010, Schaider et al. 2017). 
 The widespread use of PFASs, coupled with their water solubility and incredible 
stability under environmental conditions, has led to their occurrence in humans, wildlife, 
and the environment (Prevedouros et al. 2006, Houde et al. 2006, Jensen and Leffers 
2008, Kannan 2011, Hu et al. 2016, Strynar et al. 2015, Sun et al. 2016, Glassmeyer et al. 
2017, Barzen-Hanson et al. 2017, Wang et al. 2017). They have been detected around the 
globe, even in remote regions, in water, soil, and the atmosphere (Prevedouros et al. 
2006, Cousins et al. 2011, Gebbink et al. 2016). Furthermore, they are bioaccumulative, 
leading to high concentrations in top predators (Houde et al. 2006, Prevedouros et al. 
2006). They are of special concern because of their toxicity in animals and exposed 
human populations. 
 
1.1.2 Health Effects and Exposure 
 PFASs, especially long chain PFASs, have been linked to adverse health effects.  
The best known case of general population exposure to PFASs was the contamination of 
the Ohio River by DuPont’s Washington Works plant (Frisbee et al. 2009). This plant 
was a major producer of Teflon, and used PFOA as the processing aid in the 
polymerization reaction. PFOA from the plant was released into the adjacent Ohio River. 
The first indicator of this release was the death of a herd of cattle owned by a nearby 
rancher. Eventually, the case became a class action lawsuit, as an unusually high number 
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of people in the surrounding towns had cancer and other ailments (Frisbee et al. 2009). 
Part of the settlement was for DuPont to pay for research into the effects of PFOA 
exposure, leading to the “C8 Project” (Frisbee et al. 2009). The researchers found six 
probable links to PFOA exposure: kidney cancer, testicular cancer, ulcerative colitis, 
thyroid disease, hypercholesterolemia (high cholesterol), and pregnancy-induced 
hypertension (Frisbee et al. 2009, Lopez-Espinosa et al. 2012, Barry et al. 2013, Vieira et 
al. 2013). PFOA exposure has also been linked to liver cancer, bladder cancer, infertility, 
and developmental delays in other studies (Betts 2007, Jensen and Leffers 2008, Kannan 
2011). Other PFASs show similar health effects (Jensen and Leffers 2008). The greatest 
exposure route of PFASs is through drinking water, though exposure can also occur when 
using consumer products containing PFASs (Hu et al. 2016, Schaider et al. 2017, 
D’Hollander et al. 2010). Due to recent contamination of PFOA and PFOS in Hoosick 
Falls, New York, the United States Environmental Protection Agency (EPA) has issued a 
lifetime advisory limit of 70 parts per trillion (ppt) for PFOA and PFOS combined (EPA 
800-F-16-003). 
 Unlike other persistent organic pollutants, PFASs do not accumulate in fat tissue. 
Instead, they predominantly reside in blood serum, though they will later accumulate in 
bone and organs such as the brain, liver, bladder, and kidneys (Olsen et al. 2007, Jensen 
and Leffers 2008, Kannan 2011, Pérez et al. 2013). PFASs have relatively long half-lives 
(time in which half of the original concentration is eliminated from the body) in the body 
considering that they do not accumulate in fat: PFOA has a half-life of about 3.8 years, 
and PFOS has a half-life of about 5.4 years (Olsen et al. 2007). Over 99% of the United 
States population has measurable levels, with an average of 2 parts per billion (ppb), of 
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PFOA and PFOS in their blood (Calafat et al. 2007).  Those exposed to higher 
concentrations of PFASs, such as those studied in the C8 Project, have 20-200 ppb in 
their blood, whereas factory workers in PFAS manufacturing plants have upwards of 
1000 ppb (or 1 parts per million, ppm) in their blood (Olsen et al. 2007, Frisbee et al. 
2009).  
 PFOA is also known to bind to human serum albumin (HSA), the most abundant 
protein in human blood serum (Han et al. 2003, Jensen and Leffers 2008, Wu et al. 2009). 
The interaction between PFOA and HSA has been investigated by a variety of methods, 
including nuclear magnetic resonance (NMR), fluorescence, infrared, and circular 
dichroism spectroscopies, equilibrium dialysis, isothermal titration calorimetry (ITC), 
and molecular modeling (Han et al. 2003, Wu et al. 2009, Chen and Guo 2009, 
Salvalaglio et al. 2010, MacManus-Spencer et al. 2010, Bischel et al. 2010, Hebert and 
MacManus-Spencer 2010). The binding of PFOA to HSA has been reported to occur at 
multiple sites (up to 13) (Han et al. 2003, Wu et al. 2009, Salvalaglio et al. 2010), 
primarily to hydrophobic pockets known to interact with fatty acids, hormones, and 
hydrophobic drugs, with the strongest binding constant on the order of 10
5
 M
-1
 (Han et al. 
2003, Wu et al. 2009, Chen and Guo 2009, Salvalaglio et al. 2010, MacManus-Spencer et 
al. 2010, Bischel et al. 2010). 
 The toxicological effects of PFOA have also been studied on a variety of 
organisms, such as zebrafish. Zebrafish, particularly embryonic and larval stages, have 
emerged as an important model system in a wide range of fields including assessment of 
chemical toxicity (Yang et al. 2009, Planchart et al. 2016). Practical advantages of the 
zebrafish embryo system include ease of rearing and a high fecundity, as well as small 
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(~1 mm) and nearly transparent embryos, rapid (≤5–7 day) embryo development, and a 
fully sequenced genome. As such, the zebrafish embryo has been employed to look at a 
wide range of environmental contaminants in terms of acute and chronic toxicity (Hinton 
et al. 2005, Scholz et al. 2008, Sarmah and Marrs 2016). Acute toxicological endpoints 
(e.g., embryotoxicity, teratogenicity, neurotoxicity), which are readily accessible in the 
zebrafish embryo model, are aligned with the reported health concerns associated with 
PFOA, and the system has been used to evaluate toxicity of PFOA and related PFASs 
(Hagenaars et al. 2011, Zheng et al. 2011, Hagenaars et al. 2013, Ding et al. 2013, Ulhaq 
et al. 2015, Jantzen et al. 2016a, Jantzen et al. 2016b, Jantzen et al. 2017, Rainieri et al. 
2017). 
 
1.1.3 Current Remediation Techniques 
 Although PFOA and PFOS have been phased out of production in the United 
States and Europe, they are still detected in the environment due to their persistence (Hu 
et al. 2016, Glassmeyer et al. 2017, Wang et al. 2017). In fact, a joint study by the EPA 
and United States Geological Survery (USGS) found that every water treatment plant 
they tested had measurable levels of PFASs in the water supply, with many of the water 
supplies having levels above the EPA lifetime advisory limit of 70 ppt (Glassmeyer et al. 
2017). Furthermore, they found that the PFASs were not significantly removed during 
water treatment (Glassmeyer et al. 2017). An estimated six million Americans drink 
water exceeding the EPA limit (Hu et al. 2016). 
 Compounding the problem is the development of “emerging” PFASs by industries 
to replace “legacy” PFASs (such as PFOA and PFOS) (Wang et al. 2017). One of the 
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major types of emerging PFASs is perfluoroethercarboxylic acids, or PFECAs (Wang et 
al. 2013, Wang et al. 2017). PFECAs have an analogous structure to perfluorocarboxylic 
acids (PFCAs) like PFOA, except oxygen atoms are inserted into the carbon backbone to 
create ether functionalities. The presence of ether oxygens was expected to aid 
degradation of these compounds in the environment (Wang et al. 2013, Wang et al. 
2015). Recent studies, however, have suggested that PFECAs have similar persistence 
and potential for transport in the environment as legacy PFASs (Wang et al. 2015, Gomis 
et al. 2015), and preliminary studies indicate that they may, in fact, be more toxic than 
legacy PFASs (Gomis et al. 2018, Sheng et al. 2018). An investigation near a PFECA 
manufacturer in North Carolina, furthermore, revealed that PFECAs are not susceptible 
to advanced processes in water treatment facilities (Strynar et al. 2015, Sun et al. 2016). 
Thus, both the remaining legacy PFASs and the currently manufactured emerging PFASs 
are threats to environmental and human health. 
 Many remediation strategies for PFAS removal from the environment have been 
previously studied. Examples of these include: adsorption by activated carbon or mineral 
materials; nanofiltration and reverse osmosis; and advanced oxidation processes, 
ultrasonic degradation, and reduction (Arvaniti and Stasinakis 2015, Merino et al. 2016). 
Oxidative and reductive technologies are effective only under extreme conditions, such as 
high pressure, high temperature, very acidic or alkaline pH, and with high concentrations 
of PFASs, and thus are inefficient for remediation in environmentally relevant conditions 
at low PFAS concentrations (Arvaniti and Stasinakis 2015, Merino et al. 2016). 
Adsorption processes are much more promising, with rapid removal of PFASs using 
activated carbon; however, this process is fouled by natural organic matter such as humic 
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acid, and so is much less effective in environmental conditions (Arvaniti and Staskinakis 
2015, Dudley et al. 2015, Merino et al. 2016). Furthermore, activated carbon adsorption 
is not effective for removal of short chain PFASs currently being produced due to 
phasing out of long chain PFAS production (Dudley et al. 2015, Merino et al. 2016). New 
remediation strategies are greatly needed. 
 
1.2 Cyclodextrins 
 Cyclodextrins (CDs) are cyclic sugar oligomers composed of glucose monomers. 
They have previously been proposed as a remediation strategy for environmental 
pollutants. 
 
1.2.1 Structure and Function 
 Cyclodextrins are non-toxic, water soluble, and inexpensive. CDs were first 
isolated during bacterial transformation of potato starch in 1891 (Szejtli 1998). They are 
now readily synthesized by adding cyclodextrin glycosyltransferase (CGTase) to starch 
(Szejtli 1998). Three CDs are widely produced: α-, β-, and γ-CDs, composed of six, 
seven, and eight glucose monomers, respectively. The glucose monomers are joined by α-
1,4-glucosidic linkages, forming the CD into a truncated cone shape, with a larger side 
and smaller side. The larger side is lined with 12-16 secondary hydroxyl groups and the 
smaller side is lined with 6-8 primary hydroxyl groups, depending on the size of the CD, 
making the exterior relatively hydrophilic. The interior of the cavity, however, is lined 
with C-H bonds, rendering it relatively hydrophobic (Szejtli 1998). The glucose 
monomer and the side view of the toroid structure of β-cyclodextrin are pictured in 
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Figure 1.2. H1, H2, and H4 face towards the exterior, whereas H3 and H5 face towards 
the interior. H6 are the methylene protons adjacent to the primary hydroxyl groups, 
which have free rotation. 
 
 
Figure 1.2: Structure of β-CD. Above: The glucose monomer with labeled protons. 
Below: Side view of the toroid structure, showing the interior protons (H3 and H5), the 
secondary hydroxyl groups on the large end, and the primary hydroxyl groups (next to 
H6) on the small end. 
 
 The dual hydrophobic-hydrophilic nature of CDs makes them well-suited for 
host-guest chemistry of hydrophobic molecules in aqueous solution (Martin Del Valle 
2004). Host-guest chemistry involves a guest molecule associating with the interior of a 
host molecule. A hydrophobic molecule will readily complex with the hydrophobic CD 
cavity instead of remaining in the aqueous solution (Rekharsky and Inoue 1998). 
Furthermore, polar functionalities on the guest can hydrogen-bond with the hydroxyl 
groups lining the CD cavity perimeter to strengthen the interactions (Saenger and Steiner 
11 
 
1998, Lipkowitz 1998, Takahashi 1998, Wagner 2012). CDs can also be modified with 
charged functional groups, such as positively charged amino groups or negatively 
charged sulfonate groups, in place of the hydroxyl groups, facilitating electrostatic 
attraction between the cyclodextrin and an oppositely charged guest (Ito et al. 1996, Kitae 
et al. 1998, Szente and Szejtli 1999, Wenz et al. 2008). The host-guest inclusion complex 
is very favorable depending on the molecular size of the guest, the type of CD, and the 
ability for strong van der Waals interactions, H-bonding, or ionic bonding to occur 
(Rekharsky and Inoue 1998).  
 
1.2.2 Nuclear Magnetic Resonance Spectroscopy to Measure Host-Guest Interactions 
 Host-guest interactions have been measured by a variety of techniques. Some of 
these techniques include: NMR, fluorescence, UV-vis, infrared, and circular dichroism 
spectroscopies; mass spectrometry; X-ray crystallography; ITC; capillary electrophoresis; 
and conductivity measurements (Valente and Söderman 2014). NMR spectroscopy has 
been widely used to measure the strength of the host-guest association, as well as 
determine the structure and dynamics of the complex (Schneider et al. 1998, Pessine et al. 
2012, Valente and Söderman 2014). NMR is ideal for systems where the guest protons do 
not overlap with the CD protons, or the guest molecule has no or few protons in its 
structure. 
 NMR signals are not only dependent on the structure of the molecule: they are 
also, to a lesser extent, influenced by the environment surrounding the molecule. When a 
guest molecule is in solution, it will have one set of chemical shifts corresponding to each 
NMR-active nucleus; when it is inside a host molecule, the NMR signals will shift to 
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reflect the change in environment (whether more shielded or less shielded). This change 
in chemical shift can be measured in order to determine the strength of association 
between the host and guest (Schneider et al. 1998, Valente and Söderman 2014). If the 
equilibrium exchange is faster than the NMR time scale, then only one set of peaks will 
be observed (Schneider et al. 1998). This set of peaks will be the average between the 
fraction of free guest and the fraction of complexed guest: 
 
 𝛿𝑜𝑏𝑠 = 𝜒𝐺𝛿𝐺 + 𝜒𝐻:𝐺𝛿𝐻:𝐺 (1.1) 
 ∆𝛿𝑜𝑏𝑠 = 𝛿𝑜𝑏𝑠 − 𝛿𝐺 (1.2) 
 ∆𝛿𝐻:𝐺 = 𝛿𝐻:𝐺 − 𝛿𝐺 (1.3) 
 
The observed chemical shift, δobs, is dependent upon the fraction of guest molecules in 
the uncomplexed state, χG, (free guest, [G]) and complexed state, χH:G, (guest in host, 
[H:G]), and their respective chemical shifts, δG and δH:G. The change in observed 
chemical shift, Δδobs, is the observed chemical shift less the free guest chemical shift. The 
change in the complexed species’ chemical shift, ΔδH:G, is the difference between δH:G 
and δG. Rearrangement of these equations yields: 
 
 ∆𝛿𝑜𝑏𝑠 = 𝜒𝐻:𝐺𝛥𝛿𝐻:𝐺 (1.4) 
 
The change in observed chemical shift is thus related to the mole fraction of the 
complexed species and the change in the complexed species’ chemical shift compared to 
the uncomplexed species’ chemical shift. The association constant for the 1:1 host:guest 
interaction, K1:1, is related to the concentration of the complexed and free guest. 
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 𝐺 + 𝐻 ⇄ 𝐻:𝐺 (1.5) 
 
𝐾1:1 =
[𝐻: 𝐺]
[𝐻][𝐺]
 (1.6) 
 𝐺𝑇 = [𝐺] + [𝐻: 𝐺] (1.7) 
 𝐻𝑇 = [𝐻] + [𝐻: 𝐺] (1.8) 
 
The concentration of guest in solution, GT (or guest total), is equal to both free and 
complexed concentrations. The concentration of host in solution, HT (or host total), is 
likewise equal to both free and complexed concentrations. Combining all these equations 
yields 
 
 
∆𝛿𝑜𝑏𝑠 =
∆𝛿𝐻:𝐺
2𝐺𝑇
{𝐺𝑇 + 𝐻𝑇 +
1
𝐾1:1
− ((𝐺𝑇 + 𝐻𝑇 +
1
𝐾1:1
)
2
− 4𝐺𝑇𝐻𝑇)
1
2
} (1.9) 
 
This gives the change in observed chemical shift as a function of total host concentration 
when the guest concentration is held constant. For the 2:1 host:guest association constant, 
K2:1, the equation is: 
 
 𝐺 + 2𝐻 ⇄ 2𝐻:𝐺 (1.10) 
 
𝐾2:1 =
[2𝐻: 𝐺]
[𝐺][𝐻]2
 (1.11) 
 𝐺𝑇 = [𝐺] + [2𝐻: 𝐺] (1.12) 
 𝐻𝑇 = [𝐻] + [2𝐻: 𝐺] (1.13) 
 
14 
 
 
∆𝛿𝑜𝑏𝑠 =
∆𝛿2𝐻:𝐺
4𝐻𝑇(𝐻𝑇 + 𝐺𝑇)
{
 
 
4𝐺𝑇𝐻𝑇 + 𝐻𝑇2 +
1
𝐾2:1
− ((4𝐺𝑇𝐻𝑇 + 𝐻𝑇2 +
1
𝐾2:1
)
2
− 16𝐺𝑇𝐻𝑇2(𝐻𝑇 + 𝐺𝑇))
1
2
}
 
 
 
(1.14) 
 
For host-guest interactions exhibiting both 1:1 and 2:1 interactions: 
 
 
∆𝛿𝑜𝑏𝑠 =
∆𝛿𝐻:𝐺
2𝐺𝑇
{𝐺𝑇 + 𝐻𝑇 +
1
𝐾1:1
− ((𝐺𝑇 + 𝐻𝑇 +
1
𝐾1:1
)
2
− 4𝐺𝑇𝐻𝑇)
1
2
}
+
∆𝛿2𝐻:𝐺
4𝐻𝑇(𝐻𝑇 + 𝐺𝑇)
{
 
 
4𝐺𝑇𝐻𝑇 + 𝐻𝑇2 +
1
𝐾2:1
− ((4𝐺𝑇𝐻𝑇 + 𝐻𝑇2 +
1
𝐾2:1
)
2
− 16𝐺𝑇𝐻𝑇2(𝐻𝑇 + 𝐺𝑇))
1
2
}
 
 
 
(1.15) 
 
The change in observed chemical shift as a function of total host concentration can be 
modeled by these equations to yield accurate association constants (Schneider et al. 1998, 
Ramos Cabrer et al. 1999, Valente and Söderman 2014).  
 Competition experiments can be conducted to qualitatively compare the strength 
of host complexation between two molecules. For these experiments, the NMR spectra of 
the first complex and second complex are taken separately, and then both guest molecules 
are added to different concentrations of the host molecule and compared to the original 
15 
 
spectra. Whichever guest molecule has a stronger association constant with the host will 
determine which NMR spectrum the mixture resembles. For example, if the first guest 
molecule has a stronger association constant with the host than the second molecule, then 
the spectrum of the mixture will resemble the spectrum of the first molecule and host 
alone. Competition studies are useful to determine which host-guest complex will be 
formed in set conditions. 
 Another NMR experiment to study host-guest interactions is nuclear Overhauser 
effect (NOE) spectroscopy. NOE experiments examine the proximity of nuclei through-
space, rather than through-bond (Overhauser 1953, Solomon 1955). Two nuclei that are 
close in three dimensional space will therefore have a crosspeak in a two-dimensional 
(2D) NOE NMR spectrum. NOE experiments have been used previously to determine 
how the guest molecule is oriented inside the host molecule, as well as confirm the 
inclusion complex, by examining which host protons show crosspeaks with which guest 
nuclei (whether protons or heteronuclei) (Schneider et al. 1998).   
 
1.2.3 Applications and Previous Studies 
 Cyclodextrins have been used in various industries, including pharmaceuticals 
and drug delivery, food additives, odor elimination, nanotechnology, and 
chromatography (Szejtli 1998, Arun et al. 2008, Frömming and Szejtli 2013). These 
industries capitalize on the host-guest interactions CDs can display with a variety of 
hydrophobic guests. An emerging industry for CDs is environmental remediation of 
pollutants (Crini and Morcellet 2002, Crini 2005, Morin-Crini and Crini 2013, Nagy et al. 
2014, Moulahcene et al. 2015). CDs have the potential to encapsulate a variety of 
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pollutants in water and soil, such as organic contaminants and heavy metals. Polymeric or 
solid-support materials based on CDs have been proposed as remediation strategies (Crini 
and Morcellet 2002, Crini 2005, Morin-Crini and Crini 2013, Nagy et al. 2014, 
Moulahcene et al. 2015).  
 CDs have previously been show to exhibit host-guest interactions with 
perfluorocarboxylic acids (PFCAs) of various chain lengths (Palepu and Reinsborough 
1989, Palepu and Richardson 1989, Guo et al. 1992, Wilson and Verrall 1998a, Lima et 
al. 2007, Karoyo et al. 2011, Karoyo et al. 2013, Karoyo et al. 2015). Previously 
19
F 
NMR spectroscopy has been used to study the change in chemical shifts of each fluorine 
peak on the PFAS backbone in order to calculate the strength of complexation (Guo et al. 
1992, Wilson and Verrall 1998a, Karoyo et al. 2011, Karoyo et al. 2013, Karoyo et al. 
2015). β-CD, the mid-sized CD, is the most promising for complexation of PFCAs, and 
exhibits both 1:1 and 2:1 complexes with PFCAs (Guo et al. 1992, Wilson and Verrall 
1998a). Several β-CD polymeric materials have also been developed to remove PFOA 
and PFOS from water (Karoyo and Wilson 2013, Karoyo and Wilson 2015, Karoyo and 
Wilson 2016, Xiao et al. 2017). The fundamental host-guest interactions between PFASs 
and CDs, however, are not fully understood, and other PFASs, such as perfluorosulfonate 
derivatives and emerging PFECAs, have not been studied. Most importantly, the structure 
and dynamics of the host-guest complex between PFASs and CDs have not been 
determined. This structural information is necessary in understanding why the 
interactions between PFASs and CDs are favorable, and how these interactions can be 
utilized to create effective CD-based environmental or biological removal technologies 
for PFASs, especially emerging PFASs, and improve upon the previously tested 
17 
 
polymeric materials (Karoyo and Wilson 2013, Karoyo and Wilson 2015, Karoyo and 
Wilson 2016, Xiao et al. 2017). Furthermore, therapeutic or biological applications of the 
CD:PFAS host-guest interactions have not been explored. 
 
1.3 General Objectives of the Dissertation Projects 
 These dissertation projects aim to study the fundamental host-guest interactions 
between a variety of PFASs and CDs for eventual applications in environmental and 
biological remediation. 1D and 2D NMR spectroscopic methods were employed to 
determine the strength, dynamics and structure of the host-guest complexes. Legacy 
(Chapter 2) and emerging (Chapter 3) PFASs were studied with the three native CDs as 
well as CD derivatives (Chapter 4). A competition study using β-CD to reverse the 
binding of PFOA to HSA was conducted with NMR, circular dichroism, and fluorescence 
spectroscopies to further understand the nature of the host-guest complex (Chapter 5). 
Finally, the attenuation of the toxicity of PFOA in zebrafish embryos was tested with β-
CD to examine if the host-guest complex is a viable remediation strategy (Chapter 6). 
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CHAPTER 2 
Host-Guest Interactions between Cyclodextrins and Legacy Perfluoroalkyl Substances 
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2.1 Abstract  
Perfluoroalkyl substances (PFASs) are contaminants of serious concern because 
of their toxicological properties, widespread presence in drinking water sources, and 
incredible stability in the environment. To assess the potential application of 
cyclodextrins (CDs) for PFAS remediation, we investigated their complexation with 
linear fluorinated carboxylic acids, sulfonates, and a sulfonamide with carbon backbones 
ranging from C4-C9.  
19
F Nuclear Magnetic Resonance (NMR) spectroscopy studies 
demonstrated β-CD formed the strongest complexes with these PFASs. The polar head 
group had a modest influence, but for PFASs with backbones longer than six carbons, 
strong association constants are observed for 1:1 (K1:1 ~ 10
5 
M
-1
) and 2:1 (K2:1 ~ 10
3
 M
-1
) 
β-CD:PFAS complexes.  Excess β-CD can be used to complex 99.5% of the longer chain 
PFASs. Competition studies with adamantane-carboxylic acid and phenol confirmed the 
nature and persistence of the β-CD:PFAS complex. Detailed analyses of the individual 
NMR chemical shifts and Job plots indicate the favored positions of β-CD along the 
PFAS chain. Solution pH, ionic strength, and the presence of humic acid have modest 
influence on the β-CD:PFAS complex. The strong encapsulation of PFASs by β-CD 
under a variety of water quality conditions demonstrates the tremendous potential of CD-
based materials for the environmental remediation of PFASs. 
 
 
 
 
 
20 
 
2.2 Introduction 
Reported herein are detailed NMR studies of eight PFASs with different polar 
head groups and varying chain lengths. Adamantane-carboxylic acid, a powerful β-CD 
inclusion guest, and phenol, a model environmental pollutant, were used to confirm the 
strength and nature of the β-CD:PFOA complex. The complex is robust under a variety of 
water quality conditions, including a range of ionic strength and solution pH values, and 
in the presence of humic acid. The results demonstrate the promise of CD-based materials 
for the environmental remediation of a variety of fluorinated surfactants in a wide range 
of water quality conditions.  
 
2.3 Experimental Methods 
Perfluorobutanoic acid (PFBA), perfluoropentanoic acid (PFPA), 
perfluoroheptanoic acid (PFHpA), perfluorooctanoic acid (PFOA), perfluorononanoic 
acid (PFNA), hexafluorobenzene, adamantane-carboxylic acid, phenol, and humic acid 
were purchased from Sigma-Aldrich. Potassium perfluorooctanesulfonate (PFOS), 
perfluorooctanesulfonamide (PFOSA), and 1H,1H,2H,2H-perfluorooctanesulfonic acid 
(6:2 fluorotelomer sulfonate, 6:2 FTS) were purchased from SynQuest Labs. α-, β-, and 
γ-Cyclodextrin were purchased from Acros Organics. Deuterium oxide (99.9% D) was 
purchased from Sigma-Aldrich and stored at 4 °C. All chemicals were used without 
further purification. Structures and abbreviations can be found in Appendix 1. 
 
 
 
21 
 
2.3.1 Sample Preparation  
Solutions of 2.42 × 10
-3
 M perfluorocarboyxlic acids and 6.05 × 10
-4
 M 
perfluorosulfonates/sulfonamide were prepared in 50% D2O and 50% DI H2O, adjusted 
with 0.036 M NaOH to solution pH 7. Hexafluorobenzene (0.17 μL, 1.44 × 10-3 M) was 
added as an internal standard. Various cyclodextrins were added in different 
stoichiometric ratios. Solutions were sonicated in a cleaning bath for five minutes to 
ensure dissolution of substrates. 
 
2.3.2 Environmental Conditions and Competition Studies  
The competition studies were performed with PFOA, β-CD, and adamantane-
carboxylic acid or phenol. The studies on the effects of environmental conditions on the 
complex were performed with PFOA and β-CD. For the ionic strength experiments, NaCl 
at 0.01, 0.1, and 1.0 M was added to samples of PFOA and β-CD. For the pH 
experiments, pH was adjusted to 2, 4 and 10 using 0.1 M solutions of NaOH and HCl. 
For the humic acid experiments, 0.5 mg/mL of humic acid (Sigma-Aldrich H16752, Lot# 
STBC5468V) was added to each sample. 
 
2.3.3 NMR Spectroscopy 
19
F and 
1
H NMR spectroscopy was performed with a 400 MHz Bruker instrument 
with a quad probe. The hexafluorobenzene peak was used as an internal standard at           
-164.9 ppm for 
19
F NMR and DSS was used as an internal standard at 0 ppm for 
1
H 
NMR. The chemical shift of the internal standards did not change in the presence of the 
CD. The chemical shift of each peak was recorded. Representative spectra taken at 
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different times were unchanged over a one-week time window. Assignment of the 
fluorine and carbon positions was previously reported (Guo et al. 1992, Wilson and 
Verrall 1998a, Wilson 1998). The association constants for K1:1 (1:1 CD:PFAS) and K2:1 
(2:1 CD:PFAS) were determined using a method described by Ramos Cabrer, et al. 
(1999) (Chapter 1). Nonlinear least-squares regression analysis was performed in 
GraphPad Prism (version 5.03, La Jolla, CA) and Mathworks Matlab (version R2013b, 
Natick, MA) to determine the individual association constants.  
 
2.4 Results and Discussion 
 The PFASs and CDs were dissolved in 1 mL (50% D2O and 50% H2O) at the 
desired CD:PFAS ratios over a wide range from 1:5 to 6:1 PFAS:CD ratios. 19F NMR 
spectra were obtained at specific ratios and the chemical shifts compared (for individual 
NMR data, see Appendix 1). As the ratio of CD increases, there are distinct changes in 
the chemical shifts and shape of the 19F NMR peaks. Peak broadening is assigned to a 
more rigid structure of the guest when within the host (Karoyo et al. 2011, Karoyo et al. 
2013, Karoyo et al. 2015). Based on the results herein as well as the numerous previous 
studies, we focused on the β-CD:PFAS complexes (Guo et al. 1992, Wilson and Verrall 
1998a, Karoyo et al. 2011, Karoyo et al. 2013, Karoyo et al. 2015). Figure 2.1 shows 
representative 19F NMR spectra of perfluorooctanoic acid (PFOA) and β-cyclodextrin (β-
CD) at various ratios. The PFOA peaks are labeled by their position; for example, “F2” 
refers to the fluorine atoms attached to the second carbon (with the carboxylate carbon 
assigned position number one according to the IUPAC nomenclature rules). As the 
cyclodextrin concentration increased, the chemical shift of the fluorine atoms changed, in 
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some cases dramatically. The observed change in chemical shift becomes obvious as the 
β-CD:PFOA ratio approaches a 1:1 ratio. With the addition of more than one equivalent 
of β-CD, the chemical shift gradually decreases indicating a second feature: 2:1 β-
CD:PFOA complexation. 
 
 
 
Figure 2.1: 
19
F NMR spectra of PFOA-β-CD complex. Above: Representative 19F NMR 
spectra of PFOA (0.00242 M) with β-CD at various ratios, abbreviated to fluorines F2-F7 
(F8 and hexafluorobenzene peaks not pictured), 50% D2O/50% H2O. Below: PFOA 
numbering scheme. 
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To probe the nature of the β-CD:PFOA complex, competition experiments were 
run using adamantane-carboxylic acid (Ada-COOH). Ada-COOH is a cage-shaped 
hydrocarbon known to strongly complex to the interior of β-CD with a K1:1 = 2.0 × 10
5
 
M
-1
 (Eftink et al. 1989, Kwak and Gomez 1996). The 
1
H NMR spectra of 1:1 β-
CD:PFOA and 1:1 β-CD:Ada-COOH complexes were run to establish the chemical shifts 
of the β-CD protons in the individual complexes. The exterior protons (H1, H2, and H4) 
are unaffected by the presence of these guests, while the interior protons (H3 and H5) and 
the primary hydroxyl group (H6 of the methylene) undergo notable shifts in the presence 
of PFOA and Ada-COOH, as shown in Figure 2.2 (for Ada-COOH protons see Appendix 
1). The addition of PFOA to the robust β-CD:Ada-COOH complex results in changes in 
the chemical shifts of the protons of β-CD. The chemical shift of H3, when both guests 
are present, is most similar to a 1:1 β-CD:PFOA complex, whereas the chemical shift of 
H5 appears to be an average of the 1:1 β-CD:PFOA and 1:1 β-CD:Ada-COOH 
complexes. To further probe the complexation, the host-guest ratio was varied and 
19
F 
NMR spectra taken (Appendix 1).  At a 1:1:0.5 β-CD:Ada-COOH:PFOA ratio, the 19F 
NMR spectrum indicates a 1:1 complex between PFOA and β-CD with no evidence of 
free PFOA. The results demonstrate PFOA readily replaces Ada-COOH within β-CD. 
With addition of PFOA beyond the 0.5 equivalents, the 
19
F NMR spectra show presence 
of free PFOA, indicating a robust competition between PFOA and Ada-COOH for β-CD 
complexation, consistent with their strong association constants ~ 10
5
 M
-1
 (Eftink et al. 
1989, Guo et al. 1992, Kwak and Gomez 1996, Wilson and Verrall 1998a, Wilson 1998). 
The Ada-COOH competitive binding experiments establish encapsulation of PFOA 
within the β-CD cavity and demonstrate the persistence of the β-CD:PFOA complex. 
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Figure 2.2: PFOA-Ada-COOH competition study. 
1H NMR spectra of β-CD (0.00242 
M), D2O. a) β-CD only; b) 1:1 β-CD:Ada-COOH; c) 1:1 β-CD:PFOA; d) 1:1:0.5 β-
CD:Ada-COOH:PFOA; e) 1:1:0.75 β-CD:Ada-COOH:PFOA; f) 1:1:1 β-CD:Ada-
COOH:PFOA; g) 1:1:1.5 β-CD:Ada-COOH:PFOA; h) 1:1:2 β-CD:Ada-COOH:PFOA.  
 
An analogous competition experiment was conducted between phenol and PFOA. 
Phenol is reported to have an equilibrium constant with β-CD on the order of ~ 102 M-1 
(Rekharsky and Inoue 1998, Le Saux et al. 2006, Lo Meo et al. 2007). The proton 
spectrum of a 1:1 β-CD:phenol mixture indicates formation of a host-guest complex, as 
shown in Figure 2.3 (for the individual spectra, see Appendix 1). When PFOA is added to 
a 1:1 solution of β-CD:phenol, the chemical shifts of β-CD protons H3 and H5 mirror 
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that of a solution with only PFOA and β-CD, without phenol, indicating only PFOA is 
interacting with β-CD, with either no or minimal interaction between phenol and β-CD. 
Furthermore, the chemical shifts of the 
19
F NMR peaks suggest that at low PFOA ratios 
(1:1:0.5 and 1:1:0.75 β-CD:phenol:PFOA), 2:1 β-CD:PFOA complexes are formed in 
addition to the 1:1 complex.  Hence the 2:1 β-CD:PFOA complex is favored over the β-
CD:phenol complex. 
 
 
Figure 2.3: PFOA-Phenol competition study. 
1H NMR spectra of β-CD (0.00242 M), 
D2O. a) β-CD only; b) 1:1 β-CD:Phenol; c) 1:1 β-CD:PFOA; d) 1:1:0.5 β-
CD:Phenol:PFOA; e) 1:1:0.75 β-CD:Phenol:PFOA; f) 1:1:1 β-CD:Phenol:PFOA; g) 
1:1:1.5 β-CD:Phenol:PFOA; h) 1:1:2 β-CD:Phenol:PFOA. 
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The competition studies demonstrate β-CD can selectively complex PFOA in the 
presence of other substrates, such as phenol. Previous studies demonstrated non-
fluorinated carboxylic acids also do not disrupt the formation of the 1:1 β-CD:PFOA 
complex (Xing et al. 2007). Ada-COOH is unique in the strength of its β-CD 
complexation, but such structures are not expected to be present in the environment. 
PFOA and other perfluorinated surfactants with strong β-CD association constants are 
thus expected to be the only contaminants in environmental samples with such powerful 
complexation to β-CD. The stability of the β-CD:PFAS complex in the presence of the 
model pollutant phenol indicates promise for applications of β-CD for environmental 
PFAS remediation. 
Monitoring chemical shifts with the titration of guest over a range of host 
concentrations has been extensively used to assess host-guest interactions (Guo et al. 
1992, Wilson and Verrall 1998a, Wilson and Verrall 1998b, Wilson 1998, Ramos Cabrer 
et al. 1999, Lima et al. 2007, Karoyo et al. 2011, Pessine et al. 2012, Karoyo et al. 2013, 
Valente and Söderman 2014, Karoyo et al. 2015). Detailed analyses of the changes in 
chemical shifts of individual fluorine atoms upon complexation with β-CD can provide 
structural information about the complex. The chemical shifts of individual fluorine 
atoms were evaluated to assess the favored position of β-CD and dynamics of the host-
guest complex. Representative plots of the changes in chemical shift against β-CD 
concentration for the fluorine atoms at the individual positions F2, F5, and F8 of PFOA 
are illustrated in Figure 2.4. The magnitude of the change in chemical shift within the 
same PFOA molecule varied significantly with the addition of β-CD depending on the 
position along the backbone. For fluorine atoms F2 and F3 adjacent to the polar head 
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group, the change in chemical shift increases with increasing β-CD concentration. The 
chemical shifts of F2 and F3 do not change significantly with the addition of excess β-
CD, consistent with previous reports of F2 and F3 residing outside the β-CD cavity 
(Karoyo et al. 2015). The changes in chemical shifts of F4, F5, and F6 (F4-6) increase 
incrementally with β-CD concentration until the 1:1 stoichiometric ratio, indicating one 
β-CD complexes one PFOA. The changes in chemical shifts are greater for F4-6 
compared to F2 and F3, (ex. ΔδF5: 0.46 ppm, ΔδF2: 0.20 ppm). These observations 
suggest the β-CD molecule interacts to a much greater extent with the middle of the 
PFOA molecule, as illustrated in Figure 2.5. Above the 1:1 β-CD:PFOA ratio, the 
changes in chemical shift of F4-6 decrease with β-CD concentration, suggesting higher- 
or mixed-order complexes (Wilson and Verrall 1998a, Wilson 1998, Karoyo et al. 2011, 
Karoyo et al. 2013, Karoyo et al. 2015). The mathematical description of mixed host-
guest complexes is well established (Chapter 1). The experimental data for the β-
CD:PFOA complex are best fit by a model that takes into account 1:1 and 2:1 CD:PFAS 
complexes, as previously reported (Wilson and Verrall 1998a, Wilson 1998, Karoyo et al. 
2011, Karoyo et al. 2013, Karoyo et al. 2015). The second stage of the change in the 
chemical shift signifies the second β-CD capping the tail of the PFOA chain. For F7 and 
F8, the minimal change in chemical shift for the initial equivalent of β-CD suggests the 
host-guest interactions are mainly with the middle of the chain F4-6. Under such 
conditions the environment of F7 and F8 is not changed because the PFOA tail is outside 
the CD cavity. However, a change in chemical shifts for F7 and F8 are observed with the 
addition of a second equivalent of β-CD, consistent with a 2:1 complex, as illustrated in 
Figure 2.5. The relatively larger change in chemical shift for F7 and F8 above the 1:1 
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host-guest ratio compared to F4-6 further supports the conclusion of a second β-CD 
capping the tail end of the PFOA chain (ex. ΔδF8: -0.65 ppm; ΔδF5: -0.46 ppm).  
 
 
 
 
 
 
 
Figure 2.4: Representative graphs of change in observed chemical shift dependent on β-
CD concentration for F2, F5, and F8 of PFOA fit by Equations 1.9 or 1.15 (Chapter 1). 
Dotted line represents 1:1 β-CD:PFOA ratio.  
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Figure 2.5: 1:1 and 2:1 β-CD:PFOA complexes. 
 
Job analyses were conducted for PFOA and β-CD to further elucidate the 
stoichiometry of the complex (Job 1928). The concentrations and ratios employed to 
construct the Job plots can be found in Appendix 1. Representative plots for F2, F5, and 
F8 are shown in Figure 2.6. For F2 and F3, the maxima are at the mole fraction of 0.5 
(corresponding to a 1:1 ratio).  The maximum peak is rounded suggesting a 1:1 complex 
is formed but with a weaker equilibrium constant (~ 102-103 M-1). In contrast, the Job 
plots for F4-6 have sharp maxima at 0.5 mole fraction, suggesting a 1:1 complex with a 
stronger equilibrium constant (~ 105 M-1). For F7 and F8, however, a minimum is shown 
at 0.2 and a maximum at 0.5 mole fraction. Ulatowski, et al. have cited the limited 
applicability of Job plots when multiple complexes are formed, and that Job plots with 
minimums and maximums do not indicate the stoichiometry of the complex (2016). Since 
F7 and F8 are not influenced appreciably until the 2:1 complex is formed, the Job plot is 
not reliable.   
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Figure 2.6: Representative Job plots for β-CD interaction with F2, F5, and F8 of PFOA. 
Solid line used as a guide (not a fit). Dotted line represents maximum and minimum (if 
applicable) of plot. 
 
32 
 
Although the changes in the chemical shifts will differ based on the specific 
location of the CD and the dynamics of the complex, only one equilibrium constant is 
reported for each host-guest complex. Chemical shifts are influenced by a number of 
factors (Wilson and Verrall 1998a, Karoyo et al. 2015), but the change from a polar 
environment (solvent water) to a non-polar environment (within CD) and the shielding 
effects of the CD typically lead to the most pronounced changes in chemical shifts for the 
specific atoms of the guest contained within the CD host, with smaller changes for guest 
atoms outside the CD. This phenomenon leads to stronger equilibrium constants when 
using NMR peaks that have larger shifts than peaks with smaller shifts. The calculated 
equilibrium constants for each NMR peak for PFOA complexed with β-CD are shown in 
Table 2.1 (for other compounds, see Appendix 1). F2 and F3 have 1:1 equilibrium 
constants (K1:1) on the order of 10
3 M-1, with no values for the 2:1 equilibrium constant 
(K2:1). F4-F6 have K1:1 values on the order of ~ 10
5 M-1, with K2:1 on the order of 10
3 M-1. 
F7 and F8 exhibit K1:1 values ~ 10
4 M-1, and K2:1 ~ 10
3 M-1. Based on these results and 
previous reports, β-CD may move along the PFAS chain, but it predominantly resides at 
the middle of the chain (F4-6) with the second β-CD complexing with the end of the 
chain (F7 and F8). 
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Table 2.1: Association constants for β-CD:PFOA complex 
400 MHz 19F NMR at room temperature; values and uncertainty calculated in Prism and Matlab 
Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
2 
3.27 ± 0.94 × 10
3
 Not observed 0.212 ± 0.006 Not observed 0.987 
3 
1.73 ± 0.28 × 103 Not observed 0.448 ± 0.011 Not observed 0.993 
4 
6.77 ± 0.39 × 105 
1.01 ± 0.35 × 
103 
0.729 ± 0.027 -21.8 ± 5.8 0.997 
5 
4.04 ± 0.87 × 105 
1.30 ± 0.42 × 
103 
0.815 ± 0.028 -22.1 ± 7.2 0.997 
6 
1.36 ± 0.14 × 106 
1.18 ± 0.53 × 
103 
1.08 ± 0.05 -23.6 ± 7.9 0.993 
7 
2.27 ± 0.83 × 104 
1.32 ± 0.98 × 
103 
0.302 ± 0.110 -16.1 ± 8.0 0.988 
8 
6.07 ± 0.73 × 104 
1.17 ± 0.21 × 
103 
0.281 ± 0.020 -17.5 ± 2.3 0.999 
K1:1: 1:1 CD:PFAS association constant 
K2:1: 2:1 CD:PFAS association constant 
Δδcd-F: Maximum change in chemical shift of the 1:1 CD:PFAS complex 
Δδ2cd-F: Maximum change in chemical shift of the 2:1 CD:PFAS complex 
 
These conclusions are further supported by the molecular sizes of these 
compounds. The cross-section size of the β-CD cavity is 30.2 Å2, compared to the cross 
section of PFASs, which is 28.3 Å2 (Lo Nostro et al. 2003). In comparison, the cross-
section of the α-CD cavity is 18.9 Å2 and the γ-CD cavity is 49.0 Å2 (Lo Nostro et al. 
2003).  The model molecular fragment C3F6 (PFAS chain with three carbons) has a cross 
section and volume that matches the cavity of β-CD (Appendix 1, Lo Nostro et al. 2003), 
thus three carbons can reside within the cyclodextrin cavity (F4-6 in the case of PFOA). 
The second β-CD interacts with F7-8, leaving some remaining room in the second CD 
cavity for a water molecule as proposed by Karoyo, et al. (2015).  
To extend our study, we measured the association constants for β-CD with a series 
of perfluorinated carboxylic acids as well as sulfonates and a sulfonamide (previously not 
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reported). A summary of the measured association constants for the series of compounds 
is provided in Table 2.2 (for detailed analyses of all three CDs, see Appendix 1). The β-
CD:PFAS complexes for the long chain PFASs are strong (104-105 M-1), corresponding to 
less than 5% free PFAS at a 1:1 β-CD:PFAS ratio. The short chain PFASs (C<6) exhibit 
K1:1 ~ 10
2 M-1. The head group of the surfactant had a modest effect on the equilibrium 
constants and a 2:1 CD:PFAS interaction was also observed for all long chain PFASs 
(C>6).  The strength of the equilibrium constants K1:1 for PFASs with an eight carbon 
backbone and different head groups is as follows: PFOS (sulfonate) > PFOA 
(carboxylate) > PFOSA (sulfonamide) ~ FTS (sulfonate + CH2CH2).  The sulfonate 
and carboxylate groups possess formal negative charge capable of forming strong 
hydrogen-bonding interactions with hydroxyl groups on β-CD. For the sulfonate of PFOS 
there are three hydrogen bonding sites, whereas there are only two for the carboxylate in 
PFOA, which may be responsible for the slightly weaker K1:1 for PFOA. PFOSA is 
neutral thus will have weaker hydrogen bonding, while FTS has an CH2CH2 group 
adjacent to the sulfonate which is solvated better by water, leading to the relatively 
weaker K1:1 observed. Hydrocarbon chains also have much smaller cross sections than 
fluorocarbons, causing weaker host-guest interactions with β-CD (Wilson and Verrall 
1998b, Lo Nostro et al. 2003). 
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Table 2.2: Association constants for 1:1 and 2:1 complexes of β-cyclodextrin with PFASs 
in aqueous media at room temperature  
PFAS PFBA PFPA PFHpA PFOA PFNA PFOS* PFOSA 
6:2 
FTS 
K1:1, 
M-1 
2.90 ± 
0.24 × 
102 
7.60 ± 
0.44 × 
102 
4.30 ± 
0.85 × 
105 
5.00 ± 
0.10 × 
105 
3.37 ± 
0.35 × 
105 
6.96 ± 
0.79 × 
105 
1.02 ± 
0.16 × 
105 
8.99 ± 
0.36 × 
104 
K2:1, 
M-1 
- - 
2.30 ± 
0.27 × 
103 
1.20 ± 
0.50 × 
103 
7.80 ± 
0.66 × 
103 
5.95 ± 
1.70 × 
104 
2.70 ± 
0.57 × 
104 
1.35 ± 
0.38 × 
103 
*Reported % linear isomer is 75.4% (Herrera 2008) 
 
To expand the study to address concerns for environmental applications, the β-
CD:PFOA complex was further studied under different water quality conditions, 
including pH (2, 4, 7, 10), ionic strengths (0.01 M, 0.1 M, and 1.0 M NaCl), and in the 
presence of humic acid (refer to Appendix 1 for details). Solution pH did not have a 
significant effect on 1:1 interactions. Increased pH, however, was correlated to a 50 % 
increase in K2:1. In acidic pH, the solution has a greater percentage of positive ions, 
whereas in alkaline pH, the solution has a greater percentage of negative ions. The pKa of 
PFOA is approximately 0, and thus PFOA is expected to be predominantly anionic in all 
pHs studied (Goss 2008). When the solution is acidic, PFOA could be more solvated due 
to the favored interactions between the anionic head and the cations and/or protonation in 
solution. Thus the formation of the 2:1 complex is less favored. In alkaline solution, 
however, PFOA could be less solvated due to the repulsive interactions between the 
anionic head and the anions in solution. The formation of the 2:1 complex would in this 
case be favored. However, the 1:1 complex is unaffected, indicating that the first 
association constant is dominated by the hydrophobic interactions between the CD cavity 
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and the PFOA chain. The association of a second β-CD onto the tail, however, is 
influenced by solution pH by changing the solvation of PFOA.  
Ionic strength had a modest effect on the 1:1 interactions but did not exhibit a 
measureable effect on the 2:1 interactions. For F2 and F3 of PFOA, the individually 
calculated K1:1 decreased with increasing ionic strength; for F4-6, ionic strength did not 
have significant effects on K1:1; and for F7 and F8, K1:1 increased with increasing ionic 
strength, indicating that the favored population structure shifted towards the end of the 
chain (closer to F7 and F8 and further from F2 and F3). Ionic strength can influence the 
solvation of a compound in solution. In a previous study, Moulachene, et al. found that 
increasing ionic strength increased the association between β-CD and progesterone 
(2015). As the ionic strength of the solution increased, the solvation of the progesterone 
(a relatively hydrophobic compound) decreased, increasing the thermodynamic 
favorability of the van der Waals interactions between host and guest. PFOA, however, 
has a dual hydrophobic and hydrophilic nature. Since PFOA is anionic in these samples, 
increasing ionic strength enhances the partitioning of the carboxylate group of PFOA to 
the bulk aqueous media, as it can interact with the positive sodium ions. Such interactions 
can affect the environments of F2 and F3, enhancing their solvation because of their 
proximity to the carboxylate group. Thus, this portion of the PFOA molecule acts more 
ionic in nature and thus can interact with the salt ions in solution. On the other hand, the 
tail of PFOA does not favorably interact with the ionic solution, much like the 
progesterone in the previous study, and so it is more favorable for it to interact with the 
CD cavity. The tail of the PFOA is dominated by its hydrophobic character and thus will 
be less solvated in the ionic solution. The 2:1 interaction is not affected by ionic strength, 
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implying that the hydrophobic character of the PFOA molecule dominates and will 
overcome the ionic interactions near the head group. Previous studies with surfactants 
have found that increased ionic strength can lower the critical micelle concentration 
(cmc) (Choppinet et al. 1999), though this is not indicated under our conditions. 
Humic acid is a component of natural organic matter rich in carboxylic acid and 
phenol functionalities. Previous studies have suggested that CDs can interact with humic 
acid but PFOA does not have significant association with humic acid (Liu et al. 2004, Li 
et al. 2012). For the 1:1 interactions, presence of humic acid (0.5 g/L) decreased the 
individually calculated K1:1 of F2 and F3, did not affect K1:1 for F4-6, and increased K1:1 
of F7 and F8. This result suggests that humic acid promotes a shift in in the favored 
positions of β-CD along the backbone of PFOA. For the 2:1 interactions, the presence of 
humic acid decreased K2:1 by 50 % or more for each fluorine atom. Since humic acid-CD 
interactions have been reported, the results suggest that the humic acid is also interacting 
with β-CD. The humic acid in this study is isolated from crude lignite, which contains 
many carboxylic acid and hydroxyl groups. These functional groups could hydrogen-
bond with the hydroxyl groups on the CD perimeter. β-CD thus could be encapsulating 
the end of the PFOA chain, while also interacting via hydrogen-bonding with the humic 
acid. This structure would inhibit a second CD from interacting with the PFOA chain (the 
humic acid effectively acting as a cap to the CD cavity). Thus, the presence of humic acid 
affects the position of β-CD, and only allows one β-CD to interact strongly with the 
PFOA chain. 
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2.5 Conclusions 
 Our studies demonstrate β-CD is an outstanding complexing agent for PFHpA, 
PFOA, PFNA, PFOS, PFOSA, and 6:2 FTS, with association constants of ~10
5
 M
-1
.  The 
longer chain PFASs form 1:1 and 2:1 complexes with β-CD. The strength of the 1:1 
equilibrium constants for PFASs with an eight carbon backbone and different head groups 
with β-CD is as follows: PFOS (sulfonate) > PFOA (carboxylate) > PFOSA 
(sulfonamide) ~ FTS (sulfonate + CH2CH2). The addition of excess β-CD can 
dramatically reduce the amount of free (uncomplexed) PFAS in aqueous media to ~ 
0.5%. The β-CD:PFAS complexes for longer chain PFASs are robust, with the middle 
section of the PFASs contained inside the CD cavity as evidenced by the change in 
chemical shift data and Job plot.  The cross sectional areas and molecular volumes of the 
PFAS chain and the interior of β-CD appear to be ideal for facilitating strong attractive 
van der Waals interactions, resulting in the powerful host-guest complexation observed. 
While the β-CD:PFAS interactions are influenced by ionic strength, pH, and presence of 
humic acid, the changes are relatively small and the 1:1 β-CD:PFAS complex remains 
very strong. The strong β-CD:PFAS complexes are persistent in the presence of 
completing inclusion guests phenol and Ada-COOH. Our results demonstrate β-CD is a 
powerful complexing agent of PFASs under a variety of environmental conditions. β-CD 
can be readily attached to a number of solid and polymeric supports (Crini and Morcellet 
2002, Martin Del Valle 2004, Crini 2005, Faraji et al. 2011, Nagy et al. 2014, Wang et al. 
2014, Liu et al. 2014, Moulahcene et al. 2015, Karoyo and Wilson 2013, Karoyo and 
Wilson 2015, Karoyo and Wilson 2016, Xiao et al. 2017). With further development, the 
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practical application of host-guest chemistry using β-CD-based materials may play a 
critical role for the removal and/or separation science of PFASs. 
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CHAPTER 3 
Host-Guest Interactions between Cyclodextrins and Emerging Perfluoroalkyl Substances 
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3.1 Abstract 
 Legacy perfluoroalkyl substances (PFASs) are known environmental pollutants 
with serious adverse health effects. Perfluoroethercarboxylic acids (PFECAs), emerging 
PFASs now being substituted for legacy PFASs, have recently been detected in the 
environment. Cyclodextrins (CDs) have been proposed as agents for the remediation of 
problematic pollutants, including legacy PFASs. The current study uses 
19
F NMR 
spectroscopy to measure the complexation of mono-, di-, and triether PFECAs by CDs 
for eventual environmental applications. Eight PFECAs were characterized by 
19
F and 
13
C NMR.  The change in chemical shift of individual fluorines upon complexation of 
CDs at various stoichiometric ratios was used to determine the host-guest association 
constants. All studied PFECAs were most strongly encapsulated by β-CD, with 
association constants from 10
2
-10
5
 M
-1
 depending on chain length and number of ether 
functionalities. 
19
F-
1
H Heteronuclear Overhauser Effect Spectroscopy (HOESY) NMR 
experiments were performed for the β-CD complexes of two branched monoethers, 
PFPrOPrA (“GenX”) and PFDMMOBA, to elucidate the structural details of the 
complexes, determine the specific orientation and position of β-CD along the PFAS 
chain, and assess the roles of hydrogen-bonding and PFECA branching on the host-guest 
interactions.  The results give new understanding into the fundamental nature of the host-
guest complex between cyclodextrins and perfluorinated surfactants. 
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3.2 Introduction 
The association constants between the three cyclodextrins and eight commercially 
available PFECAs (including mono-, di-, and triethers) were determined by 
19
F NMR 
spectroscopy. The fundamental host-guest interactions between PFASs and CDs were 
further characterized by extended analyses of two branched monoethers with β-CD. 19F-
1
H Heteronuclear Overhauser Effect Spectroscopy (HOESY) NMR experiments of the 
branched ethers at 1:1 and 2:1 β-CD:PFECA ratios were conducted to determine the 
proximity of the fluorines of the PFECA (guest molecule) and protons of the CD (host 
molecule) in the complex. Furthermore, the HOESY experiment was used to elucidate the 
orientation of β-CD, which has a smaller side with primary hydroxyl groups and a larger 
side with secondary hydroxyl groups, along the PFAS backbone in the CD:PFAS 
complexes. The present study gives valuable information for the design of CD-based 
remediation strategies for legacy and emerging PFASs, as well as fundamental structural 
information and insight into the formation and nature of the host-guest complex. 
 
3.3 Experimental Methods 
 Perfluoro(3-oxabutanoic) acid (PFMOPrA), perfluoro(4-oxapentanoic) acid 
(PFMOBA), perfluoro(5-oxa-6-dimethylhexanoic) acid (PFDMMOBA), perfluoro(3,6-
dioxaheptanoic) acid (PFO2HpA), perfluoro(3,6-dioxadecanoic) acid (PFO2DA), 
perfluoro(3,6,9-trioxadecanoic) acid (PFO3DA), and perfluoro(3,6,9-trioxatridecanoic) 
acid (PFO3TDA) were purchased from SynQuest Labs. Perfluoro(2-methyl-3-
oxahexanoic) acid (PFPrOPrA, “GenX”) was purchased from Alfa Aesar. 
Hexafluorobenzene was purchased from Sigma-Aldrich. α-, β-, and γ-Cyclodextrins were 
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purchased from Acros Organics. Deuterium oxide (99.9% D) was purchased from Sigma-
Aldrich and stored at 4 °C. Sodium deuteroxide (99.5% D, 30% in D2O) was purchased 
from Cambridge Isotope Labs. All chemicals were used without further purification. For 
abbreviations and structures, refer to Appendix 2. 
 
3.3.1 Sample Preparation 
 For the titration experiments, samples were prepared as previously described 
(Chapter 2). The concentration of each PFECA was 2.42 × 10
-3
 M, except for PFO3TDA 
which had a concentration of 6.05 × 10
-4
 M because of possible micelle formation at 
higher concentrations. The solution consisted of 50 % D2O and 50 % DI H2O, adjusted to 
pH 7 with 0.036 M NaOH. Hexafluorobenzene (1.44 × 10
-3
 M) was added as an internal 
standard. Each cyclodextrin (α-, β-, γ-) was added at various stoichiometric ratios and the 
solution was sonicated until dissolution of the CD was achieved. For the 
19
F-
13
C gHMBC 
experiments, 18 μL of each PFECA was dissolved in 700 μL of CDCl3. For the 
19
F-
1
H 
HOESY experiments, samples were prepared of 0.100 M β-CD in D2O with NaOD added 
to aid dissolution. Either PFDMMOBA or PFPrOPrA (0.100 or 0.050 M) was added to 
make the 1:1 and 2:1 β-CD:PFECA ratios.  
 
3.3.2 
19
F and 
13
C NMR Spectroscopy 
 
19
F NMR spectroscopy was performed with a 400 MHz Bruker instrument with a 
quad probe (operating at 376.498 MHz for 
19
F). Hexafluorobenzene was used as the 
internal standard with a chemical shift of -164.9 ppm. For the titration experiments, the 
chemical shift of each peak was recorded, and the 1:1 and 2:1 association constants were 
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calculated in GraphPad Prism (version 5.03, La Jolla, CA) and Mathworks Matlab 
(version R2013b, Natick, MA) by Ramos Cabrer, et al.’s method (Chapter 1) (1999). 
 
19
F-
13
C gradient Heteronuclear Multiple Bond Coherence (gHMBC) NMR 
spectroscopy was performed on a 500 MHz Varian Inova spectrometer equipped with a 3 
r.f. channel console.  1D 
13
C NMR spectra of PFASs would require application of 
19
F 
decoupling over a large frequency band (about 70 ppm, or 33 kHz). Instead, the 
13
C NMR 
chemical shifts were obtained using 2D 
19
F-
13
C gHMBC experiments as an indirect 
method, which require less decoupling as well as providing a 27-fold increase in signal to 
noise compared to conventional 
13
C NMR spectra. 
19
F-
13
C gHMBC spectra were 
recorded in less than an hour. The 
19
F spectra were run on a spectral window from -40 to 
-140 ppm, in 4 transients, with a 90 ° pulse (5.3 μs), a relaxation delay of 1 s and an 
acquisition time of 3 s. The gHMBC spectrum was run on a minimal spectral window in 
f2 in 8k points. The spectral window in f1 was from 90 to 170 ppm, and 256 increments 
were used, each in 4 transients and with a relaxation delay of 1 s. The FIDs were 
weighted in f2 with a Gaussian function of 0.1 s shifted 0.08 s and in f1 with a Gaussian 
of 0.1 s. The polarization transfer delay was 16.7 ms, corresponding to a coupling 
constant of 30 Hz, which yielded cross-peaks for couplings over one bond (easily 
identified by their splitting of ~ 280 Hz) and couplings over two bonds. 
 
3.3.3 
19
F-
1
H HOESY NMR Spectroscopy 
 The NMR spectra for the HOESY experiments were run on a Varian Inova 
spectrometer, operating at 500 MHz for 
1
H, equipped with a 3 r.f. channel console, at 25 
°C. The probe was a 5 mm probe with two channels, 1H and 19F, connected to channels 1 
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and 3 in the console, correspondingly. 
1
H and 
19
F chemical shifts were referenced on the 
TMS and CFCl3 scales. 
The 
1
H NMR spectra were run on a spectral window from -0.5 to 9.5 ppm, in 1 
transient, with a 90 ° pulse (19 μs), a relaxation delay of 1 s and an acquisition time of 3.2 
s. The 
19
F spectra were run on a spectral window from -60 to -170 ppm, in 16 transients, 
with a 90 ° pulse (12 μs), a relaxation delay of 1 s and an acquisition time of 0.63 s. The 
HOESY spectrum was run with observation of 
19
F and a mixing time of 50 ms for 
PFDMMOBA and 100 ms for PFPrOPrA, on a spectral window from -170 to -60 ppm 
and 16k points in f2. The spectral window in f1 was from 3 to 5 ppm for PFDMMOBA 
and 3 to 4 ppm for PFPrOPrA, and 128 increments were used, with a total experiment 
time of 20 hrs for the 2:1 ratios and 5 hrs for the 1:1 ratios. 
 
3.4 Results and Discussion 
 The PFECA structures were numbered according to the position of the fluorine 
atoms (see Appendix 2), with “F2” referring to the fluorines on the carbon next to the 
carboxylate head group. Chain length is defined as the longest continuous chain of 
carbons and oxygens starting at the carbonyl carbon (does not include branching). The 
PFECAs are divided into short chain (chain length < 7) and long chain (chain length ≥ 7). 
In this report we will refer to PFECAs with “high oxygen content” (HOC) and “low 
oxygen content” (LOC). These designations refer to the ratio of oxygen atoms to chain 
length. An HOC PFECA is defined as an PFECA with a oxygen:chain length ratio of 0.5 
or greater (including the carboxylate oxygens), and a LOC PFECA has an oxygen:chain 
length ratio less than 0.5 (for HOC and LOC designations, refer to Appendix 2). 
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3.4.1 Assignment of the PFECA 
19
F NMR Spectra  
 Assignments of individual fluorine peaks of the eight studied PFECAs, as shown 
in Figure 3.1, were determined by chemical shift, splitting pattern, integration, peak 
broadening, and comparison with 
19
F NMR spectra of legacy PFASs. Assignments were 
confirmed by the 
19
F-
13
C gHMBC experiments. 
19
F and 
13
C NMR chemical shifts are 
displayed in Figure 3.1 (for detailed coupling constants and splitting patterns of 
19
F NMR 
peaks, refer to Appendix 2). Seven general types of fluorine peaks were observed and 
assigned to specific structures, with consistent chemical shifts regardless of chain length 
and number of oxygens, as shown in Table 3.1. The fluorine peaks shifted more 
downfield when adjacent to an oxygen atom and more upfield when surrounded by 
fluoromethylene subunits (with similar chemical shifts to legacy PFASs) (Guo et al. 
1992, Wilson and Verrall 1998a). Downfield chemical shifts are correlated to decreased 
shielding, whereas upfield chemical shifts are correlated to increased shielding. The 
presence of the ether oxygen leads to deshielding of the adjacent fluorines, causing their 
chemical shift to be shifted downfield compared to what is expected from a legacy PFAS. 
The splitting patterns were also examined. Through-space coupling, instead of through-
bond coupling, is characteristic for saturated perfluorinated molecules (Petrakis and 
Sederholm 1961).
 
Fluorines that are four bonds apart are closer in space than fluorines 
three bonds apart in PFAS structures (refer to the structures included in Figure 3.1). Thus, 
in general, four bond coupling constants were observed (
4
JF-F ≈ 8-11 Hz), but not three 
bond coupling constants (
3
JF-F ≈ 0-3 Hz). The HOC PFECAs generally had sharper peaks 
and a more defined splitting pattern than LOC PFECAs due to the oxygen linkages 
extending the distance between fluorine atoms, and thus decreasing the amount and 
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strength of coupling interactions along the fluorinated backbone. Peak broadening was 
observed for longer chain PFECAs, especially LOC PFECAs, in the middle of the chain, 
due to the complex splitting pattern arising from the number and variety of other 
fluorines within coupling proximity.  
 
 
Figure 3.1: 
19
F and 
13
C NMR chemical shifts of the studied PFECAs. The 
19
F NMR 
chemical shifts (in D2O; referenced to hexafluorobenzene) are listed first; the 
13
C NMR 
chemical shifts (in CDCl3; referenced to CDCl3) are listed second in parentheses. 
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Table 3.1: Chemical shifts of PFECA 
19
F NMR peaks
a
 
Structure 
(peak in bold) 
Chemical shift, ppm 
-OOC-CF2-O- -79 
-OOC-CF2-CF2- -119 – -122 
-O-CF2-CF2-O- -90 – -92 
-O-CF2-CF2-CF2- -83 – -87 
-O-CF2-CF2-CF2- -128 – -129 
-CF2-O-CF3 -57 
-CF2-CF2-CF3 -82 – -83 
a Referenced to hexafluorobenzene (-164.9 ppm) 
 
3.4.2 Association Constants of PFECAs with α-, β-, and γ-Cyclodextrin 
 The 
19
F NMR spectrum of each PFECA was monitored as a function of CD 
concentration. The individual CD:PFECA association constants were determined via non-
linear least-squares regression analysis of the change in observed chemical shift (Ramos 
Cabrer et al. 1999). The association constants determined for individual fluorines were 
then averaged to find the average association constant for each PFECA with each CD. 
The results are shown in Table 3.2 (for 
19
F NMR spectra, non-linear regression plots, and 
individual association constants, see Appendix 2).  
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Table 3.2: Average association constants of emerging PFASs with α-, β-, and γ-CDs 
PFAS (chain length), 
oxygen content 
α-CD (M-1) β-CD (M-1) γ-CD (M-1) 
PFMOPrA (5), HOC 2.60 ± 1.14 × 10
1
 1.54 ± 0.52 × 10
2
 
no significant 
association 
PFMOBA (6), HOC 3.37 ±  1.40 × 10
1
 1.48 ± 0.36 × 10
3
 
no significant 
association 
PFPrOPrA (6), HOC 2.36 ± 1.10 × 10
2
 7.45 ± 4.27 × 10
2
 
no significant 
association 
PFDMMOBA (7), LOC 
no significant 
association 
2.66 ± 0.61 × 10
4
 6.85 ± 1.82 × 10
2
 
PFO2HpA (7), HOC 5.34 ± 0.48 × 10
1
 
4.74 ± 2.04 × 10
2 
(1:1) 
3.87 ± 1.40 × 10
2
 
(2:1) 
8.43 ± 3.24 × 10
1
 
PFO2DA (10), LOC 
no significant 
association 
1.38 ± 0.40 × 10
4
 
(1:1) 
7.72 ± 2.43 × 10
3
 
(2:1) 
1.39 ± 0.38 × 10
3
 
PFO3DA (10), HOC 9.28 ± 2.80 × 10
1
 
3.03 ± 1.09 × 10
3
 
(1:1) 
4.12 ± 1.08 × 10
3
 
(2:1) 
7.60 ± 2.10 × 10
2
 
PFO3TDA (13), LOC 
no significant 
association 
5.93 ± 1.20 × 10
5
 
(1:1) 
1.36 ± 0.28 × 10
5
 
(2:1) 
3.48 ± 1.50 × 10
3
 
 
 The CD association constants with PFECAs did not have a direct relationship 
with chain length as observed with legacy PFASs (Chapter 2, Wilson and Verrall 1998a). 
Instead, the magnitude of association appears to depend on a number of factors, including 
oxygen content and branching. For α-CD, weak association constants are observed for the 
short chain PFECAs (chain length < 7). For long chain PFECAs (chain length ≥ 7), HOC 
PFO2HpA and PFO3DA show association with α-CD at the terminal –CF2OCF3 group, 
whereas the long chain LOC PFECAs, with a continuous chain of perfluorinated carbons 
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at the tail, exhibited no significant association with α-CD. The cross-sectional area of the 
α-CD cavity cannot fit the PFAS chain (cross-section of 18.9 Å2 for α-CD cavity and 
28.3 Å2 for PFASs) (Lo Nostro et al. 2003), leading to the weak or non-existent 
complexation (on the order of 10
1
-10
2
 M
-1
) with the studied PFECAs that may be 
attributed to association besides host-guest (i.e., aggregate formation). For γ-CD, 
moderate association constants (on the order of 10
2
-10
3
 M
-1
) were observed for the long 
chain PFECAs. LOC PFECAs had stronger association with γ-CD when compared to 
HOC PFECAs of the same chain length (for example, PFO2DA vs. PFO3DA). The cross-
section size of γ-CD (49.0 Å2) is larger than necessary to accommodate PFASs, resulting 
in weaker host-guest interactions (Lo Nostro et al. 2003). Since –CF2– groups have a 
larger van der Waals radius than oxygen, the PFECAs with more fluorinated carbons 
(LOC) will have more favorable interactions with the γ-CD cavity than HOC PFECAs. 
Short chain PFECAs are too small in comparison to the γ-CD cavity to exhibit attractive 
molecular interactions leading to relatively insignificant host-guest interactions observed. 
 β-CD exhibited the strongest interactions with all studied PFECAs. Stronger 
association constants were observed for longer chain PFECAs and LOC PFECAs when 
compared with shorter chain PFECAs and HOC PFECAs respectively. β-CD has the 
ideal cavity cross-section (30.2 Å2) to accommodate linear perfluorinated carbon chains 
as guests, resulting in strong van der Waals interactions between the fluorinated chain 
and β-CD cavity (Lo Nostro et al. 2003). Oxygen, which has a smaller van der Waals 
radius than –CF2–, does not fit tightly within the β-CD cavity, thus weakening the 
interactions promoting complexation between the PFECA and β-CD. The 1:1 β-
CD:PFECA association constants are affected by chain length and oxygen content. Long 
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chain PFECAs (except PFDMMOBA) also form stable 2:1 β-CD:PFECA complexes, like 
those described for legacy PFASs (Chapter 2, Wilson and Verrall 1998a). The 2:1 β-
CD:PFECA association constants increase with chain length with the strongest 
association observed for the longest chain PFECA (PFO3TDA), suggesting that chain 
length is the most important factor in determining the strength of the 2:1 CD:PFAS 
complex. 
 The β-CD:PFECA and β-CD:legacy perfluorocarboxylic acid association 
constants are compared in Table 3.3. The comparison was made between compounds 
with the same chain length, defined as the longest continuous chain of atoms from the 
head group, not number of carbons. The PFECAs have weaker complexation with β-CD 
than the corresponding legacy PFAS (including perfluoropentanoic acid, PFPA; 
perfluorohexanoic acid, PFHxA; perfluoroheptanoic acid, PFHpA; and perfluorodecanoic 
acid, PFDA) of the same chain length. Generally, for each ether oxygen substituted for 
carbon in the PFAS chain, the association constant decreased by an order of magnitude. 
These results demonstrate that ether functionalities have weaker complexation with β-CD 
than the fluorinated carbon chain, and thus weaken the overall association. The interior of 
the cyclodextrin cavity is hydrophobic, and thus strongly associates with the hydrophobic 
fluorinated chain while having weak or nonexistent interactions with the smaller, more 
polar oxygens in the ether functionalities. LOC PFECAs not only have fewer ether 
oxygens per chain length, but also have longer sections of a continuous fluorinated 
carbon chain, facilitating strong association of β-CD with the fluorine-rich section of the 
chain.  
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Table 3.3: β-CD:PFECA association constants compared with β-CD:legacy PFASs 
Chain 
length 
Legacy 
PFAS 
Association 
constant (M-1) 
Emerging 
PFAS 
Association 
constant (M-1) 
Decrease 
(1:1) 
5 PFPAa 7.60 +/- 0.44 x 102 PFMOPrA 1.54 +/- 0.52 x 102 < 10 
6 PFHxAb 2.35 +/- 0.46 x 104 
PFMOBA 1.48 +/- 0.36 x 103 ~10 
PFPrOPrA 7.45 +/- 4.27 x 102 ~100 
7 PFHpAa 
4.30 +/- 0.85 x 105 
(1:1) 
2.30 +/- 0.27 x 103 
(2:1) 
PFDMMOBA 2.66 +/- 0.61 x 104 ~10 
PFO2HpA 
4.74 +/- 2.04 x 102 
(1:1) 
3.87 +/- 1.40 x 102 
(2:1) 
~1000 
10 PFDAc 
~105 (1:1) 
~103 (2:1) 
PFO2DA 
1.38 +/- 0.40 x 104 
(1:1) 
7.72 +/- 2.43 x 103 
(2:1) 
~10 
PFO3DA 
3.03 +/- 1.09 x 103 
(1:1) 
4.12 +/- 1.08 x 103 
(2:1) 
~100 
Legacy PFAS association constants from: a Chapter 2, b Wilson and Verrall 1998a, and c 
estimated based on association constants from PFOA and PFNA in Chapter 2 
 
The effects of branching on the association constants were investigated in more 
detail with two branched monoethers, PFPrOPrA and PFDMMOBA. Both have segments 
of three fluorinated carbons, which should lead to favorable CD encapsulation (Chapter 
2). For PFPrOPrA, branching occurs adjacent to the carboxylate head group, whereas for 
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PFDMMOBA, branching occurs after the ether near the tail (forming a fluorinated 
isopropyl group tail). β-CD displays much stronger complexation (~ 40 ×) with 
PFDMMOBA than PFPrOPrA. The position of branching has a dramatic effect on the 
strength of β-CD encapsulation, with branching near the tail leading to stronger host-
guest complexation than branching near the head.  
This result can be explained when taking into account the association constant of 
β-CD with linear PFMOBA. PFMOBA, with K = 1.48 × 103 M-1, has a –CF2CF2CF2– 
segment attached to the carboxylate group and a perfluoromethyl ether as the tail section, 
an analogous structure to PFDMMOBA. In comparison, PFPrOPrA has an association 
constant of 7.45 × 10
2
 M
-1
, and PFDMMOBA has an association constant of 2.66 × 10
4
 
M
-1
, with β-CD. All three compounds contain a –CF2CF2CF2– segment, and they are 
pictured in Figure 3.2 along with their 1:1 β-CD:PFECA association constants. From our 
previous work we have found that β-CD has a strong preference for association with the  
–CF2CF2CF2– segment, due to van der Waals interactions between the guest molecule 
and host cavity, and the molecular sizes of the PFASs and β-CD (Chapter 2). The 
measured association constants of the three ether compounds, however, indicate that 
other factors are also important in the host-guest interactions.   
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Figure 3.2: Structures of PFPrOPrA, PFMOBA, and PFDMMOBA, along with the 1:1 β-
CD:PFECA association constants. Blue highlights the linear three carbon segment ideal 
for β-CD:PFAS interactions; red highlights branched portions of the molecule. 
 
 One major difference between these three compounds is the presence and 
placement of branched structures. The trifluoromethyl group (–CF3) has an effective size 
between that of a hydrogenated isopropyl and tert-butyl group; thus, a fluorinated 
isopropyl group would be larger than a hydrogenated tert-butyl group (approximately the 
size of –CBr3) (Dawson et al. 1980, Hughes et al. 2000, Krafft et al. 2009). Since the 
linear PFAS has a virtually perfect fit with the β-CD cavity, and the effective sizes of 
fluorinated functional groups are larger than their hydrocarbon counterparts, branching 
renders fluorocarbons too large to fit within the cavity. With this in mind, β-CD can only 
encapsulate the linear perfluorinated carbon chains and cannot accommodate the 
branched portion of the PFAS within the β-CD cavity. β-CD can thread over the tail, but 
not the branched head, of PFPrOPrA; the tail or the head of PFMOBA; and the head, but 
not the branched tail, of PFDMMOBA. 
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 In addition to the effect of branching on encapsulation within the CD cavity, 
branching can also influence hydrogen-bonding between the host and guest. The 
carboxylate of linear perfluorocarboxylic acids, similar to other guest molecules 
containing a carboxylate, can hydrogen-bond to the hydroxyl groups lining the perimeter 
of the β-CD cavity (Saenger and Steiner 1998, Lipkowitz 1998, Takahashi 1998, Wagner 
2012). The β-CD hydroxyls can be within a favorable distance for hydrogen-bonding to 
the carboxylate of both PFMOBA and PFDMMOBA, as the –CF2CF2CF2– segment that 
the CD will encapsulate is next to the carboxylate group. The branched portion of 
PFPrOPrA, however, prevents β-CD from moving along the fluorinated chain to be close 
enough to interact with the carboxylate head group. In contrast, the branched portion of 
PFDMMOBA prevents β-CD from sliding towards the tail end of the fluorinated chain, 
keeping the CD close enough to hydrogen-bond with the carboxylate. PFMOBA had no 
branching, and so although it can hydrogen-bond with β-CD, β-CD can still freely move 
along the PFMOBA chain, decreasing the chances of the hydrogen-bonding interactions.   
The association constant of PFMOBA is greater than PFPrOPrA due to hydrogen-
bonding, and the association constant of PFDMMOBA is greater than PFMOBA due to 
hindered movement of the CD along the tail end of chain. From these results it appears 
that the strength of CD:PFAS interactions is determined not only by hydrophobic 
interactions between the fluorinated chain and CD cavity, but also by hydrogen-bonding 
between the PFAS carboxylate and the hydroxyl groups along the CD perimeter. 
Branching close to the polar head group inhibits this hydrogen-bonding, while branching 
at the tail enhances association by stabilizing the complex. These results suggest that it is 
favorable for the carboxylate to thread through the CD cavity (as would be necessary in 
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the case of PFDMMOBA), even though this would cause the hydrophilic and anionic 
carboxylate to be in close proximity to the hydrophobic CD cavity and removed from the 
bulk aqueous solution. Previous studies of carboxylate-CD interactions, however, support 
our conclusions, by providing evidence of carboxylate inclusion in the CD cavity 
(Bergeron et al. 1977, Bergeron et al. 1978, Simova and Schneider 2000, Liu et al. 2001, 
Wang and Chen 2011, Saha et al. 2016). For example, α,ω-alkyl dicarboxylates have 
similar association constants with α-CD as their corresponding monocarboxylates 
(Watanbe et al. 1992, Wilson and Verrall 1998b, Wilson and Verrall 2000), suggesting 
that other factors, such as van der Waals interactions between the CD cavity and 
hydrophobic chain (either hydrogenated or fluorinated), are more important than the 
inclusion or threading of the hydrophilic moiety in or through the CD cavity for favorable 
host-guest complexation. The measured association constants of the PFECAs suggest that 
the carboxylate threading through the CD cavity has little effect on the host-guest 
complexation (as evidenced by the strong association between β-CD and PFDMMOBA, 
where this threading is required for inclusion). Instead, van der Waals interactions, 
hydrogen-bonding, and physical structure (branching vs. linear) of the PFECA are critical 
factors for strong encapsulation. 
 
3.4.3 Structural Characterization of the CD:PFAS Complex  
 To further probe the structural details of the β-CD:PFECA complexes, and PFASs 
in general, 
19
F-
1
H Heteronuclear Overhauser Effect Spectroscopy (HOESY) NMR 
experiments were conducted (Battiste 2006). In HOESY NMR experiments, through-
space nuclear Overhauser effects (NOEs) are observed between different nuclei. HOESY 
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signals are observed as a function of the distance between the nuclear spins of the 
fluorines on the PFAS (guest) and the protons on the CD (host). The intensity of the 
HOESY signal increases non-linearly with decreasing distance (1/r
6
) between individual 
fluorines and protons. 
19
F-
1H HOESY experiments were conducted on the β-CD:PFECA 
mixtures to determine the relative positon of fluorine atoms on the PFECA guest to the 
protons on the β-CD host.  
 The structure of β-CD is shown in Chapter 1 (Figure 1.2). H1, H2, and H4 extend 
to the outside of the CD, whereas H3 and H5 point towards the interior of the CD cavity. 
H6 are the methylene protons attached to the primary hydroxyl groups lining the smaller 
opening of the CD. Thus, NOEs between interior protons H3 and H5 and the perimeter 
protons H6 with the fluorines on the PFECA backbone contained within the CD interior 
are expected to be observed for the host-guest inclusion complex. The exterior protons 
(H1, H2, and H4) are not expected to exhibit any NOE with the PFECA fluorines. 
Furthermore, cyclodextrins are not cylinders, but truncated cones, having a smaller end 
and a larger end. The smaller side is lined with seven primary hydroxyl groups and the 
larger side is lined with fourteen secondary hydroxyl groups. H6 and H5 are closer to the 
smaller opening and H3 is closer to the larger opening. Thus, the orientation of the CD in 
the host-guest complex can be elucidated from the HOESY signals or crosspeaks of the 
fluorines along the backbone with H3, H5, and H6. The specific orientation of the CD 
relative to the head and tail of PFASs in solution has previously not been confirmed (Guo 
et al. 1992, Wilson and Verrall 1998a, Karoyo et al. 2011, Karoyo et al. 2013, Karoyo et 
al. 2015). The 
19
F-
1H HOESY spectra of both 1:1 and 2:1 β-CD:PFECA ratios of 
PFDMMOBA and PFPrOPrA were analyzed.  
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The HOESY results are visualized by the proton slices across f1 at the f2 
frequencies of the fluorine signals. For the β-CD:PFDMMOBA complex, all fluorines 
display crosspeaks with H3, H5 and H6 of the cyclodextrin, confirming the existence of 
the host-guest inclusion complex, as shown in Figure 3.3. No NOEs were observed 
between any of the fluorines and H1, H2, or H4. The intensities of the proton crosspeaks 
vary depending on the position of the fluorines, indicating relative distances. For the 
spectral slice of the 2D crosspeaks at F2, F3, and F4, H5 and H6 are dominant, whereas 
for the crosspeaks at F6 and F7, H3 is most intense. These results clearly show that the 
smaller opening of the cyclodextrin, with the primary hydroxyl groups, is facing the 
carboxylate head of PFDMMOBA, while the larger opening of the cyclodextrin, with the 
secondary hydroxyl groups, is facing the tail end of the PFECA, as shown in Figure 3.3. 
The NOE patterns for the 1:1 and 2:1 β-CD:PFDMMOBA ratios are the same, 
confirming that only a 1:1 complex is formed as concluded from the titration studies.  
 
Figure 3.3: 
19
F-
1H HOESY of β-CD:PFDMMOBA complex. The proton slices for each 
fluorine peak are shown. The host-guest structure is elucidated from the NOEs observed 
between each fluorine and proton. H3 is a triplet; H5 is a doublet; H6 is a broad singlet. 
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Likewise, all the fluorines of PFPrOPrA display crosspeaks with H3, H5, and H6 
in the β-CD:PFPrOPrA complex, as pictured in Figure 3.4. Again, no crosspeaks were 
observed between any fluorine and H1, H2, or H4. For the slices at F2 and F3, H5 and H6 
are dominant; for F5, H5 is most intense; and for F6 and F7, H3 is dominant. Again, the 
cyclodextrin is oriented with the primary hydroxyl groups facing the carboxylate, 
pictured in Figure 3.4. Only a 1:1 complex appears to be formed due to the same NOE 
pattern for both the 1:1 and 2:1 β-CD:PFPrOPrA ratios, confirming the results from the 
titration experiments.  
 
 
Figure 3.4: 
19
F-
1H HOESY of β-CD:PFPrOPrA complex. The proton slices for each 
fluorine peak are shown. The host-guest structure is elucidated from the NOEs observed 
between each fluorine and proton. H3 is a triplet; H5 is a doublet; H6 is a broad singlet. 
 
It is clear from the HOESY spectra that the primary hydroxyl groups are oriented 
towards the PFAS carboxylate in the CD:PFAS host-guest complex, regardless of 
branching, suggesting an optimal geometry for the CD:PFAS complex. The primary 
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hydroxyl groups are less sterically hindered and have more freedom of rotation than the 
secondary hydroxyl groups, which may make it more favorable for hydrogen-bonding 
between the primary hydroxyl groups of the CD and the carboxylate of the PFAS. 
Furthermore, the primary hydroxyl groups are further away from the bulk of the CD 
cavity, which would allow adequate separation of the PFAS chain-CD cavity interactions 
and the PFAS carboxylate-CD hydroxyl group interactions. These results support the 
conclusion that PFPrOPrA forms a weaker host-guest complex than PFDMMOBA with 
β-CD because of hindered hydrogen-bonding with the carboxylate due to the branched 
structure. Threading of the carboxylate through the CD cavity is also supported by the 
confirmed inclusion of PFDMMOBA by β-CD. Finally, the molecular sizes of PFASs, 
combined with the HOESY results, suggest that PFASs can enter the β-CD cavity by both 
the head and tail ends, as long as the primary hydroxyl side is facing the head group.  
 
3.5 Conclusions 
 The host-guest inclusion complexes between three cyclodextrins and eight 
emerging perfluoroethercarboxylic acids were examined via 1D and 2D 
19
F NMR 
spectroscopy. β-CD formed the strongest complexes with all studied PFECAs, while 
moderate interactions with γ-CD and weak interactions with α-CD were observed 
depending on PFECA chain length and the number of oxygens. Increasing number of 
ether oxygens per chain length lead to decreased 1:1 association constants with β-CD, 
with each additional oxygen corresponding to an order of magnitude decrease in 
association constant compared with legacy PFASs. 2:1 β-CD:PFECA association 
constants, however, appear to be mainly dependent on chain length. 
19
F-
1
H HOESY 
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NMR experiments of two branched monoethers gave two insights into the structure of the 
host-guest complex: 1) the small side of the CD (primary hydroxyl) faces the carboxylate 
in perfluorocarboxylic acids and 2) hydrogen-bonding plays an important role in the 
strength of the CD:PFAS host-guest interactions. Thus, 1:1 β-CD:PFAS association is 
affected by hydrophobic (van der Waals interactions between perfluorinated chain and 
CD cavity) and hydrophilic interactions (hydrogen-bonding between PFAS polar head 
group and CD primary hydroxyl groups), while 2:1 association is only dependent on 
hydrophobic interactions (chain length). Knowing the orientation of the CD in the 
complex as well as the intermolecular forces responsible for 1:1 and 2:1 β-CD:PFAS 
host-guest interactions will allow for the design of CD-based polymers or solid-support 
materials that are well-suited for CD:PFAS complexation. 
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CHAPTER 4 
Host-Guest Interactions between β-Cyclodextrin Derivatives and Short Chain 
Perfluoroalkyl Substances 
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4.1 Abstract 
Short chain perfluoroalkyl substances (PFASs) are being more widely used due to 
known negative health and environmental effects of long chain legacy PFASs such as 
perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS). However, the 
transport and persistence of short chain PFASs (whether fully fluorinated or with an ether 
functionality) is on par with legacy long chain PFASs, and preliminary tests suggest they 
have similar toxic effects. Previous tests with cyclodextrins (CDs) have been mixed, with 
association constants on the order of 10
1
 – 103 M-1 with β-CD (compared with PFOA and 
PFOS with association constants on the order of 10
5
 M
-1
). These association constants are 
on the same order of magnitude as most other organic pollutants, making β-CD not 
selective enough for emerging short chain PFASs to be useful for remediation purposes. 
Modifications to β-CD could increase this selectivity by increasing the association 
constant. In this study we have conducted 
19
F NMR titration experiments to determine the 
association constants of various β-CD derivatives with short chain PFASs. Positively 
charged β-CD derivatives were chosen for their potential ionic interactions with 
negatively charged PFASs as well as their commercial availability. A negatively charged 
derivative was also chosen for comparison. Addition of positively charged groups on β-
CD generally increased the association constants compared to the complex formed with 
native β-CD. The results give further understanding to the nature of the CD:PFAS host-
guest complex and the various intermolecular forces that drive encapsulation. 
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4.2 Introduction 
In this study, NMR titration experiments have been conducted to determine the 
association constants of various β-CD derivatives with short chain PFASs, as well as to 
further elucidate the nature of the host-guest complex. Positively charged β-CD 
derivatives have been chosen for their potential ionic interactions with negatively charged 
PFASs. A negatively charged β-CD derivative has also been chosen for comparison.  
 
4.3 Experimental Methods 
Perfluorobutanoic acid (PFBA), perfluoropentanoic acid (PFPA), and 
hexafluorobenzene were purchased from Sigma-Aldrich. Perfluoro(3-oxabutanoic) acid 
(PFMOPrA), perfluoro(4-oxapentanoic) acid (PFMOBA), and perfluoro(5-oxa-6-
dimethylhexanoic) acid (PFDMMOBA) were purchased from SynQuest Labs. 
Perfluoro(2-methyl-3-oxahexanoic) acid (PFPrOPrA, “GenX”) was purchased from Alfa 
Aesar. 6-Monodeoxy-6-monoamino-β-cyclodextrin hydrochloride (mono-am-β-CD), 
heptakis(6-deoxy-6-amino)-β-cyclodextrin heptahydrochloride (hepta-am-β-CD), (2-
hydroxy-3-N,N,N-trimethylamino)propyl-β-cyclodextrin chloride (QACD; degree of 
substitution ~ 3-4), and sulfobutylated β-cyclodextrin sodium salt (SBECD; degree of 
substitution ~ 6.5) were purchased from Cyclolab Ltd (see Appendix 3 for structures). 
Deuterium oxide (99.9% D) was purchased from Sigma-Aldrich and stored at 4 °C. All 
chemicals were used without further purification. 
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4.3.1 Sample Preparation 
For the titration experiments, samples were prepared as previously described 
(Chapter 2). The concentration of each PFAS was 2.42 × 10
-3
 M. The solution consisted 
of 50 % D2O and 50 % DI H2O, adjusted to pH 7 with 0.036 M NaOH. 
Hexafluorobenzene (1.44 × 10
-3
 M) was added as an internal standard. Each cyclodextrin 
was added at various stoichiometric ratios and the solution was sonicated for one minute 
to ensure dissolution of the compounds. 
 
4.3.2 
19
F NMR Spectroscopy 
 
19
F NMR spectroscopy was performed with a 400 MHz Bruker instrument with a 
quad probe (operating at 376.498 MHz for 
19
F). Hexafluorobenzene was used as the 
internal standard with a chemical shift of -164.9 ppm. For the titration experiments, the 
chemical shift of each peak was recorded, and the 1:1 CD:PFAS association constants 
were calculated in GraphPad Prism (version 5.03, La Jolla, CA) and Mathworks Matlab 
(version R2013b, Natick, MA) by Ramos Cabrer, et al.’s method (Chapter 1) (1999). 
 
4.4 Results and Discussion 
 The chemical shift of the peaks corresponding to each fluorine changed as a 
function of CD concentration (refer to Appendix 3). This change in chemical shift was 
monitored and used to calculate the individual association constants of each fluorine with 
the CD. The average of these individual association constants is reported in Table 4.1 for 
each short chain PFAS with each β-CD derivative, along with the association constants 
for native β-CD calculated in previous studies (Chapters 2 and 3). 
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Table 4.1: Average association constants of short chain PFASs with β-CD derivatives 
PFAS β-CD (M-1) 
Mono-am-β-
CD (M-1) 
Hepta-am-
β-CD (M-1) 
QACD  
(M-1) 
SBECD  
(M-1) 
PFBA 
2.90 ± 0.24 × 
102  a 
2.16 ± 1.04 
× 102 
1.02 ± 0.40 
× 103 
1.46 ± 0.31 
× 102 
No 
significant 
association 
PFPA 
7.60 ± 0.44 × 
102  a 
1.01 ± 0.61 
× 103 
2.62 ± 0.79 
× 103 
6.68 ± 3.41 
× 102 
1.07 ± 0.18 
× 102 
PFMOPrA 
1.54 ± 0.52 × 
102  b 
6.39 ± 1.06 
× 102 
3.06 ± 1.33 
× 103 
6.92 ± 1.56 
× 102 
No 
significant 
association 
PFMOBA 
1.48 ± 0.36 × 
103  b 
1.76 ± 1.02 
× 103 
4.56 ± 1.22 
× 103 
3.29 ± 0.63 
× 103 
9.68 ± 2.29 
× 101 
PFPrOPrA 
7.45 ± 4.27 × 
102  b 
1.55 ± 0.62 
× 104 
1.86 ± 1.13 
× 103 
4.43 ± 1.66 
× 102 
3.70 ± 2.32 
× 102 
PFDMMOBA 
2.66 ± 0.61 × 
104  b 
2.75 ± 0.39 
× 104 
2.12 ± 0.49 
× 105 
2.02 ± 0.57 
× 105 
6.49 ± 2.79 
× 103 
a: From Chapter 2; b: from Chapter 3 
 
 General trends were observed for each β-CD derivative. For the negatively 
charged SBECD, the association constant decreased compared to native β-CD, with the 
shortest chain PFASs studied (PFBA and PFMOPrA) experiencing no significant 
association. All studied PFASs are expected to be negatively charged under the 
experimental conditions (long chain PFASs have pKas of approximately 0) (Goss 2008), 
and thus they are repulsed by SBECD, leading to weaker complexation than neutral β-
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CD. For the three positively charged β-CD derivatives (mono-am-β-CD, hepta-am-β-CD, 
and QACD), complexation with the short chain PFASs generally increased compared to 
neutral β-CD, due to the electrostatic attraction between the positively charged β-CD 
derivative and the negatively charged PFAS. For QACD, the legacy PFASs (PFBA and 
PFPA) and PFPrOPrA (GenX) experience slightly decreased association, whereas the 
ether PFASs besides PFPrOPrA (PFMOPrA, PFMOBA, and PFDMMOBA) experience 
increased association. For mono-am-β-CD, the complexation remained similar to β-CD 
for PFBA, PFMOBA, and PFDMMOBA, and increased for PFPA, PFMOPrA, and 
PFPrOPrA. Finally, for hepta-am-β-CD, the association constant increased for all studied 
short chain PFASs compared with the association constant with β-CD. 
 Our previous studies (Chapters 2 and 3) have elucidated the major factors causing 
the favorable encapsulation of PFASs by β-CD. PFASs have strong interactions with β-
CD due to the cross-sectional sizes of the PFASs and β-CD (28.3 and 30.2 Å2, 
respectively), leading to favorable van der Waals forces between the PFAS fluorinated 
chain and the β-CD cavity (Lo Nostro et al. 2003). These hydrophobic interactions 
dominate the host-guest complex: legacy PFASs have stronger interactions with β-CD 
than PFECAs, which have ether oxygen moieties interspersed throughout the fluorinated 
chain, disrupting the van der Waals forces. Secondary to the hydrophobic interactions is 
the hydrogen-bonding interactions between the PFAS head group (carboxylate, sulfonate, 
etc.) and the primary hydroxyl groups lining the perimeter of the small side of the β-CD 
cavity. When this hydrogen-bonding is prevented (as in the case of the β-CD:PFPrOPrA 
complex, due to branching of the PFAS next to the carboxylate), encapsulation is 
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weakened; when it is forced (as in the case of the β-CD:PFDMMOBA complex, due to 
branching of the PFAS at the tail), encapsulation is strengthened.   
 The calculated association constants for the complexes between the β-CD 
derivatives and the short chain PFASs provide additional insight into the nature of 
CD:PFAS host-guest interactions. PFMOPrA, PFPrOPrA, and PFDMMOBA have the 
largest changes in association constants with the positively charged β-CD derivatives, as 
seen in Table 4.2. PFPrOPrA has increased complexation with mono-am-β-CD (20 ×), 
and PFDMMOBA has increased complexation with both QACD (8 ×) and hepta-am-β-
CD (8 ×). PFMOPrA has increased complexation with all three studied positively 
charged β-CD derivatives, especially hepta-am-β-CD (20 ×). 
 
Table 4.2: Increase in β-CD derivative:PFAS association constants compared with β-
CD:PFAS association constants 
PFAS Mono-am-β-CD Hepta-am-β-CD QACD SBECD 
PFBA 0.7 3.5 0.5 0 
PFPA 1.3 3.4 0.9 0.1 
PFMOPrA 4.2 20 4.5 0 
PFMOBA 1.2 3.1 2.2 0.08 
PFPrOPrA 20 2.5 0.6 0.5 
PFDMMOBA 1.0 8.0 8.0 0.2 
 
 Branching in the PFAS structure is an important factor in the strength of 
complexation. PFDMMOBA, branched at the tail, must enter β-CD head first (threading 
the carboxylate through the CD cavity). In native β-CD, once PFDMMOBA has threaded 
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through the cavity, the primary hydroxyl groups will hydrogen-bond with the 
PFDMMOBA carboxylate, locking PFDMMOBA in place. For the mono-am-β-CD 
complex, there is no increase in association constant, suggesting that the complex with β-
CD is already so stable that the presence of a single positive charge does not affect the 
strength of complexation. For the hepta-am-β-CD complex, the presence of seven 
positive charges, however, does have an effect on the complexation, and increases the 
association constant relative to the β-CD complex by 8 × (about an order of magnitude). 
Thus, multiple positives charges can strengthen the complex, whereas the presence of one 
positive charge has roughly the same effect as the hydrogen-bonding interactions. 
Furthermore, the QACD:PFDMMOBA association constant is also 8 × stronger than the 
β-CD complex. The QACD has a propyl linker between the CD cavity and the quaternary 
amine group (compared with mono-am-β-CD or hepta-am-β-CD which have methylene 
linkers). The increased length of the linker may allow this side chain to curl back around 
the PFDMMOBA head group so that both the hydroxyl group in the middle of the linker 
and the positively charged quaternary amine group at the end of the linker can interact 
with the PFDMMOBA carboxylate through hydrogen-bonding and electrostatic 
interactions, respectively. These potential dual interactions could also be a great enough 
difference compared to the native β-CD neutral hydroxyl groups and the single amino 
group of the mono-am-β-CD to produce a noticeable increase in association.  
 Branching also produces changes in the PFPrOPrA complexes. PFPrOPrA can 
only enter the CD cavity tail first (threading the fluorinated tail through the CD cavity) 
due to this branching next to the carboxylate head group. The amino groups of mono-am-
β-CD and hepta-am-β-CD are substituted on the small side of the CD, which is the 
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opening that the fluorinated chain of PFPrOPrA must pass through to enter the CD 
cavity. Although the association constant for the hepta-am-β-CD:PFPrOPrA complex 
increased compared to the β-CD complex, the increase was smaller than all the other 
studied PFASs. Most likely this is observed because it is unfavorable for the fluorinated 
chain to pass through the ring of positively charged amino groups, whereas all the other 
studied PFASs can enter the CD cavity through the other opening (threading the 
carboxylate through the CD cavity). The mono-am-β-CD:PFPrOPrA complex, however, 
is 20 × stronger than the complex with β-CD. For this complex, PFPrOPrA does not have 
to thread through a ring of multiple positive charges. From the previous results (Chapter 
3), the amino group is expected to be too far from the PFPrOPrA carboxylate in the 
complex. Electrostatic attraction may still occur, however, leading to the large increase in 
association. For the complex with QACD, the association constant is decreased compared 
to β-CD. The long side chain may block PFPrOPrA from threading through the CD 
cavity, leading to decreased interactions. 
 Finally, PFMOPrA had unusual increases in association constants with the three 
positively charged β-CD derivatives, especially for hepta-am-β-CD, compared with the 
other linear PFASs (PFBA, PFPA, and PFMOBA). PFMOPrA is the only PFAS studied 
that does not have the –CF2CF2CF2– subunit. From the molecular sizes of the PFASs and 
the β-CD cavity, three fluorinated carbons will be encapsulated in the cavity during the 
host-guest interactions (Chapter 2; Lo Nostro et al. 2003). As this functionality is 
extremely hydrophobic, its interactions with the hydrophobic β-CD cavity lead to the 
favorable van der Waals forces that drive the strong complexation of PFASs by β-CD. 
PFMOPrA does not have this functionality; it has two fluorinated carbons between the 
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carboxylate and ether functionalities, with a –CF3 group on the other side of the ether 
oxygen. Thus, the encapsulation of PFMOPrA by native β-CD is relatively unfavorable 
due to the hydrophilic ether oxygen within the hydrophobic CD cavity during 
complexation. Since this complex is unfavorable, complexes with slightly more favorable 
conditions lead to large increases in association constant. For the mono-am-β-
CD:PFMOPrA and QACD:PFMOPrA complexes, the association constants are about 4 × 
the value of the association constant for the β-CD:PFMOPrA complex. Although the van 
der Waals interactions are the driving force behind the host-guest complexation and the 
interactions between the PFAS carboxylate and the hydroxyl groups of the β-CD cavity 
perimeter are secondary, the change of one of the hydroxyl groups to a positively charged 
amino group, or the addition of the side chain with a quaternary amine, cause a larger 
change in the association constant than other PFASs due to the unfavorable hydrophobic 
interactions in the CD cavity. This association constant is increased further (20 ×) by the 
replacement of all the primary hydroxyl groups by positively charged amino groups in 
hepta-am-β-CD. This result indicates that the presence of positively charged groups that 
can experience ionic bonding interactions with the negatively charged PFAS carboxylate 
become increasingly important to the favorability of the host-guest complex if there is no 
–CF2CF2CF2– group present in the PFAS structure. As the van der Waals forces are 
decreased, electrostatic interactions can help drive the host-guest interactions.  
These conclusions further explain why PFBA, PFPA, and PFMOBA experience 
very similar changes in association constant depending on the β-CD derivative: they all 
have three fluorinated carbon subunits within their structure, despite PFMOBA having an 
ether functionality. Almost no increase in complexation is observed when only one or 
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two positively charged groups are present (mono-am-β-CD and QACD), as the van der 
Waals forces are still the major driver of the host-guest complex, and the ionic bonding 
interactions play a minor role. A slight increase (3 ×) in association constant occurs when 
the seven positively charged groups are present (hepta-am-β-CD), as the electrostatic 
interactions between the carboxylate and amino groups are more likely and thus become 
a greater factor in the overall strength of complexation. In contrast, for PFMOPrA, any 
presence of cationic groups that can facilitate electrostatic attraction will lead to increases 
in the encapsulation, as the weak van der Waals forces within the cavity are a more minor 
component in the association.  
 
4.5 Conclusions 
 Positively charged β-CD derivatives increased encapsulation of short chain 
PFASs relative to native β-CD. Linear PFASs with a –CF2CF2CF2– group had little or no 
increase with mono-am-β-CD and QACD, and moderate increase with hepta-am-β-CD, 
compared to β-CD. Favorable interactions between the hydrophobic fluorinated chain and 
the CD cavity dominate these complexes, while ionic bonding interactions between the 
PFAS carboxylate and the CD amino groups are secondary. A linear PFAS without the   
–CF2CF2CF2– group (PFMOPrA) had moderate increases in complexation with mono-
am-β-CD and QACD and a large increase with hepta-am-β-CD compared to β-CD. 
PFMOPrA does not have strong van der Waals interactions between the PFAS chain and 
the CD cavity, and thus the electrostatic attraction due to addition of amino groups in the 
CD structure dominates the host-guest complex. PFDMMOBA, the PFAS branched at the 
tail, had moderate increases in association with QACD and hepta-am-β-CD compared 
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with β-CD. The presence of a positively charged side chain (QACD) or multiple 
positively charged amino groups (hepta-am-β-CD) can further lock PFDMMOBA into 
the CD cavity and hinder dissociation, increasing the strength of complexation beyond 
the base hydrophobic interactions. PFPrOPrA, the PFAS branched next to the carboxylate 
head group, had a large increase in association constant with mono-am-β-CD compared 
with β-CD, but not with the other positively charged β-CD derivatives. Since PFPrOPrA 
must enter the CD cavity through the primary hydroxyl, and thus amino-substituted, side, 
the presence of the positively charged side chain (QACD) or multiple positively charged 
amino groups (hepta-am-β-CD) make the complex unfavorable, whereas the presence of 
one positively charged group (mono-am-β-CD) allows PFPrOPrA to enter the CD cavity 
leading to potential favorable electrostatic interactions.  
 The addition of positive groups on β-CD allows for greater complexation with 
short chain PFASs than neutral β-CD. A negatively charged β-CD derivative causes 
weaker complexation than neutral β-CD. Thus, the interaction between the PFAS 
carboxylate and the β-CD primary hydroxyl groups, or their substitutions, is important to 
the strength of the host-guest complex. This interaction, however, is secondary to the 
hydrophobic interactions between the PFAS fluorinated chain and the β-CD cavity, which 
are the primary drivers of the host-guest complex. The ionic interactions with the 
positively charged amino groups are only important to the host-guest interactions 
(leading to large increases) when the hydrophobic interactions are unfavorable, such as in 
the case of PFMOPrA, or when branching has either hindered the host-guest complex 
originally (PFPrOPrA) or stabilized it (PFDMMOBA). These results give further insight 
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into the host-guest chemistry between PFASs and CDs, and can be utilized in the design 
of CD-based remediation technologies for short chain and emerging PFASs.   
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CHAPTER 5 
β-Cyclodextrin Reverses Binding of Perfluorooctanoic Acid to Human Serum Albumin 
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5.1 Abstract 
 Perfluorooctanoic acid (PFOA), a persistent organic pollutant known to cause 
adverse health effects, strongly binds to human serum albumin (HSA). β-Cyclodextrin (β-
CD), a non-toxic cyclic sugar, strongly complexes PFOA in a host-guest complex, and 
has been proposed for environmental remediation of PFOA. The interactions between 
HSA, PFOA, and β-CD were investigated in order to determine if β-CD can reverse the 
binding of PFOA to HSA, with potential therapeutic applications towards exposure to 
PFOA. 
19
F Nuclear magnetic resonance (NMR), circular dichroism, and fluorescence 
spectroscopies were used to study these interactions. Multiple PFOA binding sites to 
HSA, one with strong affinity and others with low affinity, are evident from changes in 
the fluorescence emission spectra of HSA and the fluorescence lifetimes of the single Trp 
residue in HSA with increasing PFOA concentration. Structural changes in the protein 
are also evident from changes in the circular dichroism spectra of HSA upon titration of 
PFOA. Addition of β-CD to PFOA and HSA reversed these changes, indicating that 
formation of the β-CD:PFOA host-guest complex is favored even in the presence of 
HSA. Equimolar β-CD to PFOA (1:1 β-CD:PFOA ratio) causes dissociation of the 
weakly bound PFOA from HSA, whereas excess β-CD relative to PFOA (5:1 β-
CD:PFOA ratio) leads to the complete disassociation of the strongly bound PFOA 
molecule from HSA. The 
19
F NMR studies further suggest that the 2:1 β-CD:PFOA 
complex inhibits PFOA binding to HSA. These data demonstrate that β-CD has potential 
to be used in therapeutic applications for PFOA in human blood.  
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5.2 Introduction 
In this study, we have investigated the interactions between PFOA, HSA, and β-
CD by employing 
19
F NMR, circular dichroism, and fluorescence (both steady state and 
frequency-resolved) spectroscopies to elucidate the potential for β-CD to reverse the 
binding of PFOA to HSA. The association between PFOA and β-CD in the presence of 
HSA was characterized by 
19
F NMR. Circular dichroism experiments elucidated the 
conformational changes of HSA upon addition of PFOA. Steady state fluorescence and 
fluorescence lifetime experiments were employed to examine the binding between PFOA 
and HSA in the absence/presence of β-CD. Finally, a fluorescence competition study was 
used to further probe these interactions and determine potential binding sites. 
 
5.3 Experimental Methods 
PFOA, hexafluorobenzene, and 8-anilinonaphthalene-1-sulfonic acid (1,8-ANS) 
were purchased from Sigma-Aldrich. β-CD was purchased from Acros Organics. HSA 
(66,248 Da, ≥ 99 % by agarose gel electrophoresis, fatty acid and globulin free) and 
deuterium oxide (99.9 % D) were purchased from Sigma-Aldrich and stored at 4 °C. All 
chemicals were used without further purification. 
 
 5.3.1 Sample Preparation 
 For the 
19
F NMR experiments, a solution of 2.42 mM PFOA was prepared in     
50 % D2O and 50 % 100 mM sodium phosphate buffer (pH 7.4) solution in H2O. 
Hexafluorobenzene (1.44 mM) was added as an internal standard. Various stoichiometric 
ratios of β-CD were added to the PFOA solution, and the samples were sonicated to 
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ensure dissolution (Chapter 2). After analysis, HSA (35 μM) was added to each sample, 
and the samples were analyzed again. 
 For the circular dichroism and fluorescence spectroscopy experiments, stock 
solutions of PFOA (10 mM and 100 μM), β-CD (5 mM), and HSA (20 μM) were 
prepared with a 50 mM sodium phosphate buffer (pH 7.4) solution in polypropylene 
tubes (MacManus-Spencer et al. 2010). The concentration for a stock solution of 1,8-
ANS (2.77 mM) was calculated by measuring the UV-visible absorbance at 350 nm of 
the solution and using ε350 = 5000 M
-1
cm
-1
 (Gonzalez and Miksovska 2014). All the stock 
solutions were shaken to ensure dissolution of each compound.  
 
5.3.2 
19
F NMR Spectroscopy 
NMR experiments were performed with a 400 MHz Bruker instrument with a 
quad probe (operating at 376.498 MHz for 
19
F). Hexafluorobenzene was used as the 
internal standard with a chemical shift of -164.9 ppm (Chapter 2). The chemical shift of 
each peak was recorded, and the 1:1 and 2:1 β-CD:PFOA association constants were 
calculated in GraphPad Prism (version 5.03, La Jolla, CA) and Mathworks Matlab 
(version R2013b, Natick, MA) by Ramos Cabrer, et al.’s method (Chapter 1) (1999). 
 
5.3.3 Circular Dichroism Spectroscopy 
 Circular dichroism experiments were performed with a JASCO J-815 CD 
Spectrometer. The ellipticity was measured between 200 and 300 nm. The concentration 
of HSA was 10 μM. PFOA was titrated into the sample at various concentrations. The 
79 
 
spectra were corrected to account for dilution. The experiment was performed in 
triplicate. 
 
5.3.4 Fluorescence Spectroscopy 
 Steady state emission experiments were performed with a PC1 Fluorometer (ISS 
Inc, Champaign, IL). The excitation wavelength was 295 nm, and the emission spectra 
were recorded between 305 and 440 nm using 1 nm slit width for both excitation and 
emission. The emission spectra were corrected for the inner filter effect; however, the 
inner filter effect was insignificant at the HSA concentrations used in this study (refer to 
Appendix 4). Fluorescence lifetime experiments (frequency-resolved) were performed 
with a ChronoFD Fluorometer (ISS Inc, Champaign, IL). The excitation wavelength was 
280 nm and 2,5-diphenyloxazole (PPO) was used as a lifetime reference. The 
fluorescence decay was modeled using a sum of three exponential decays according to 
Equation 5.1,  
  𝐼(𝑡) =  ∑𝛼𝑖 𝑒
(
−𝑡
𝜏𝑖
)
                                                   (5.1) 
where I(t) is the intensity decay at time t, τ  is the fluorescence lifetime, and α is the pre-
exponential factor (Lakowicz 2006, Ross and Jameson 2008). Data were analyzed using 
Globals for Spectroscopy Software (Laboratory of Fluorescence Dynamics, Irvine, CA). 
For both steady state and fluorescence lifetime experiments, the concentration of HSA 
was 10 μM. PFOA and then β-CD were titrated into the sample at various concentrations 
and the spectra were corrected to account for dilution. Each experiment was performed in 
triplicate. The Stern-Volmer quenching constant (KSV) and bimolecular quenching rate 
constant (kq) were determined from Stern-Volmer plots by measuring the emission 
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intensity (I) and average fluorescence lifetime (<  >) as a function of quencher 
concentration ([Q]) and using Equations 5.2 and 5.3,  
𝐼𝑜
𝐼
= 1 + 𝐾𝑆𝑉[𝑄]                                                       (5.2) 
< 𝜏𝑜 >
< 𝜏 >
= 1 + 𝑘𝑞 < 𝜏0 > [𝑄]                                              (5.3) 
where Io and < o > are the emission intensity and average fluorescence lifetime in the 
absence of quencher, respectively.  
 Steady state emission competition experiments with 1,8-ANS were performed 
with a Cary Eclipse Fluorescence Spectrophotometer. The excitation wavelength was 350 
nm, and the emission spectra were measured between 370 and 650 nm. The slit width 
was 2.5 nm for both excitation and emission. The concentration of HSA was 10 μM. 1,8-
ANS, PFOA, and β-CD were titrated into the sample at various concentrations and the 
spectra were corrected to account for dilution. The experiment was performed in 
triplicate. 
 
5.4 Results and Discussion 
5.4.1 
19
F NMR Studies 
 
19
F NMR spectroscopy has previously been used to study the 1:1 and 2:1 β-
CD:PFOA host-guest complexes formed in aqueous solution (Chapter 2). Changes in the 
19F chemical shift of PFOA titrated with β-CD were monitored to compare the host-guest 
association in the presence and absence of 35 μM HSA (see Appendix 4). The observed 
change in chemical shift of each fluorine peak varied differently as a function of β-CD 
concentration. The samples containing HSA showed broadened peaks, suggesting PFOA 
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is binding to HSA. The 1:1 and 2:1 β-CD:PFOA association constants were calculated by 
non-linear least-squares regression analysis for each fluorine (see Appendix 4). The 
association constants for the fluorines closer to the PFOA carboxylate head group with β-
CD are weaker in the presence of HSA, whereas the fluorines towards the end of the 
alkyl chain (tail) experience a stronger interaction with β-CD in the presence of HSA. 
The 1:1 and 2:1 β-CD:PFOA association constants averaged for all fluorines are listed in 
Table 5.1. The 1:1 β-CD:PFOA association constant decreases in the presence of HSA 
likely due to the interaction of the carboxylate group of PFOA with HSA (supported by 
the changes in the individual fluorines) that weakens the PFOA association to -CD. The 
association constants for the formation of 2:1 β-CD:PFOA complexes in the presence and 
absence of HSA are within the calculated error, suggesting that the formation of the 2:1 
complex between -CD and PFOA inhibits PFOA binding to HSA. 
 
Table 5.1: Association constants for β-CD:PFOA complexes in 50 mM phosphate buffer 
(pH 7.4) 
Condition K1:1, M
-1 K2:1, M
-1 
 No HSA 4.16 ± 0.88 × 105 6.42 ± 1.78 × 102 
35 μM HSA 1.67 ± 0.33 × 105 9.09 ± 1.27 × 102 
 
5.4.2 Steady State Fluorescence and Circular Dichroism 
 HSA has a single Trp residue (Trp-214) located between IIA and IIB subdomains 
that is often employed as an internal fluorescence probe to monitor the mechanism of the 
interactions of organic molecules with HSA (Dugaiczyk et al. 1982, Fanali et al. 2012). 
As PFOA is titrated into a solution of HSA, both the emission intensity (Figure 5.1a; also 
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see Appendix 4) as well as the emission maximum (λmax; Figure 5.1b) for the Trp-214 
residue changed. At concentrations up to 10 μM PFOA, the 1:1 molar ratio between 
PFOA and HSA, the fluorescence intensity increased by 20 % without a significant shift 
in λmax. Further increase in PFOA concentration leads to a decrease in the fluorescence 
intensity of HSA, and the λmax shifted to shorter wavelengths (from 335 nm to 320 nm). 
At 200 μM PFOA (the 20:1 ratio between PFOA and HSA), the fluorescence intensity 
and λmax plateaued suggesting no additional PFOA binding to HSA.  
 
 
 
Figure 5.1: a) Fluorescence emission intensity measured at 335 nm and b) the maximum 
emission wavelength (λmax) of 10 μM HSA titrated with increasing concentrations of 
PFOA. For each PFOA concentration, β-CD was added to achieve 1:1 and 2:1 β-
CD:PFOA ratios. The error bars are within the symbols. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
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Circular dichroism can be used to determine the secondary structures of proteins 
by measuring the absorption of circularly polarized light by the peptide bonds at 
wavelengths less than 240 nm (Kelly et al. 2005). α-Helical secondary structure is evident 
from circular dichroism ellipticity minimums at 208 and 220 nm. The circular dichroism 
spectra of HSA as a function of PFOA concentration showed similar changes as the 
fluorescence spectra (Figure 5.2; also see Appendix 4). At ratios up to 1:1 PFOA:HSA, 
the ellipticity at 208 and 220 nm decreased by ~ 8 % whereas at PFOA concentrations 
above the 1:1 ratio, the ellipticity slightly increased (~ 1 %). At a twenty-fold excess of 
PFOA, the ellipticity plateaued.  
 
 
Figure 5.2: Circular dichroism ellipticity measured at 220 and 208 nm for 10 μM HSA 
titrated with increasing concentrations of PFOA. The error bars are within the symbols. 
 
 These results are consistent with previously published data and indicate a 
presence of multiple binding sites for PFOA in HSA (Wu et al. 2009, Chen and Guo 
2009, MacManus-Spencer et al. 2010). The first site, which is significantly populated at 
the 1:1 molar ratio, has a strong binding constant (Ka,1 > 10
5
 M
-1
), and PFOA association 
leads to the increase in the -helical structure of HSA from 47 % in the absence of the 
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ligand to 52 % upon PFOA binding (refer to Appendix 4). Association of PFOA to 
additional binding sites slightly destabilizes the protein structure as is evident from the 
hypsochromic shift of the λmax. Analysis of the fluorescence emission data at PFOA:HSA 
ratios greater than 1:1 using the double logarithm plot to model fluorescence quenching 
(Appendix 4) provided an equilibrium binding constant Ka,2 = 1.39 × 10
4
 M
-1
 with one 
binding site, suggesting the presence of single lower affinity binding site (Wei et al. 
2010). An alternative model (the modified Scatchard plot) suggests up to eight low 
affinity binding sites (see Appendix 4), which agrees more closely with previous studies 
that observed multiple low affinity sites (Han et al. 2003, Wu et al. 2009, Salvalaglio et 
al. 2010, Wei et al. 2010). The equilibrium binding constant for the lower affinity site 
reported herein is consistent with the equilibrium constant reported from ITC 
measurements (Ka = 2.47 × 10
4
 M
-1
) (Wu et al. 2009), whereas the equilibrium constant 
for the high affinity site (Ka,1) is comparable to that determined in previous fluorescence 
measurements (2.7 × 10
5
 M
-1
) (Chen and Guo 2009). Finally, at the 20:1 PFOA:HSA 
ratio, the binding sites are occupied as no further changes in fluorescence intensity, λmax, 
or ellipticity are observed. Nonetheless, additional PFOA molecules may bind or have 
weak association with HSA but lead to insignificant changes in the fluorescence or 
circular dichroism spectra.  
 For HSA titrations carried out at 1:1 or 2:1 β-CD:PFOA ratios, the fluorescence 
intensities followed analogous trends as observed in the absence of β-CD, with an 
increase in emission intensity to the 1:1 PFOA:HSA ratio and subsequent quenching at 
elevated PFOA concentrations.  Reduced fluorescence quenching at elevated PFOA 
concentrations was observed with an increased ratio of β-CD to PFOA. These results 
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suggest that β-CD can inhibit the binding of PFOA to HSA. The blue shift in the HSA 
emission spectra is less pronounced for the 1:1 β-CD:PFOA ratio, and absent for the 2:1 
β-CD:PFOA ratio, indicating that β-CD is competing with HSA for PFOA and effectively 
inhibits associating of PFOA molecules to lower affinity sites on the protein surface. The 
fluorescence intensity is increased when β-CD is added; however, the values do not 
return to the intensity values observed for HSA alone, suggesting that β-CD at the 1:1 
and 2:1 ratio with PFOA cannot completely reverse the first PFOA binding to HSA. 
 In order to further investigate this, 500 μM PFOA was added to 10 μM HSA (50:1 
PFOA:HSA ratio), and β-CD was titrated into the sample (Figure 5.3). As the β-CD 
concentration approached the 1:1 β-CD:PFOA ratio (500 μM ), the fluorescence intensity 
and λmax dramatically increased and then experienced much smaller increases around the 
2:1 ratio (1000 μM -CD). At the 5:1 ratio (2500 μM -CD), the fluorescence intensity 
and λmax returned to the values observed for HSA in the absence of PFOA. These 
observations demonstrate that an equimolar concentration of β-CD to PFOA can disrupt 
the weaker PFOA binding to HSA, and that a 5:1 molar ratio between β-CD and PFOA 
effectively disrupts PFOA molecules bound to the high affinity site. These data support 
the hypothesis that an excess of β-CD compared to PFOA can totally reverse PFOA 
binding to HSA.  
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Figure 5.3: Fluorescence emission intensity measured at 335 nm and the maximum 
emission wavelength (λmax) of 10 μM HSA and 500 μM PFOA titrated with increasing 
concentrations of β-CD. The error bars are within the symbols. 
 
5.4.3 Lifetimes 
 The fluorescence lifetimes (τ) for the single Trp residue in HSA (Trp-214) were 
measured as PFOA was titrated into the sample (Figure 5.4a; for the average lifetime, see 
Appendix 4). Three lifetimes (1 = 0.48 ns, 2 = 3.75 ns, 3 = 7.85 ns) were resolved for 
the single Trp-214 residue, which is consistent with previous studies (Albani 2007, Amiri 
et al. 2010a, Amiri et al. 2010b). The molecular origin of the three distinct lifetimes 
observed for the single Trp residue in HSA was investigated previously and associated 
with the presence of three distinct substructures of Trp in the excited state (Albani 2007, 
Amiri et al. 2010a). The two shorter lifetimes (1 and 2) are similar to those found for 
Trp residues in aqueous solutions and thus originate from the molecular structure of Trp, 
whereas the longest lifetime is only observed for Trp in proteins and was attributed to the 
Trp interactions with hydrophobic residues in the core of the protein (Albani 2007, Amiri 
et al. 2010a). The addition of PFOA does not alter the shortest fluorescence lifetime, 
whereas 2 and 3 increase at low concentrations of PFOA. After the 1:1 PFOA:HSA 
87 
 
ratio, 2 and 3 decrease. In addition, the pre-exponential factors (α), which represent the 
fraction of Trp with the corresponding lifetime, are also sensitive to the PFOA 
association to the protein, with increasing α values after the 1:1 PFOA:HSA ratio (Figure 
5.4b). Increase in 3, and to a smaller extent 2, upon PFOA association to the high 
affinity site suggest that this site may be located in the vicinity of the Trp residue, and 
that binding of PFOA increases the hydrophobicity of the Trp-214 environment, which is 
supported by previous molecular modeling studies (Salvalaglio et al. 2010).  
 
 
 
Figure 5.4: a) Fluorescence lifetimes and b) α values for the fluorescence lifetimes of 10 
μM HSA titrated with increasing concentrations of PFOA. The error bars, when not 
apparent, are within the symbols. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
b) 
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The decrease of 2 and 3 suggests an efficient quenching of Trp emission upon 
PFOA association to the lower affinity sites. This decrease in the Trp emission and 
lifetime can be analyzed either in terms of dynamic quenching, dynamic and static 
quenching, and/or can be associated with the PFOA-triggered changes in protein structure 
that lead to the alteration of the Trp environment. The absence of spectral overlay 
between the absorption spectrum of PFOA and the emission spectrum of HSA exclude 
fluorescence resonance energy transfer (FRET) from being the major mechanism for Trp 
emission quenching. To determine whether the quenching is dynamic or dynamic and 
static, Stern-Volmer plots were analyzed for linearity. Stern-Volmer plots using emission 
intensities and average lifetime data (Figure 5.5) are both linear and provide matching 
Stern-Volmer constants of 9370 ± 750 M
-1
 and 9400 ± 440 M
-1
, respectively, suggesting 
a purely dynamic quenching of Trp emission due to the PFOA association to the low 
affinity site. The value of the bimolecular quenching rate constant calculated using 
Equation 5.3,  kq = 1.54 × 10
12
 M
-1
s
-1
, is two orders of magnitude larger than a value 
expected for the diffusion limited process (10
10
 M
-1
s
-1
), which is consistent with PFOA 
binding to HSA triggering structural changes in the protein that affect the environment of 
Trp-214 (Lakowicz 2006). 
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Figure 5.5: Stern-Volmer plots of fluorescence emission intensities and average lifetimes 
of 10 μM HSA titrated with PFOA. 
 
 When β-CD is titrated into a sample of PFOA and HSA (at a 50:1 PFOA:HSA 
ratio),  1 does not change, and 2 and 3 increase (Figure 5.6a; for the average lifetime, 
see Appendix 4). The pre-exponential factors (α1 and α2 values) for the first and second 
lifetimes decrease, and the α3 value slightly increases (Figure 5.6b), suggesting that -CD 
inhibits binding of PFOA to the low affinity sites. At the 5:1 β-CD:PFOA ratio, the 
observed  and  values decrease and are identical to those determined for HSA in the 
absence of PFOA. These results again support that β-CD at low concentrations can 
disrupt the second binding of PFOA to HSA, and that excess β-CD can totally reverse all 
PFOA binding to HSA. 
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Figure 5.6: a) Fluorescence lifetimes and b) α values for the fluorescence lifetimes of 10 
μM HSA and 500 μM PFOA titrated with increasing concentrations of β-CD. The error 
bars, when not apparent, are within the symbols. 
 
We also determined the impact of -CD on the protein conformation. Addition of 
-CD to HSA in the absence of PFOA resulted in a negligible decrease in HSA emission 
intensity (less than 2 %) and a slight decrease in fluorescence average lifetime (from 6.14 
ns to 6.08 ns) at the highest β-CD concentration (2500 μM). A previous study found that 
the binding between HSA and β-CD is weak, with an equilibrium constant of 185 M-1, 
which is much weaker than PFOA affinity for HSA or β-CD (Ghosh et al. 2014). These 
results indicate that under experimental conditions used in this study, -CD does not bind 
a) 
 
 
 
 
 
 
 
 
 
 
 
b) 
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to HSA, and thus the impact of -CD on the spectroscopic properties of HSA in the 
presence of PFOA can be associated with the formation of -CD:PFOA complexes, and 
thus PFOA dissociation from HSA. 
 
5.4.4 Competition Study with 1,8-ANS 
 A competition study was performed using steady state fluorescence to further 
confirm the results. 8-anilinonaphthalene-1-sulfonic acid (1,8-ANS) is a model 
compound known to bind to hydrophobic pockets in HSA that bind fatty acids, 
hormones, and drugs (Gasymov and Glasgow 2007, Takehara et al. 2009, Kuznetsova et 
al. 2012). A previous study found that 1,8-ANS binds to three sites on HSA, including 
the site in proximity to Trp-214, with very strong binding constants (on the order of 10
5
-
10
6
 M
-1
), while another study suggests that 1,8-ANS can bind to 14 sites on HSA with 
slightly weaker binding constants (on the order of 10
3
-10
5
 M
-1
) (Takehara et al. 2009, 
Kuznetsova et al. 2012). Due to similar binding constants, it is expected that PFOA will 
successfully compete with 1,8-ANS for HSA binding. Furthermore, it is important to note 
that 1,8-ANS has extremely weak complexation to β-CD, with an association constant of 
65 M
-1
, and thus 1,8-ANS is expected to be bound to HSA or quenched in aqueous 
solution during the course of the competition study, and that only PFOA will interact 
meaningfully with β-CD (Schneider et al. 1991). 
The fluorescence emission of 1,8-ANS was measured in the presence of HSA, 
PFOA, and β-CD. First, 10 μM HSA was titrated with 1,8-ANS. The fluorescence 
intensity at 470 nm increased as the concentration of 1,8-ANS increased until saturation 
of HSA occurred (at about 60 μM 1,8-ANS). Next, PFOA was titrated into the sample 
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and the fluorescence intensity decreased, indicating that PFOA replaces 1,8-ANS bound 
to the protein. The 1,8-ANS fluorescence intensity was not fully quenched even at the 
highest PFOA concentration (1 mM), however, suggesting that 1,8-ANS binds to sites on 
HSA that PFOA does not. Significant overlap of binding sites on HSA for 1,8-ANS and 
PFOA are expected, due to both 1,8-ANS and PFOA being hydrophobic molecules with 
negatively charged groups (sulfonate in the case of 1,8-ANS and carboxylate in the case 
of PFOA). Their structures, however, are widely different. 1,8-ANS is aromatic and 
planar whereas PFOA is aliphatic and linear, and thus they are not expected to 
completely share all binding sites. When β-CD was titrated into the sample, the 1,8-ANS 
fluorescence emission intensity at 470 nm increased, and at the 5:1 β-CD:PFOA ratio, the 
intensity returned to the value observed for 1,8-ANS and HSA in the absence of PFOA 
(Figure 5.7). These results indicate that β-CD can reverse the binding of PFOA to HSA, 
further confirming that β-CD strongly encapsulates PFOA, even in the presence of HSA.  
 
Figure 5.7: Fluorescence emission spectra of 100 μM 1,8-ANS with 10 μM HSA. When 
PFOA (500 μM pictured) is added, the fluorescence intensity decreases. As β-CD is 
added to this solution, the fluorescence intensity returns to the original intensity. 
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5.5 Conclusions 
 Prior to testing the ability of β-CD to reverse PFOA binding to HSA, the 
interactions between PFOA and HSA (in the absence of β-CD) were characterized and 
compared to previous studies. PFOA binds to multiple sites in HSA, with a strong affinity 
for the first binding site and weaker affinities for the remaining binding sites, as 
evidenced by the steady state and frequency-resolved fluorescence spectra and the 
circular dichroism spectra. The strongest binding site is likely located near the Trp-214 
residue, as evidenced by the increase in emission intensity and fluorescence lifetimes 2 
and 3, indicating an increase in the hydrophobic environment of the Trp residue. Binding 
of PFOA to the lower affinity sites, however, causes destabilization of the protein and 
dynamic quenching of the Trp emission, as indicated by the Stern-Volmer plots. Upon 
addition of β-CD, PFOA dissociates from the lower affinity sites on HSA and complexes 
with β-CD via encapsulation of the PFOA tail, while still interacting with hydrophilic 
moieties on the surface of HSA, as evidenced from the NMR studies. Excess β-CD 
results in complete dissociation of PFOA from HSA, supported by the return of the 
fluorescence emission spectra and fluorescence lifetimes of HSA to that of the protein 
alone. The NMR studies suggest that the 2:1 β-CD:PFOA complex can be formed in 
these conditions, with the strong β-CD encapsulation of PFOA preventing binding to 
HSA.  
Our results indicate that β-CD can reverse binding of PFOA to HSA, and thus, 
may attenuate the toxicity of PFOA. The half-life and toxicological properties of PFOA 
in humans may arise from binding to HSA: PFOA cannot be eliminated from the body 
while it is bound to HSA, and HSA is known to transport hormones, fatty acids, and other 
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biological molecules to the liver, kidneys, and thyroid, the organs where PFOA 
accumulates and exerts its toxic effects. Although our studies were not conducted at 
physiologically relevant concentrations, the results clearly demonstrate the principle of 
using β-CD to inhibit and reverse PFOA binding to HSA. These results have possible 
applications for a therapeutic strategy to address PFOA exposure and contamination, and 
could possibly be extended to other problematic perfluorinated compounds. Further 
research is needed at physiologically relevant concentrations and in biological organisms 
exposed to PFOA to fully investigate the therapeutic potential of β-CD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
β-Cyclodextrin Attenuates Perfluorooctanoic Acid Toxicity in the Zebrafish Embryo 
Model 
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6.1 Abstract 
Perfluorooctanoic acid (PFOA) has been linked to negative health outcomes 
including cancer, thyroid disease, infertility, and developmental delays. β-Cyclodextrin 
(β-CD), a cyclic sugar, has been previously shown to form strong host–guest complexes 
with PFOA, and is proposed as a means of environmental remediation with respect to this 
widespread contaminant. In the present study, β-CD was directly examined with regards 
to possible attenuation of the toxicity of PFOA, specifically employing the zebrafish 
(Danio rerio) embryo model. Zebrafish embryos were exposed to various concentrations 
of PFOA without β-CD, and with equimolar (1:1) and excess (2:1) molar ratios of β-CD 
to PFOA, and assessed for lethality and developmental toxicity through seven days post-
fertilization (dpf). Rapid onset of lethality with limited morphological abnormalities was 
observed at relatively low concentrations of PFOA (LC50 ≈ 50 ppm), along with effects 
on morphometric and neurobehavioral parameters in surviving embryos. A highly 
significant difference (p < 0.0001) was observed between the 2:1 treatment, and both 1:1 
and PFOA only treatments, with respect to lethal concentration and apparent 
neurobehavioral effects, suggesting an effectively reduced toxicity of the fully complexed 
PFOA. In contrast, however, neither β-CD treatment reduced developmental toxicity with 
respect to the morphometric endpoint. Whereas LC50 of PFOA alone did not change over 
7 dpf, the 1:1 and 2:1 values decreased slightly over time, suggesting either delayed or 
alternative toxic effects on later developmental stages at presumptively lowered levels. 
This study indicates β-CD may be an effective agent to reduce toxicity of and mitigate 
environmental health concerns associated with PFOA, but that further study is required to 
elucidate the mechanism of complexation as it relates to the attenuation of toxicity. 
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6.2 Introduction 
To test the hypothesis that β-CD:PFOA complex will effectively reduce the 
toxicity of PFOA in the zebrafish embryo, relevant metrics of toxicity (e.g., lethal 
concentrations, developmental impairment, and neurobehavioral effects) were assessed 
for PFOA alone, and in the presence of equimolar (1:1) and excess (2:1) β-CD. The goal 
of the study was to evaluate potential reduction of toxicity in relation to complex 
formation. Although various human health effects have been linked to much lower 
environmental concentrations, relatively high concentrations of PFOA (i.e., parts-per-
million (ppm) levels) were used in the current study rather than environmentally relevant 
concentrations such that acute toxicological endpoints, as a proxy of PFOA toxicity, 
could be assessed. This study provides direct insight into the potential utility of 
cyclodextrins for attenuating the toxic effects of PFOA. 
 
6.3 Experimental Methods 
Perfluorooctanoic acid (PFOA) was purchased from Sigma-Aldrich. β-
Cyclodextrin (β-CD) was purchased from Acros Organics. Both chemicals were used 
without further purification. Stock solutions of PFOA (7.25 mM, i.e., 3000 ppm), 1:1 β-
CD:PFOA (β-CD: 7.25 mM, PFOA: 7.25 mM), and 2:1 β-CD:PFOA (β-CD: 14.50 mM, 
PFOA: 7.25 mM) were prepared with deionized water in polypropylene tubes. The 
solutions were sonicated until dissolution of the solids was achieved. A control solution 
of deionized water was also stored in a polypropylene tube. Stock solutions were 
subsequently diluted over a relevant range of concentrations (see below) for assessment 
of zebrafish embryo toxicity. 
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6.3.1 Zebrafish Rearing and Breeding 
To obtain embryos, zebrafish (PS strain) were reared and bred as previously 
described (Berry et al. 2007, Jaja-Chimedza et al. 2017). Briefly, adult zebrafish were 
maintained in 30-L tanks at 28 °C with 14 h: 10 h light/dark cycle, and bred (from 
approximately 10–30 individuals) above 10-L tanks in mesh enclosures. Eggs were 
collected (from the bottom of tanks) within 1 h of the end of the dark cycle, and, 
following collection and washing, transferred to plates containing E3 medium (Brand et 
al. 2002). Eggs containing dead or obviously poor quality embryos were removed. The 
remaining embryos were used, within ~ 2 h post-fertilization (hpf), for toxicity assays. 
All rearing and breeding was conducted under protocols approved by the University of 
Miami’s Institutional Animal Care and Use Committee (IACUC), and performed by 
trained investigators. 
 
6.3.2 Zebrafish Embryo Toxicity Assay 
Zebrafish embryo toxicity assays were adapted from previously described 
methods (Berry et al. 2007, Jaja-Chimedza et al. 2017). Assays were conducted in 
polypropylene 24-well plates (Evergreen Scientific, Los Angeles, CA) with five embryos 
(4- to 32-cell stage) per replicate, i.e., well (n = 4), in E3 medium for a total of 20 
zebrafish embryos per treatment/concentration (Brand et al. 2002). Embryos were 
exposed via static exposure (i.e., without replenishment) to a range of PFOA 
concentrations (30, 50, 100, 150, 200, 250 and 300 ppm) alone, and in 1:1 and 2:1 ratios 
with β-CD, and subsequently observed at 1, 2, 3, 4 and 7 days post-fertilization (dpf) with 
a dissecting light microscope to assess mortality and relevant developmental toxicity. 
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Exposures and assessments were repeated several times, in preliminary studies, to 
determine relevant concentration levels for PFOA, and generally confirm results. 
Lethality was calculated as the concentration corresponding to 50 % mortality (LC50); the 
LC50 values, and their 95 % confidence intervals, were calculated via Probit Analysis in 
SPSS (version 22.0, IBM Corporation, Armonk, NY). In addition to lethality, inhibition 
of embryo development was morphometrically assessed based on the interocular distance 
between eyes (as a proxy for body size) of 7 dpf embryos (eleuthero-embryo stage) as 
measured using Olympus DP2-BSW imaging software (2009, Center Valley, PA). 
Apparent neurobehavioral effects were additionally measured as the percent of 7-dpf 
eleuthero-embryos displaying listing (i.e., falling to one side) behavior within a 30 s 
period (with shaking between each measurement to allow embryos to right themselves). 
All toxicity assays involving zebrafish were conducted under protocols approved by the 
Florida International University’s Institutional Animal Care and Use Committee 
(IACUC), and performed by trained investigators. 
 
6.3.3 Statistical Analyses 
One-way analysis of variance (ANOVA) of the LC50 values, as well as the 
interocular distance and percent listing at 7 dpf, was performed in GraphPad Prism 
(version 5.03, La Jolla, CA). The significance level was set at p = 0.05. 
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6.4 Results and Discussion 
6.4.1 PFOA Toxicity in the Zebrafish Embryo Model 
A rapid onset of embryotoxicity was observed for PFOA with mortality, 
characterized by coagulation of embryos, occurring within a few hours of exposure. By 
24 hpf, a significant dose-dependent response with respect to lethality was observed 
(Figure 6.1) with all embryos dead at PFOA concentrations above 100 ppm. The 
observed dose response, with respect to mortality, remained largely unchanged, and the 
calculated LC50 values did not significantly change over the course of the exposure (i.e., 
7 dpf; Figure 6.2). Notably, aside from a higher number of mortalities, no clear pattern of 
developmental deformities was observed: by 7 dpf, for example, only ~ 5 % of both 
control and PFOA-treated embryos showed any discernible deformities, which included 
bent spines and edemas. Similarly, the hatching rates were unaffected with the majority 
of surviving embryos, in both control and PFOA treatments, hatched by 3 dpf. 
 
 
Figure 6.1: Concentration dependent toxicity of PFOA, and 1:1 and 2:1 β-CD:PFOA 
treatments, in terms of rapid onset lethality. Shown is percent mortality at 24 hpf (error 
bars represent ± one standard deviation, n = 4) fit by the dose-response curve. 
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Apparent inhibition of embryo growth (i.e., reduced body size), however, was 
observed, with the surviving PFOA-treated embryos being smaller at the end of the 
exposure (i.e., 7 dpf) compared to controls. Inhibition of development was specifically 
evaluated morphometrically based on interocular distance at 7 dpf: significantly (p < 
0.0001) reduced interocular distances were measured for surviving PFOA-treated 
embryos at sub-lethal concentrations (i.e., ≤50 ppm, pooled; 0.25 ± 0.06 mm) versus 
untreated control (0.41 ± 0.14 mm) embryos (Figure 6.3). In terms of other relevant 
endpoints, apparent neurobehavioral effects were observed for surviving embryos, and 
specifically a high frequency of listing was observed for PFOA-treated embryos. At low 
PFOA concentrations below the LC50 (i.e., ≤50 ppm, pooled), the percent of surviving 
embryos observed to list within a 30 s period (96 ± 9%) was significantly higher (p < 
0.0001) than controls without PFOA (20 ± 13%; Figure 6.4). 
 
6.4.2 Attenuation of PFOA Toxicity by β-CD 
To evaluate the ability of β-CD to reduce the toxicity of PFOA, the LC50 values 
for each treatment (PFOA alone, 1:1 and 2:1 β-CD:PFOA ratios) were calculated and 
compared. At 1 dpf, a significantly (p < 0.0001) higher LC50 was observed for 2:1 β-
CD:PFOA (159.3 ± 22.9 ppm) compared to both PFOA alone (47.3 ± 3.6 ppm), and the 
1:1 β-CD:PFOA treatment (69.9 ± 5.7 ppm). The lethal concentration for 1:1 β-
CD:PFOA was higher than PFOA alone, but the difference was not statistically 
significant. However, whereas LC50 did not change over time for PFOA alone, calculated 
values for both 1:1 and 2:1 β-CD:PFOA treatments notably decreased over 7 days of 
exposure (Figure 6.2) due to additional, post-hatch mortalities. By 4 dpf, the 1:1 β-
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CD:PFOA LC50 (48.1 ± 14.2 ppm) was essentially equal to that of PFOA alone. Although 
the LC50 for the 2:1 β-CD:PFOA treatment decreased (e.g., 80.5 ± 9.3 pm by 7 dpf), it 
was still significantly (p < 0.0001) higher than either PFOA alone, or PFOA in a 1:1 ratio 
with β-CD. No discernible toxicity was observed for β-CD alone, within the range of 
tested concentrations, including the maximum concentration (i.e., 1645 ppm, or 1.45 mM, 
β-CD) evaluated in the 2:1 ratio treatments. 
 
 
Figure 6.2: Calculated lethal concentrations for 50% of the population (LC50 values) for 
PFOA only, 1:1 β-CD:PFOA, and 2:1 β-CD:PFOA over 7 dpf. The 2:1 β-CD:PFOA LC50 
values are significantly different (*** = p < 0.0001) than PFOA only, and 1:1 β-
CD:PFOA. The LC50 values for PFOA only and 1:1 β-CD:PFOA are not significantly 
different from each other. Error bars represent 95% confidence intervals. 
 
In contrast to lethality, β-CD did not reduce apparent developmental toxicity in 
terms of the morphometric variable (interocular distance) (Figure 6.3). Comparing 
surviving embryos at, or below, the LC50 (i.e., ≤50 ppm), the measure of interocular 
distance for 7-dpf embryos was significantly (p < 0.0001) lower in both 1:1 β-CD:PFOA 
(0.25 ± 0.07 mm) and 2:1 β-CD:PFOA (0.29 ± 0.07 mm) treatments when compared to 
controls, and nearly identical to PFOA alone. Similar to lethality, on the other hand, the 
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apparent neurobehavioral effect (i.e., listing) among 7-dpf embryos was reduced among 
surviving embryos at sub-lethal concentrations (i.e., ≤50 ppm) in the 2:1 β-CD:PFOA 
treatment: percent listing in this treatment was not significantly different from untreated 
controls (Figure 6.4). Frequency of listing in the 1:1 treatment was decreased, compared 
to that of PFOA alone, but it was still significantly higher (p < 0.01) than untreated 
controls. 
 
 
Figure 6.3: Interocular distance, as a morphometric measure of embryo body size, for 
untreated embryos (“Control”) compared to surviving embryos in sub-lethal 
concentrations (≤50 ppm) of PFOA only, and 1:1 and 2:1 β-CD:PFOA treatments, at 7 
dpf. All three treatments are significantly different (*** = p < 0.0001) than controls. The 
three treatments are not significantly different from each other. Error bars represent 95% 
confidence intervals. 
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Figure 6.4. Percent listing after 30 s for the untreated embryos (“Control”) compared to 
surviving embryos in sub-lethal concentrations (≤50 ppm) of PFOA only, and 1:1 and 2:1 
β-CD:PFOA treatments, at 7 dpf. The control values are significantly different from 
PFOA only (*** = p < 0.0001) and 1:1 β-CD:PFOA (** = p < 0.01). The 2:1 β-
CD:PFOA values were not significantly different from controls (“ns”). Error bars 
represent 95% confidence intervals. 
 
6.4.3 Discussion 
Toxicity of PFOA in the zebrafish embryo model, including embryotoxicity, 
reduced body size, and neurobehavioral effects observed in the present study, is generally 
consistent with prior studies (Hagenaars et al. 2011, Zheng et al. 2011, Hagenaars et al. 
2013). Aligned with these previous studies (Zheng et al. 2011), a rapid onset of lethality 
(≤24 hpf) and relatively limited occurrence of developmental deformities, including bent 
spines and edemas, were similarly observed in the current study. Lethal concentrations 
for PFOA in the current study, however, were considerably lower than measured in prior 
studies, which have typically reported LC50 values above 500 ppm and/or test ranges 
(Hagenaars et al. 2011, Rainieri et al. 2017), although others (Zheng et al. 2011, Ding et 
al. 2013) have reported somewhat lower values (e.g., 262 and 371 ppm, respectively). It 
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has been suggested (Jantzen et al. 2016a) that the LC50 of PFOA may be, in fact, ten 
times lower than originally reported, which would put it within the range presently 
observed. Variability in lethal concentrations is presumably due to genetic differences of 
zebrafish lines used and/or other experimental conditions, and were not addressed further 
in the present study. Both reduced body size and locomotory effects have been, likewise, 
reported for PFOA-treated zebrafish embryos at sub-lethal concentrations (Hagenaars et 
al. 2011, Jantzen et al. 2016a, Jantzen et al. 2016b, Jantzen et al. 2017). Notably, these 
sub-lethal effects were observed in previous studies (Jantzen et al. 2016b, Jantzen et al. 
2017) at considerably lower (i.e., micro- to nanomolar) exposure concentrations, and 
effects extended into (following embryonic exposure) adult stages. 
Consistent with formation of host–guest complexes, β-CD generally reduced 
toxicity of PFOA. Although a 1:1 ratio decreased both rapid lethality at early embryonic 
stages (i.e., ≤3 dpf), and neurobehavioral effects, only the measured decreases 
(approximately two-fold) associated with the 2:1 ratio were statistically significant 
through 7 dpf. That being said, neither β-CD treatment significantly attenuated a 
morphometric variable (interocular distance) indicative of reduced embryo growth and 
body size associated with PFOA toxicity. Furthermore, while the LC50 of PFOA alone 
did not change during the exposure, values decreased over 7 dpf for both 1:1 and 2:1 
ratios. These latter observations suggest a toxicity toward post-hatch larvae at either 
presumably lowered concentrations of non-complexed PFOA or alternatively less toxic 
and/or bioavailable complexes, which are uncoupled from the potent embryotoxicity 
associated with rapid onset lethality at early embryonic stages. 
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The mechanism whereby β-CD reduces toxicity via complex formation remains to 
be clarified in future studies. However, the current state of knowledge with respect to the 
formation of the β-CD:PFOA host–guest complex points to a few possibilities. It appears 
that the ratio of β-CD, rather than the concentration of β-CD, determines the inhibition of 
PFOA toxicity. Differences in bioavailability, and thus uptake, of the two complexes, 
may explain the differential toxicity observed between 1:1 and 2:1 β-CD treatments. 
Indeed, it has been shown that relative lipophilicity significantly effects and is correlated 
with uptake in the zebrafish embryo model (De Koning et al. 2015). It would be expected 
that increased complexation of PFOA would decrease log P values and, thus, uptake. 
This model, however, largely assumes stoichiometric, stepwise and stable host–
guest complexes. Alternatively, it is possible that non-stoichiometric and/or non-
sequential complex formation could lead to non-stoichiometrically reduced levels of free 
PFOA which would, in turn, be quantitatively dependent on the relative β-CD 
concentration. Such an alternative model could explain quantitative differences in 
toxicity between 1:1 and 2:1 ratios whereby formation of 2:1 complexes under equimolar 
(1:1) conditions would lead to persistence of uncomplexed (and thus toxic) PFOA. 
Presence of free PFOA in solution, and corresponding sub-lethal toxicity might, in this 
regard, be further exacerbated by bioaccumulation of PFOA, and subsequent release at 
later stages. Previous studies have shown high levels of bioconcentration of PFOA in 
zebrafish embryos including intestine and bile (and potential enterohepatic recirculation), 
as well as yolk, as a means of bioaccumulation and release at later embryonic stages 
(Ulhaq et al. 2015). Competition between bioaccumulation and complex formation might 
explain toxicity at higher concentrations even in 2:1 treatments including both post-hatch 
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toxicity, and inability of either β-CD treatment to effectively reduce developmental 
toxicity, in terms of morphometric parameters. Quantitative analysis of PFOA and β-CD 
complexes with respect to both exposure medium and bioaccumulation/uptake (e.g., 
critical body residue), including tissue specific bioavailability, in future studies could 
address these interrelated mechanisms. 
 
6.5 Conclusions 
The results of this study directly suggest that β-CD, particularly in excess molar 
ratios, can largely attenuate the toxicity of PFOA in solution as evidenced by reduced 
toxicity in the zebrafish embryo model. The ratio of β-CD to PFOA, rather than the 
concentration of β-CD, drives this attenuation. It is proposed that the host–guest complex 
may exhibit less biological activity, or alter bioavailability, compared to PFOA alone. 
Alternatively, β-CD may simply reduce by way of the variable formation of 1:1 and 2:1 
complexes levels of free PFOA in solution in a concentration-dependent manner. Further 
research is needed to understand the mechanism of decreased toxicity, as well as to 
determine efficacy of β-CD at environmentally relevant concentrations of PFOA, and 
with respect to non-acute toxicological endpoints (specifically relevant to human health). 
However, these findings suggest that β-CD is a potentially promising tool for 
environmental remediation and mitigation of toxic effects of PFOA and, perhaps, related 
perfluorinated compounds as they relate to environmental health concerns. 
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CHAPTER 7 
General Conclusions 
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The fundamental host-guest interactions between PFASs and CDs are of 
paramount importance when developing CD-based environmental remediation and 
therapeutic strategies for PFAS contamination. The driving force behind the host-guest 
complexation is the favorable hydrophobic interactions between the PFAS fluorinated 
chain and the CD cavity. These van der Waals interactions are strongest for the complex 
between β-CD and legacy PFASs, due to the molecular sizes of these compounds, as well 
as the fully fluorinated chain of the legacy PFASs. Emerging ether PFASs also interact 
most favorably with β-CD, though these interactions are weaker than the legacy PFASs 
due to the insertion of hydrophilic ether oxygens along the perfluorinated backbone, 
disrupting the van der Waals forces. Second to the hydrophobic interactions arising from 
the fluorinated chain within the CD cavity are the hydrophilic interactions between the 
PFAS head group (carboxylate, sulfonate, sulfonamide) and the groups along the 
perimeter of the CD cavity. In native β-CD, hydrogen-bonding can occur between the 
PFAS head group and the primary hydroxyl groups. The host-guest complex is always 
formed in this configuration (PFAS head group oriented towards the smaller side of β-CD 
with the primary hydroxyl groups) even in cases of branching in the PFAS structure. 
Branching that favors this hydrogen bonding, such as branching near the PFAS tail, 
increases the strength of the complex; branching that inhibits or weakens this hydrogen 
bonding, such as branching near the PFAS head group, decreases the strength of the 
complex. Positively charged derivatives of β-CD can increase the strength of the 
complex, while negatively charged derivatives will weaken it. The effect of the positive 
charge depends upon the preexisting van der Waals forces and branching in the PFAS 
structure. PFASs that already have favorable hydrophobic interactions with the CD cavity 
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will only experience a slight to moderate increase in association with positively charged 
β-CD derivatives due to ionic bonding being stronger than hydrogen-bonding, whereas 
PFASs with weak preexisting van der Waals forces with the CD cavity will experience a 
large increase in association. Branching can either have a moderate to large increase in 
association or, alternatively, no change in association with positively charged β-CD 
derivatives, depending upon position of the branching and number of positively charged 
groups on the CD. Finally, 2:1 β-CD:PFAS interactions are most dependent upon PFAS 
chain length, with these complexes only being observed for PFASs with greater than six 
carbons or oxygens in a linear chain.   
 Studies with one of the most problematic legacy PFASs, PFOA, and β-CD 
suggest that β-CD has the potential to be used in real world therapeutic or remediation 
strategies. Addition of β-CD to the PFOA-HSA complex reversed the binding of PFOA 
to HSA, especially when using excess β-CD. Furthermore, a 2:1 β-CD:PFOA ratio 
corresponded to a highly significant increase in LC50 of zebrafish embryos compared to 
PFOA only or 1:1 β-CD:PFOA ratio conditions, suggesting that excess β-CD can inhibit 
the toxic effects of PFOA. These results agree with the NMR studies in which the β-
CD:PFOA complex was not significantly disturbed in different environmental conditions 
and while in the presence of competing CD guests.  
The conclusions gained from the fundamental studies, paired with the 
demonstration of principle with HSA and the zebrafish embryos, give insight into the 
mechanisms, dynamics, strength and structure of the host-guest complexation between 
CDs and PFASs. The unique structural characteristics of PFASs make them ideal guests 
for β-CD encapsulation. PFASs were found to have some of the strongest association 
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constants with β-CD and its derivatives reported in the literature. Thus, it is expected that 
β-CD and its derivatives will be highly selective towards encapsulation of PFASs in 
environmental and biological samples. Future research should be directed towards 
capitalizing upon these favorable host-guest interactions to develop remediation and 
therapeutic technologies for PFAS removal and sequestration.  
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APPENDICES 
 
Appendix 1: Chapter 2 
 
Structures 
 
Figure A1: Structures of cyclodextrins: a) α-CD; b) β-CD; c) γ-CD. 
 
Figure A2: PFASs included in this study: a) perfluorooctanoic acid (PFOA), a 
representative perfluorocarboxylic acid (four others were studied with carbon number of 
4, 5, 7, and 9); b) perfluorooctane sulfonate (PFOS); c) perfluorooctanesulfonamide 
(PFOSA); and d) 6:2 fluorotelomer sulfonate (6:2 FTS). Fluorines labeled by position. 
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19
F NMR Spectra of CD:PFAS Interactions 
 
 
 
 
Figure A3: 
19
F NMR spectra of perfluorobutanoic acid with a) α-CD; b) β-CD; and c) γ-
CD. [PFBA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from left to 
right: F4, F2, F3.  
a) 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A4: 
19F NMR spectra of perfluoropentanoic acid with a) α-CD; b) β-CD; and c) γ-
CD. [PFPA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from left to 
right: F5, F2, F3, F4. 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A5: 
19F NMR spectra of perfluoroheptanoic acid with a) α-CD; b) β-CD; and c) γ-
CD. [PFHpA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from left 
to right: F7, F2, F4, F5, F3, F6. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A6: 
19F NMR spectra of perfluorooctanoic acid with a) α-CD; b) β-CD; and c) γ-
CD. [PFOA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from left 
to right: F8, F2, F4, F5, F3, F6, F7. 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A7: 
19F NMR spectra of perfluorononanoic acid with a) α-CD; b) β-CD; and c) γ-
CD. [PFNA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from left 
to right: F9, F2, F4-6, F3, F7, F8. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A8: 
19
F NMR spectra of perfluorooctane sulfonate with a) α-CD; b) β-CD; and c) 
γ-CD. [PFOS] = 6.05 x 10-4 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks from 
left to right: F8, F1, F3, F4-5, F2, F6, F7. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A9: 
19
F NMR spectra of perfluorooctanesulfonamide with a) α-CD; b) β-CD; and 
c) γ-CD. [PFOSA] = 6.05 x 10-4 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks 
from left to right: F8, F1, F3, F2, F4, F5, F6, F7. 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A10: 
19F NMR spectra of 6:2 fluorotelomer sulfonate with a) α-CD; b) β-CD; and 
c) γ-CD. [6:2 FTS] = 6.05 x 10-4 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. Peaks 
from left to right: F8, F3, F5, F6, F4, F7. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Adamantane-Carboxylic Acid Competition Study 
 
 
Figure A11: 
19
F NMR spectra of adamantane-carboxylic acid competition study, detail of 
F2-F7 of PFOA. D2O, 400 MHz NMR. 
 
 
 
Figure A12: 
1
H NMR spectra of adamantane-carboxylic acid competition study, detail of 
adamantane-carboxylic acid protons. D2O, 400 MHz NMR. 
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Phenol Competition Study 
 
 
Figure A13: 
19
F NMR spectra of phenol competition study, detail of F2-F7 of PFOA. 
D2O, 400 MHz NMR. 
 
 
Figure A14: 
1
H NMR spectra of phenol competition study, detail of phenol protons. D2O, 
400 MHz NMR. 
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Job Analysis of β-CD:PFOA Interactions 
 
Table A1: Job Analysis of β-Cyclodextrin and Perfluorooctanoic Acid Interactions 
PFOA (μL) β-CD (μL) PFOA (mM) β-CD (mM) χPFOA 
([PFOA]/([PFOA]+[CD]) 
100 900 0.484 4.356 0.1 
200 800 0.968 3.872 0.2 
300 700 1.452 3.388 0.3 
400 600 1.936 2.904 0.4 
500 500 2.420 2.420 0.5 
600 400 2.904 1.936 0.6 
700 300 3.388 1.452 0.7 
800 200 3.872 0.968 0.8 
900 100 4.356 0.484 0.9 
1000 0 4.840 0.000 1.0 
 
 
 
 
Average Association Constants of CD:PFAS Interactions 
 
Table A2: Average Association Constants for α-, β-, and γ-CD with PFASs 
PFAS (#C) α-CD (M-1) β-CD (M-1) γ-CD (M-1) 
PFBA (4C) 8.2 ± 5.4 × 100 2.90 ± 0.24 × 102 
No significant 
association 
PFPA(5C) 3.1 ± 1.6 × 10
1
 7.60 ± 0.44 × 10
2
 
No significant 
association 
PFHpA (7C) 
No significant 
association 
4.30 ± 0.85 × 105 (1:1) 
2.30 ± 0.27 × 103 (2:1) 
3.50 ± 0.38 × 102 
PFOA (8C) 
No significant 
association 
5.00 ± 0.10 × 105 (1:1) 
1.20 ± 0.50 × 103 (2:1) 
8.80 ± 1.40 × 102 
PFNA (9C) 4.7 ± 2.1 × 101 
3.37 ± 0.35 × 105 (1:1) 
7.80 ± 0.66 × 103 (2:1) 
1.80 ± 0.96 × 103 
PFOS (8C) 
No significant 
association 
6.96 ± 0.79 × 105 (1:1) 
5.95 ± 1.70 × 104 (2:1) 
1.07 ± 0.42 × 103 
PFOSA (8C) 
No significant 
association 
1.02 ± 0.16 × 105 (1:1) 
2.70 ± 0.57 × 104 (2:1) 
9.80 ± 3.00 × 102 
6:2 FTS (8C) 2.60 ± 1.80 × 102 
8.99 ± 0.36 × 104 (1:1) 
1.35 ± 0.38 × 103 (2:1) 
6.70 ± 1.60 × 102 
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Individual Association Constants of CD:PFAS Interactions 
 
Table A3: Regression Analysis Results for Perfluorobutanoic Acid and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 9.3 ± 5.6 × 100 3.4 ± 1.9 0.999 
3 8.7 ± 5.4 × 100 7.6 ± 4.4 0.999 
4 6.7 ± 5.2 × 100 11.1 ± 8.1 0.999 
β 
2 2.30 ± 0.23 × 102 1.3 ± 0.1 0.999 
3 2.30 ± 0.23 × 102 0.91 ± 0.04 0.999 
4 4.10 ± 0.27 × 102 0.025 ± 0.005 0.945 
γ 
2 
No significant association 3 
4 
 
 
Table A4: Regression Analysis Results for Perfluoropentanoic Acid and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 1.37 ± 17.2 × 100 8.50 ± 10.50 0.989 
3 2.48 ± 1.61 × 101 1.13 ± 0.59 0.995 
4 3.22 ± 1.59 × 101 1.65 ± 0.63 0.996 
5 3.58 ± 1.36 × 101 2.21 ± 0.63 0.997 
β 
2 7.80 ± 0.44 × 102 1.02 ± 0.13 0.975 
3 7.62 ± 0.43 × 102 1.63 ± 0.22 0.974 
4 7.25 ± 0.41 × 102 0.37 ± 0.05 0.974 
5 7.72 ± 0.46 × 102 -0.42 ± 0.06 0.972 
γ 
2 
No significant association 
3 
4 
5 
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Table A5: Regression Analysis Results for Perfluoroheptanoic Acid and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
2 
No significant association 
3 
4 
5 
6 
7 
β 
2 
6.20 ± 0.24 × 
105 
7.56 ± 1.20 × 102 0.35 ± 0.01 -15.2 ± 3.5 0.953 
3 
2.62 ± 0.21 × 
104 
7.74 ± 0.41 × 103 1.3 ± 0.1 -6.5 ± 5.4 0.949 
4 
1.06 ± 0.43 × 
106 
2.49 ± 0.12 × 103 0.77 ± 0.04 -3.9 ± 1.0 0.794 
5 
6.92 ± 0.44 × 
105 
7.61 ± 1.66 × 102 0.57 ± 0.10 -17.3 ± 11.8 0.943 
6 
7.81 ± 0.40 × 
104 
8.90 ± 5.30 × 102 0.14 ± 0.01 -16.3 ± 2.4 0.993 
7 
9.22 ± 0.41 × 
104 
1.15 ± 0.28 × 103 
0.0023 ± 
0.0011 
-13.1 ± 8.2 0.995 
γ 
2 
4.18 ± 0.50 × 
102 
Not observed 0.47 ± 0.02 Not observed 0.999 
3 
6.71 ± 0.38 × 
102 
Not observed 0.35 ± 0.05 Not observed 0.966 
4 
2.15 ± 0.39 × 
10
2
 
Not observed -0.41 ± 0.03 Not observed 0.997 
5 
3.09 ± 0.15 × 
102 
Not observed -0.43 ± 0.07 Not observed 0.976 
6 
1.25 ± 0.46 × 
102 
Not observed -0.13 ± 0.03 Not observed 0.992 
7 No significant association 
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Table A6: Regression Analysis Results for Perfluorooctanoic Acid and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
2 
No significant association 
3 
4 
5 
6 
7 
8 
β 
2 
3.27 ± 0.94 × 
103 
Not observed 0.212 ± 0.006 Not observed 0.987 
3 
1.73 ± 0.28 × 
103 
Not observed 0.448 ± 0.011 Not observed 0.993 
4 
6.77 ± 0.39 × 
105 
1.01 ± 0.35 × 
103 
0.729 ± 0.027 -21.8 ± 5.8 0.997 
5 
4.04 ± 0.87 × 
105 
1.30 ± 0.42 × 
103 
0.815 ± 0.028 -22.1 ± 7.2 0.997 
6 
1.36 ± 0.14 × 
106 
1.18 ± 0.53 × 
103 
1.08 ± 0.05 -23.6 ± 7.9 0.993 
7 
2.27 ± 0.83 × 
104 
1.32 ± 0.98 × 
103 
0.302 ± 0.110 -16.1 ± 8.0 0.988 
8 
6.07 ± 0.73 × 
104 
1.17 ± 0.21 × 
103 
0.281 ± 0.020 -17.5 ± 2.3 0.999 
γ 
2 
1.55 ± 0.31 × 
103 
Not observed 0.21 ± 0.01 Not observed 0.997 
3 No significant association 
4 
3.91 ± 0.51 × 
102 
Not observed -0.66 ± 0.03 Not observed 0.998 
5 
7.46 ± 1.04 × 
102 
Not observed -0.59 ± 0.02 Not observed 0.998 
6 
1.10 ± 0.14 × 
103 
Not observed 0.30 ± 0.01 Not observed 0.999 
7 
6.35 ± 0.87 × 
102 
Not observed -0.15 ± 0.01 Not observed 0.998 
8 No significant association 
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Table A7: Regression Analysis Results for Perfluorononanoic Acid and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
2 No significant association 
3 
4.43 ± 1.48 × 
101 
Not observed 0.532 ± 0.128 Not observed 0.997 
4,5,6 
9.19 ± 6.42 × 
101 
Not observed 0.104 ± 0.042 Not observed 0.970 
7 
1.45 ± 0.50 × 
101 
Not observed 0.286 ± 0.860 Not observed 0.927 
8 
4.31 ± 1.49 × 
101 
Not observed 0.884 ± 0.220 Not observed 0.997 
9 
4.25 ± 0.74 × 
101 
Not observed 1.41 ± 0.18 Not observed 0.999 
β 
2 
2.82 ± 0.12 × 
105 
1.43 ± 0.28 × 
104 
-0.396 ± 
0.030 
4.18 ± 1.59 0.969 
3 No significant association 
4,5,6 
6.12 ± 0.75 × 
105 
4.37 ± 0.34 × 
103 
0.664 ± 0.126 -6.35 ± 0.68 0.948 
7 
7.36 ± 0.83 × 
105 
6.43 ± 1.30 × 
103 
1.30 ± 0.10 -10.6 ± 0.8 0.992 
8 
3.09 ± 0.12 × 
104 
6.89 ± 0.21 × 
103 
0.756 ± 0.424 -8.80 ± 0.38 0.999 
9 
2.66 ± 0.51 × 
104 
7.10 ± 0.80 × 
103 
0.813 ± 0.048 -9.03 ± 0.52 0.999 
γ 
2 
2.52 ± 0.63 × 
103 
Not observed 0.222 ± 0.007 Not observed 0.997 
3 No significant association 
4,5,6 
9.87 ± 6.50 × 
102 
Not observed 
-0.572 ± 
0.079 
Not observed 0.969 
7 
3.98 ± 2.50 × 
103 
Not observed 0.208 ± 0.013 Not observed 0.980 
8 
7.42 ± 5.50 × 
102 
Not observed 
-0.169 ± 
0.031 
Not observed 0.957 
9 
9.04 ± 4.80 × 
102 
Not observed 0.135 ± 0.016 Not observed 0.979 
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Table A8: Regression Analysis Results for Perfluorooctane Sulfonate and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
1 
No significant association 
2 
3 
4,5 
6 
7 
8 
β 
1 
6.14 ± 0.46 × 
105 
6.24 ± 1.92 × 
104 
-0.530 ± 
0.125 
4.00 ± 0.26 0.821 
2 
8.97 ± 1.26 × 
105 
9.49 ± 3.78 × 
104 
1.16 ± 0.31 -15.8 ± 7.9 0.975 
3 No significant association 
4,5 
1.41 ± 0.21 × 
106 
7.76 ± 1.10 × 
104 
0.837 ± 0.066 -8.55 ± 1.91 0.982 
6 
2.30 ± 0.49 × 
105 
8.21 ± 2.03 × 
104 
0.794 ± 0.044 -12.2 ± 1.2 0.982 
7 
3.10 ± 0.22 × 
105 
2.42 ± 0.49 × 
104 
0.201 ± 0.011 -4.50 ± 0.51 0.993 
8 
7.15 ± 0.21 × 
105 
1.62 ± 0.88 × 
104 
0.193 ± 0.500 -11.1 ± 1.6 0.931 
γ 
1 
1.53 ± 0.65 × 
103 
Not observed 
-0.557 ± 
0.065 
Not observed 0.965 
2 
8.92 ± 2.70 × 
10
2
 
Not observed 
-0.400 ± 
0.043 
Not observed 0.984 
3 
No significant association 
4,5 
6 
1.68 ± 0.25 × 
102 
Not observed 0.221 ± 0.022 Not observed 0.914 
7 No significant association 
8 
1.69 ± 0.75 × 
103 
Not observed 0.206 ± 0.024 Not observed 0.959 
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Table A9: Regression Analysis Results for Perfluorooctanesulfonamide and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
1 
No significant association 
2 
3 
4 
5 
6 
7 
8 
β 
1 No significant association 
2 
8.00 ± 1.08 × 
103 
1.34 ± 0.48 × 
103 
0.0592 ± 
0.0081 
-27.8 ± 7.0 0.995 
3 No significant association 
4 
6.34 ± 1.23 × 
104 
3.59 ± 1.37 × 
104 
0.849 ± 0.200 -9.88 ± 1.17 0.972 
5 
3.20 ± 0.66 × 
104 
2.58 ± 0.58 × 
104 
0.922 ± 0.081 -27.9 ± 4.7 0.991 
6 
1.99 ± 0.37 × 
105 
4.46 ± 0.66 × 
104 
0.885 ± 0.057 -17.4 ± 1.3 0.996 
7 
1.76 ± 0.25 × 
105 
2.15 ± 0.36 × 
104 
0.240 ± 0.015 -7.77 ± 0.88 0.996 
8 
1.33 ± 0.14 × 
105 
3.30 ± 0.42 × 
104 
0.370 ± 0.024 -9.59 ± 0.81 0.996 
γ 
1 
8.25 ± 0.28 × 
10
2
 
Not observed 
-0.373 ± 
0.005 
Not observed 1.000 
2 No significant association 
3 
1.00 ± 0.20 × 
103 
Not observed 
-0.300 ± 
0.020 
Not observed 0.993 
4 6.21 ± 1.40 × 
102 
Not observed 
-0.567 ± 
0.053 
Not observed 0.993 
5 
6 
9.97 ± 0.46 × 
103 
Not observed 
-0.132 ± 
0.007 
Not observed 0.966 
7 No significant association 
8 
1.47 ± 0.65 × 
103 
Not observed 0.123 ± 0.015 Not observed 0.955 
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Table A10: Regression Analysis Results for 6:2 Fluorotelomer Sulfonate and α-, β-, and γ-
Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
3 
6.86 ± 5.69 × 
101 
Not observed 1.64 ± 1.11 Not observed 0.991 
4 
1.79 ± 1.97 × 
102 
Not observed 0.877 ± 0.630 Not observed 0.949 
5 
1.89 ± 1.05 × 
103 
Not observed 
0.0678 ± 
0.0094 
Not observed 0.937 
6 
8.92 ± 5.70 × 
102 
Not observed 0.127 ± 0.029 Not observed 0.937 
7 
7.82 ± 6.03 × 
101 
Not observed 0.954 ± 0.585 Not observed 0.990 
8 
8.65 ± 3.72 × 
101 
Not observed 1.09 ± 0.37 Not observed 0.997 
β 
3 
1.98 ± 0.36 × 
104 
1.10 ± 0.47 × 
103 
0.0507 ± 
0.0116 
-38.4 ± 2.5 0.993 
4 No significant association 
5 
1.47 ± 0.37 × 
105 
7.13 ± 0.11 × 
103 
0.831 ± 0.117 -18.8 ± 2.1 0.918 
6 
2.14 ± 1.35 × 
105 
6.74 ± 0.31 × 
102 
0.553 ± 0.041 -59.4 ± 3.2 0.875 
7 
1.13 ± 0.18 × 
104 
1.76 ± 0.55 × 
103 
0.00653 ± 
0.00323 
-15.8 ± 2.5 0.987 
8 
5.76 ± 0.29 × 
104 
1.86 ± 0.73 × 
103 
0.00906 ± 
0.00595 
-24.79 ± 1.31 0.995 
γ 
3 
2.71 ± 1.02 × 
103 
Not observed 
0.0642 ± 
0.0051 
Not observed 0.967 
4 
8.59 ± 0.88 × 
102 
Not observed 
0.0578 ± 
0.0214 
Not observed 0.818 
5 
7.55 ± 1.38 × 
102 
Not observed 
-0.358 ± 
0.024 
Not observed 0.995 
6 
8.83 ± 1.40 × 
102 
Not observed 
-0.336 ± 
0.019 
Not observed 0.996 
7 
4.57 ± 1.34 × 
102 
Not observed 
-0.127 ± 
0.018 
Not observed 0.990 
8 
3.73 ± 2.90 × 
102 
Not observed 
0.0267 ± 
0.0105 
Not observed 0.934 
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Cross-Sectional Sizes 
 
Table A11: Cyclodextrin Cavity Size Compared with Size of Fluorinated Chain Fragment [5] 
Molecule 
Diameter (Å) 
CD: Cavity, PFAS: 
Molecule 
Cross Section (Å2) 
CD: Cavity, PFAS: 
Molecule 
Volume (Å3) 
CD: Cavity, PFAS:  
Molecule 
α-CD 4.9 18.9 174 
β-CD 6.2 30.2 262 
γ-CD 7.9 49.0 427 
CF2CF2CF2 6.0 28.3 249 
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19F NMR Spectra of β-CD:PFOA Interactions in Different Environmental Conditions 
 
 
 
 
Figure A15: 
19
F NMR spectra of PFOA and β-CD with a) 0.01 M NaCl; b) 0.1 M NaCl; 
and c) 1.0 M NaCl. [PFOA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A16: 
19F NMR spectra of PFOA and β-CD in a) pH 2; b) pH 4; and c) pH 10. 
[PFOA] = 0.00242 M, 50% D2O/50% H2O, 400 MHz NMR. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A17: 
19F NMR spectra of PFOA and β-CD with 0.5 g/L Humic acid. [PFOA] = 
0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
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Association Constants of β-CD:PFOA Interactions in Different Environmental 
Conditions 
 
Table A12: Regression Analysis Results for Effects of Ionic Strength on β-CD:PFOA Complex 
 [NaCl], M Fluorine K1:1, M
-1
 K2:1, M
-1 Δδcd-F, ppm 
Δδ2cd-F, 
ppm 
R
2
 
0.01 
2 
7.60 ± 1.98 
× 102 
Not observed 
0.270 ± 
0.017 
Not 
observed 
0.977 
3 
6.19 ± 1.25 
× 102 
Not observed 
0.508 ± 
0.027 
Not 
observed 
0.985 
4 
1.75 ± 0.55 
× 106 
5.98 ± 1.20 × 
102 
0.582 ± 
0.027 
-23.1 ± 2.4 0.944 
5 
1.19 ± 0.14 
× 106 
6.41 ± 0.81 × 
102 
0.646 ± 
0.029 
-27.8 ± 8.8 0.963 
6 
7.55 ± 0.23 
× 105 
6.33 ± 1.73 × 
102 
0.899 ± 
0.048 
-26.6 ± 3.3 0.930 
7 
1.64 ± 0.46 
× 105 
1.74 ± 0.51 × 
102 
0.153 ± 
0.007 
-67.0 ± 5.9 0.998 
8 
2.78 ± 0.15 
× 105 
3.30 ± 0.2 × 
102 
0.189 ± 
0.003 
-39.3 ± 5.8 0.999 
0.1 
2 
6.35 ± 1.43 
× 102 
Not observed 
0.302 ± 
0.017 
Not 
observed 
0.981 
3 
6.06 ± 1.31 
× 102 
Not observed 
0.535 ± 
0.030 
Not 
observed 
0.983 
4 
5.55 ± 0.27 
× 105 
3.82 ± 0.4 × 
102 
0.600 ± 
0.012 
-36.6 ± 8.3 0.984 
5 
6.05 ± 0.93 
× 105 
7.14 ± 0.45 × 
102 
0.668 ± 
0.025 
-26.6 ± 9.0 0.991 
6 
8.30 ± 0.81 
× 105 
5.25 ± 0.34 × 
102 
0.942 ± 
0.032 
-34.7 ± 4.4 0.976 
7 
3.11 ± 0.51 
× 105 
5.40 ± 0.58 × 
102 
0.181 ± 
0.0076 
-24.8 ± 3.3 0.997 
8 
2.80 ± 0.16 
× 105 
6.55 ± 0.27 × 
102 
0.202 ± 
0.017 
-21.5 ± 2.7 0.997 
1.0 
2 
2.39 ± 0.37 
× 102 
Not observed 
0.460 ± 
0.029 
Not 
observed 
0.991 
3 
3.30 ± 0.41 
× 102 
Not observed 
0.693 ± 
0.030 
Not 
observed 
0.994 
4 
2.31 ± 0.73 
× 104 
1.59 ± 0.18 × 
103 
0.791 ± 
0.270 
-18.7 ± 3.4 0.948 
5 
6.10 ± 0.99 
× 104 
1.23 ± 0.43 × 
103 
0.821 ± 
0.051 
-27.0 ± 3.1 0.980 
6 
2.04 ± 0.75 
× 105 
5.35 ± 0.77 × 
102 
0.944 ± 
0.100 
-48.7 ± 6.0 0.974 
7 
3.50 ± 0.57 
× 104 
1.78 ± 0.41 × 
103 
0.317 ± 
0.044 
-14.5 ± 2.0 0.998 
8 
2.10 ± 0.50 
× 105 
1.13 ± 0.23 × 
103 
0.275 ± 
0.020 
-20.2 ± 3.0 0.999 
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Table A13: Regression Analysis Results for Effects of pH on β-CD:PFOA Complex 
pH Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm 
Δδ2cd-F, 
ppm 
R2 
2 
2 
1.56 ± 0.47 × 
103 
Not observed 0.234 ± 0.012 
Not 
observed 
0.977 
3 
8.32 ± 1.68 × 
102 
Not observed 0.492 ± 0.022 
Not 
observed 
0.986 
4 
5.93 ± 1.18 × 
105 
1.54 ± 0.22 × 102 0.633 ± 0.022 -95.4 ± 3.8 0.980 
5 
7.41 ± 0.61 × 
105 
2.02 ± 0.52 × 102 0.658 ± 0.034 
-85.2 ± 
12.4 
0.986 
6 
7.61 ± 1.36 × 
105 
1.64 ± 0.66 × 102 0.956 ± 0.040 -107 ± 8 0.972 
7 
6.46 ± 0.30 × 
104 
1.60 ± 0.32 × 102 0.169 ± 0.008 -78.5 ± 2.3 0.998 
8 
1.56 ± 0.11 × 
104 
1.40 ± 0.50 × 102 0.206 ± 0.011 -94.5 ± 9.3 0.998 
4 
2 
1.56 ± 0.37 × 
103 
Not observed 0.244 ± 0.016 
Not 
observed 
0.969 
3 
1.06 ± 0.23 × 
103 
Not observed 0.478 ± 0.021 
Not 
observed 
0.984 
4 
9.39 ± 0.99 × 
105 
6.38 ± 0.77 × 102 0.650 ± 0.015 -25.4 ± 8.1 0.984 
5 
8.25 ± 0.30 × 
105 
1.25 ± 0.31 × 103 0.724 ± 0.022 -18.0 ± 3.1 0.988 
6 
7.93 ± 0.16 × 
105 
8.56 ± 0.33 × 102 0.993 ± 0.029 -23.9 ± 6.4 0.974 
7 
3.32 ± 0.17 × 
105 
6.73 ± 1.94 × 102 0.193 ± 0.008 -20.9 ± 2.1 0.995 
8 
4.87 ± 0.28 × 
104 
4.63 ± 1.18 × 102 0.215 ± 0.005 -30.7 ± 4.4 0.996 
10 
2 
8.57 ± 1.60 × 
102 
Not observed 0.263 ± 0.011 
Not 
observed 
0.988 
3 
6.01 ± 0.77 × 
102 
Not observed 0.518 ± 0.018 
Not 
observed 
0.994 
4 
6.23 ± 0.35 × 
105 
3.44 ± 0.88 × 102 0.592 ± 0.058 
-39.7 ± 
11.4 
0.961 
5 
3.72 ± 0.20 × 
105 
6.12 ± 0.87 × 102 0.669 ± 0.078 -31.4 ± 7.8 0.968 
6 
7.47 +/- 0.21 × 
105 
2.61 ± 0.11 × 102 0.904 ± 0.075 -61.8 ± 3.3 0.944 
7 
1.98 ± 0.46 × 
104 
2.00 ± 0.91 × 103 0.279 ± 0.079 
-9.59 ± 
2.39 
0.993 
8 
2.55 ± 0.15 × 
104 
1.83 ± 0.15 × 103 0.293 ± 0.019 -10.5 ± 3.0 0.992 
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Table A14: Regression Analysis Results for Effects of Presence of Humic Acid on β-CD:PFOA 
Complex 
Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
2 
1.63 ± 0.46 × 
103 
Not observed 0.226 ± 0.010 
Not 
observed 
0.980 
3 
8.53 ± 1.72 × 
102 
Not observed 0.476 ± 0.021 
Not 
observed 
0.986 
4 
9.55 ± 1.50 × 
105 
4.26 ± 0.30 × 102 0.615 ± 0.071 -34.0 ± 9.4 0.962 
5 
8.23 ± 0.44 × 
105 
4.96 ± 0.20 × 102 0.658 ± 0.046 -36.5 ± 2.2 0.975 
6 
1.05 ± 0.41 × 
106 
4.23 ± 0.97 × 102 0.922 ± 0.160 -40.8 ± 2.6 0.953 
7 
1.36 ± 0.80 × 
105 
5.46 ± 0.40 × 102 0.196 ± 0.010 -25.6 ± 2.2 0.999 
8 
9.97 ± 0.22 × 
104 
5.79 ± 2.49 × 102 0.216 ± 0.020 -25.4 ± 9.2 0.998 
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Appendix 2: Chapter 3 
 
Numbering System of PFECAs 
Table A15: Structures of Studied Perfluoroethercarboxylic Acids 
Name 
(Abbreviation) 
Oxygen 
content 
(#O / 
chain 
length) 
Structure 
Perfluoro(3-
oxabutanoic) acid 
(PFMOPrA) 
HOC 
(0.6) 
 
Perfluoro(4-
oxapentanoic) 
acid (PFMOBA) 
HOC 
(0.5) 
 
Perfluoro(2-
methyl-3-
oxahexanoic) acid 
(PFPrOPrA, 
“GenX”) 
HOC 
(0.5) 
 
Perfluoro(5-oxa-
6-
dimethylhexanoic) 
acid 
(PFDMMOBA) 
LOC 
(0.4) 
 
Perfluoro(3,6-
dioxaheptanoic) 
acid (PFO2HpA) 
HOC 
(0.6) 
 
Perfluoro(3,6-
dioxadecanoic) 
acid (PFO2DA) 
LOC 
(0.4) 
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Perfluoro(3,6,9-
trioxadecanoic) 
acid (PFO3DA) 
HOC 
(0.5) 
 
Perfluoro(3,6,9-
trioxatridecanoic) 
acid (PFO3TDA) 
LOC 
(0.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
152 
 
Characterization of PFECAs by 
19
F and 
13
C NMR 
Note: 
19
F coupling constants depend on conformation of the compound 
 
Perfluoro(3-oxabutanoic) acid (PFMOPrA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -57.0 (t, J = 9.1 Hz, 3F), -90.0 (m, 2F), -122.7 (t, J = 3.2 Hz, 2F). 
13
C NMR (CDCl3; referenced to CDCl3) δ = 160.0, 119.1, 114.9, 106.2. 
 
Perfluoro(4-oxapentanoic) acid (PFMOBA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -57.8 (t, J = 9.3 Hz, 3F), -87.7 (q, J = 9.3 Hz, 2F), -119.9 (t, J = 
9.3 Hz, 2F), -129.4 (s, 2F). 
13
C NMR (CDCl3; referenced to CDCl3) δ = 160.9, 119.0, 
114.7, 108.1, 107.6. 
 
Perfluoro(2-methyl-3-oxahexanoic) acid (PFPrOPrA, “GenX”):  19F NMR (D2O; 
referenced to hexafluorobenzene) δ = -82.8 (m, 1F), -83.1 (t, J = 7.4 Hz, 3F), -84.3 (d, J = 
3.3 Hz, 3F), -87.6 (m, 1F), -128.7 (d, J = 21.0, 1F), -131.7 (s, 2F). 
13
C NMR (CDCl3; 
referenced to CDCl3) δ = 161.5, 117.8, 117.0, 115.8, 106.4, 100.3. 
 
Perfluoro(5-oxa-6-dimethylhexanoic) acid (PFDMMOBA): 
19
F NMR (D2O; 
referenced to hexafluorobenzene) δ = -82.3 (td, J = 5.8 Hz, 2.2 Hz, 6F), -83.2 (br, 2F), -
119.6 (t, J = 8.0 Hz, 2F), -128.8 (t, J = 3.2 Hz, 2F), -147.1 (t, J = 21.3 Hz, 1F). 
13
C NMR 
(CDCl3; referenced to CDCl3) δ = 160.2, 117.4, 115.9, 108.3, 107.6, 101.8. 
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Perfluoro(3,6-dioxaheptanoic) acid (PFO2HpA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -57.0 (t, J = 8.9 Hz, 3F), -79.6 (t, J = 10.4 Hz, 2F), -90.3 (t, J = 
10.4 Hz, 2F), -92.5 (q, J = 8.9 Hz, 2F). 
13
C NMR (CDCl3; referenced to CDCl3) δ = 
159.4, 119.1, 114.0, 113.3, 112.9. 
 
Perfluoro(3,6-dioxadecanoic) acid (PFO2DA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -79.7 (t, J = 10.5 Hz, 2F), -82.9 (t, J = 9.2 Hz, 3F), -85.4 (br, 2F), 
-90.5 (m, 4F), -128.3 (t, J = 9.2 Hz, 2F), -128.4 (br, 2F). 
13
C NMR (CDCl3; referenced to 
CDCl3) δ = 159.2, 117.1, 115.5, 114.4, 114.0, 112.2, 108.1, 107.9. 
 
Perfluoro(3,6,9-trioxadecanoic) acid (PFO3DA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -57.0 (t, J = 9.0 Hz, 3F), -79.7 (t, J = 10.4 Hz, 2F), -90.3 (m, 4F), 
-90.5 (m, 2F), -92.3 (q, J = 9.0 Hz, 2F). 
13
C NMR (CDCl3; referenced to CDCl3) δ = 
159.3, 119.1, 114.3, 114.1, 114.0, 113.1, 112.9. 
 
Perfluoro(3,6,9-trioxatridecanoic) acid (PFO3TDA): 
19
F NMR (D2O; referenced to 
hexafluorobenzene) δ = -79.6 (t, J = 10.9 Hz, 2F), -82.9 (t, J = 8.5 Hz, 3F), -85.4 (br, 2F), 
-90.6 (m, 4F), -90.8 (s, 4F), -128.4 (br, 2F), -128.5 (br, 2F). 
13
C NMR (CDCl3; referenced 
to CDCl3) δ = 158.8, 117.0, 115.5, 114.3, 114.2, 114.1, 113.9, 112.9, 108.0, 107.9. 
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19
F NMR Spectra of CD:PFECA Interactions 
 
Figure A18: 
19
F NMR spectra of perfluoro(3-oxabutanoic) acid with a) α-CD; b) β-CD; 
and c) γ-CD. [PFMOPrA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
Peaks from left to right: F5, F3, F2. 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A19: 
19
F NMR spectra of perfluoro(4-oxapentanoic) acid with a) α-CD; b) β-CD; 
and c) γ-CD. [PFMOBA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
Peaks from left to right: F6, F4, F2, F3. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A20: 
19
F NMR spectra of perfluoro(2-methyl-3-oxahexanoic) acid with a) α-CD; 
b) β-CD; and c) γ-CD. [PFPrOPrA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz 
NMR. Peaks from left to right: F5a, F7, F3, F5b, F2, F6. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A21: 
19
F NMR spectra of perfluoro(5-oxa-6-dimethylhexanoic) acid with a) α-
CD; b) β-CD; and c) γ-CD. [PFDMMOBA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 
MHz NMR. Peaks from left to right: F7, F4, F2, F3, F6. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A22: 
19
F NMR spectra of perfluoro(3,6-dioxaheptanoic) acid with a) α-CD; b) β-
CD; and c) γ-CD. [PFO2HpA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
Peaks from left to right: F7, F2, F4, F5. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A23: 
19
F NMR spectra of perfluoro(3,6-dioxadecanoic) acid with a) α-CD; b) β-
CD; and c) γ-CD. [PFO2DA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
Peaks from left to right: F2, F10, F7, F4-F5, F8, F9. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A24: 
19
F NMR spectra of perfluoro(3,6,9-trioxadecanoic) acid with a) α-CD; b) β-
CD; and c) γ-CD. [PFO3DA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
Peaks from left to right: F10, F2, F4-5, F7, F8. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
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Figure A25: 
19
F NMR spectra of perfluoro(3,6,9-trioxatridecanoic) acid with a) α-CD; b) 
β-CD; and c) γ-CD. [PFO3TDA] = 6.05 x 10-4 M, pH 7, 50% D2O/50% H2O, 400 MHz 
NMR. Peaks from left to right: F2, F13, F10, F4-5, F7-8, F11, F12. 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
c) 
162 
 
Individual Association Constants of CD:PFECA Interactions 
 
Table A16: Regression Analysis Results for PFMOPrA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 2.50 ± 1.54 × 101 1.24 ± 0.62 0.995 
3 2.62 ± 1.03 × 101 2.37 ± 0.75 0.998 
5 2.67 ± 0.84 × 101 3.15 ± 0.79 0.999 
β 
2 1.17 ± 0.47 × 102 1.37 ± 0.29 0.989 
3 1.23 ± 0.47 × 102 1.44 ± 0.29 0.990 
5 2.22 ± 0.63 × 102 -0.206 ± 0.024 0.992 
γ 
2 
No significant association 3 
5 
 
Table A17: Regression Analysis Results for PFMOBA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 3.10 ± 1.57 × 101 0.85 ± 0.33 0.996 
3 3.69 ± 1.44 × 101 1.53 ± 0.45 0.997 
4 3.62 ± 1.28 × 101 1.48 ± 0.39 0.997 
6 3.05 ± 1.30 × 101 2.98 ± 0.99 0.997 
β 
2 1.47 ± 0.36 × 103 1.20 ± 0.05 0.995 
3 1.46 ± 0.37 × 103 2.10 ± 0.09 0.995 
4 1.45 ± 0.36 × 103 1.01 ± 0.04 0.995 
6 1.55 ± 0.35 × 103 -0.193 ± 0.007 0.996 
γ 
2 
No significant association 
3 
4 
6 
 
Table A18: Regression Analysis Results for PFPrOPrA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 1.74 ± 0.95 × 102 0.177 ± 0.045 0.974 
3 1.56 ± 0.49 × 102 0.202 ± 0.031 0.992 
5 2.54 ± 1.78 × 102 0.186 ± 0.052 0.954 
6 1.70 ± 0.67 × 102 0.207 ± 0.038 0.987 
7 4.24 ± 1.60 × 102 0.0744 ± 0.0089 0.985 
β 
2 2.12 ± 1.39 × 103 1.88 ± 0.17 0.978 
3 1.01  ± 0.65 × 103 0.507 ± 0.116 0.942 
5a 
5b 
3.58 ± 1.01 × 102  
9.18 ± 3.82 × 102  
-3.12 ± 0.30 
4.09 ± 0.37 
0.992  
0.986 
6a,b 4.66 ± 2.70 × 101 -1.24 ± 0.51 0.991 
7 1.77 ± 1.04 × 101 -2.04 ± 1.02 0.998 
γ 
2 
No significant association 
3 
5 
6 
7 
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Table A19: Regression Analysis Results for PFDMMOBA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
α 
2 
No significant association 
3 
4 
6 
7 
β 
2 1.07 ± 0.57 × 104 0.878 ± 0.026 0.995 
3 2.00 ± 0.21 × 104 2.12 ± 0.05 0.996 
4 1.79 ± 1.15 × 104 1.84 ± 0.05 0.970 
6 2.26 ± 0.43 × 102 -1.28 ± 0.10 0.997 
7 5.77 ± 0.49 × 104 0.294 ± 0.028 0.999 
γ 
2 7.14 ± 1.24 × 102 0.319 ± 0.014 0.997 
3 6.05 ± 0.81 × 102 0.939 ± 0.033 0.998 
4 7.34 ± 4.68 × 101 0.344 ± 0.137 0.984 
6 1.07 ± 0.33 × 103 -0.937 ± 0.059 0.990 
7 9.64 ± 3.26 × 102 -0.184 ± 0.013 0.988 
  
 
Table A20: Regression Analysis Results for PFO2HpA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
2 
No significant association 
4 
5 
5.61 ± 0.42 × 
101 
Not observed 0.425 ± 0.022 
Not 
observed 
0.999 
7 
5.06 ± 0.53 × 
10
1
 
Not observed 1.17 ± 0.09 
Not 
observed 
0.999 
β 
2 
6.51 ± 3.29 × 
102 
3.45 ± 1.23 × 
102 
0.979 ± 0.264 -31.7 ± 5.5 0.992 
4 
5.46 ± 2.16 × 
102 
3.07 ± 1.41 × 
102 
0.797 ± 0.357 -36.1 ± 6.3 0.988 
5 
2.26 ± 0.68 × 
102 
5.10 ± 1.57 × 
102 
0.861 ± 0.127 -28.9 ± 3.9 0.989 
7 
2.02 ± 0.59 × 
101 
Not observed -2.58 ± 0.62 
Not 
observed 
0.996 
γ 
2 
5.26 ± 1.16 × 
101 
Not observed 0.527 ± 0.080 
Not 
observed 
0.998 
4 
1.33 ± 0.75 × 
102 
Not observed 
0.0446 ± 
0.0129 
Not 
observed 
0.977 
5 No significant association 
7 
6.74 ± 1.05 × 
101 
Not observed 0.222 ± 0.022 
Not 
observed 
0.999 
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Table A21: Regression Analysis Results for PFO2DA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
α 
2 
No significant association 
4 
5 
7 
8 
9 
10 
β 
2 
2.85 ± 0.40 × 
104 
5.18 ± 1.24 × 103 0.706 ± 0.028 -7.13 ± 2.23 0.993 
4 
8.83 ± 2.33 × 
102 
Not observed 1.45 ± 0.08 
Not 
observed 
0.975 
5 
1.74 ± 0.62 × 
104 
9.23 ± 2.07 × 103 2.29 ± 0.21 -15.7 ± 2.06 0.987 
7 
9.27 ± 1.66 × 
103 
1.01 ± 0.28 × 104 2.60 ± 0.24 -18.2 ± 2.5 0.990 
8 
1.64 ± 0.53 × 
104 
1.02 ± 0.65 × 104 1.17 ± 0.95 -9.42 ± 2.16 0.966 
9 
6.76 ± 1.79 × 
103 
5.47 ± 0.40 × 103 0.896 ± 0.014 -13.6 ± 5.6 0.997 
10 
1.77 ± 0.88 × 
104 
6.11 ± 1.60 × 103 0.764 ± 0.154 -7.43 ± 0.45 0.994 
γ 
2 
1.10 ± 0.22 × 
103 
Not observed 0.631 ± 0.025 
Not 
observed 
0.996 
4 
1.83 ± 0.37 × 
10
3
 
Not observed 
-0.308 ± 
0.010 
Not 
observed 
0.997 
5 
1.83 ± 0.37 × 
103 
Not observed 
-0.308 ± 
0.010 
Not 
observed 
0.997 
7 No significant association 
8 
2.80 ± 1.90 × 
101 
Not observed 0.290 ± 0.155 
Not 
observed 
0.994 
9 
3.13 ± 1.20 × 
103 
Not observed 
-0.295 ± 
0.013 
Not 
observed 
0.992 
10 
4.05 ± 0.74 × 
102 
Not observed 0.270 ± 0.016 
Not 
observed 
0.997 
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Table A22: Regression Analysis Results for PFO3DA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm 
Δδ2cd-F, 
ppm 
R2 
α 
2 
No significant association 
4 
5 
7 
8 
1.59 ± 0.44 × 
102 
Not observed 0.125 ± 0.020 
Not 
observed 
0.999 
10 
2.66 ± 1.17 × 
101 
Not observed 1.34 ± 0.51 
Not 
observed 
0.999 
β 
2 
4.22 ± 1.39 × 
103 
3.76 ± 1.15 × 103 0.716 ± 0.031 
-8.19 ± 
2.40 
0.988 
4 
4.73 ± 2.34 × 
103 
Not observed 0.514 ± 0.022 
Not 
observed 
0.966 
5 
6.64 ± 1.70 × 
103 
1.70 ± 0.48 × 103 0.771 ± 0.082 -21.1 ± 5.3 0.981 
7 
2.47 ± 1.11 × 
102 
4.69 ± 1.27 × 103 14.0 ± 5.6 
-81.7 ± 
33.1 
0.984 
8 
1.25 ± 0.35 × 
103 
5.63 ± 1.32 × 103 1.56 ± 0.12 -16.7 ± 4.5 0.996 
10 
1.12 ± 0.66 × 
103 
4.81 ± 1.16 × 103 0.962 ± 0.105 -11.8 ± 5.1 0.996 
γ 
2 
4.28 ± 0.58 × 
102 
Not observed 0.516 ± 0.022 
Not 
observed 
0.998 
4 
No significant association 
5 
7 
6.75 ± 1.16 × 
102 
Not observed -0.356 ± 0.016 
Not 
observed 
0.997 
8 
1.52 ± 0.33 × 
103 
Not observed -0.205 ± 0.007 
Not 
observed 
0.996 
10 
4.17 ± 3.34 × 
102 
Not observed 
-0.0388 ± 
0.0099 
Not 
observed 
0.950 
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Table A23: Regression Analysis Results for PFO3TDA and α-, β-, and γ-Cyclodextrin 
CD Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm 
Δδ2cd-F, 
ppm 
R2 
α 
2 
No significant association 
4 
5 
7 
8 
10 
11 
12 
13 
β 
2 
8.28 ± 0.47 × 
105 
3.79 ± 1.51 × 104 0.361 ± 0.023 
-3.62 ± 
1.37 
0.968 
4 
1.75 ± 0.64 × 
106 
6.45 ± 0.76 × 104 0.853 ± 0.050 
-6.32 ± 
1.42 
0.960 
5 
3.25 ± 0.21 × 
105 
1.94 ± 0.99 × 105 0.113 ± 0.032 2.77 ± 0.33 0.936 
7 No significant association 
8 
3.68 ± 0.97 × 
103 
1.78 ± 0.36 × 105 0.147 ± 0.068 4.50 ± 0.97 0.951 
10 
4.88 ± 0.39 × 
105 
3.62 ± 0.29 × 105 0.152 ± 0.090 1.04 ± 0.70 0.920 
11 
5.72 ± 0.30 × 
104 
1.57 ± 0.23 × 105 
-0.335 ± 
0.257 
5.26 ± 1.33 0.967 
12 
6.93 ± 1.20 × 
10
5
 
7.27 ± 0.73 × 104 0.442 ± 0.059 
-5.89 ± 
1.22 
0.976 
13 
6.03 ± 0.86 × 
105 
2.21 ± 1.01 × 104 0.263 ± 0.019 
-4.47 ± 
0.83 
0.975 
γ 
2 
9.16 ± 1.18 × 
102 
Not observed 0.817 ± 0.026 
Not 
observed 
0.996 
4 
No significant association 
5 
7 
8 
10 
11 
12 
1.95 ± 0.93 × 
103 
Not observed 0.921 ± 0.075 
Not 
observed 
0.955 
13 
7.58 ± 3.46 × 
103 
Not observed 1.03 ± 0.04 
Not 
observed 
0.971 
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Appendix 3: Chapter 4 
 
Structures 
 
 
 
Figure A26: Structures of β-CD derivatives: a) mono-am-β-CD; b) hepta-am-β-CD; c) 
QACD; d) SBECD. “DS” refers to the degree of substitution. 
 
 
 
 
 
 
 
 
 
 
168 
 
19
F NMR Spectra of β-CD Derivative:PFAS Interactions 
 
 
 
Figure A27: 
19
F NMR spectra of perfluorobutanoic acid with (clockwise, from top left): 
mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. [PFBA] = 0.00242 M, pH 7, 50% 
D2O/50% H2O, 400 MHz NMR. 
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Figure A28: 
19
F NMR spectra of perfluoropentanoic acid with (clockwise, from top left): 
mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. [PFPA] = 0.00242 M, pH 7, 50% 
D2O/50% H2O, 400 MHz NMR. 
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Figure A29: 
19
F NMR spectra of perfluoro(3-oxabutanoic) acid with (clockwise, from top 
left): mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. [PFMOPrA] = 0.00242 M, 
pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
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Figure A30: 
19
F NMR spectra of perfluoro(4-oxapentanoic) acid with (clockwise, from 
top left): mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. [PFMOBA] = 0.00242 
M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
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Figure A31: 
19
F NMR spectra of perfluoro(2-methyl-3-oxahexanoic) acid with 
(clockwise, from top left): mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. 
[PFPrOPrA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
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Figure A32: 
19
F NMR spectra of perfluoro(5-oxa-6-dimethylhexanoic) acid with 
(clockwise, from top left): mono-am-β-CD; hepta-am-β-CD; QACD; and SBECD. 
[PFDMMOBA] = 0.00242 M, pH 7, 50% D2O/50% H2O, 400 MHz NMR. 
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Individual Association Constants of Emerging PFASs with CD Derivatives 
 
Table A24: Regression analysis results for PFBA with Mono-am-β-CD, Hepta-am-β-CD, QACD, 
and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 2.10 ± 1.02 × 102 1.51 ± 0.31 0.982 
3 2.04 ± 1.00 × 102 1.36 ± 0.29 0.982 
4 2.33 ± 1.10 × 102 0.0803 ± 0.0156 0.982 
Hepta-am-
β-CD 
2 7.05 ± 3.26 × 102 1.11 ± 0.13 0.981 
3 1.28 ± 0.51 × 103 0.897 ± 0.065 0.988 
4 1.09 ± 0.35 × 103 0.265 ± 0.017 0.991 
QACD 
2 1.93 ± 0.37 × 102 2.20 ± 0.19 0.997 
3 1.17 ± 0.27 × 102 1.76 ± 0.22 0.997 
4 1.28 ± 0.28 × 102 0.319 ± 0.036 0.997 
SBECD 
2 
No significant association 3 
4 
 
 
Table A25: Regression Analysis Results for PFPA with Mono-am-β-CD, Hepta-am-β-CD, 
QACD, and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 1.04 ± 0.61 × 103 0.731 ± 0.087 0.975 
3 1.01 ± 0.59 × 103 1.54 ± 0.19 0.974 
4 9.66 ± 5.68 × 102 0.445 ± 0.055 0.974 
5 1.02 ± 0.65 × 103 -0.402 ± 0.052 0.971 
Hepta-am-
β-CD 
2 5.69 ± 4.23 × 10
2
 0.703 ± 0.144 0.956 
3 1.22 ± 0.70 × 103 1.10 ± 0.12 0.977 
4 1.72 ± 1.03 × 103 0.488 ± 0.045 0.978 
5 6.98 ± 1.02 × 103 -0.0269 ± 0.0028 0.945 
QACD 
2 6.70 ± 3.09 × 102 1.60 ± 0.19 0.981 
3 6.11 ± 3.02 × 102 1.96 ± 0.26 0.978 
4 5.34 ± 2.82 × 102 0.637 ± 0.095 0.975 
5 8.57 ± 4.72 × 102 -0.203 ± 0.025 0.976 
SBECD 
2 1.06 ± 0.18 × 102 2.29 ± 0.22 0.998 
3 1.06 ± 0.17 × 102 3.01 ± 0.27 0.999 
4 9.96 ± 1.48 × 101 0.859 ± 0.072 0.999 
5 1.17 ± 0.21 × 102 -0.302 ± 0.029 0.998 
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Table A26: Regression Analysis Results for PFMOPrA with Mono-am-β-CD, Hepta-am-β-CD, 
QACD, and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 7.16 ± 0.83 × 102 0.670 ± 0.019 0.999 
3 6.64 ± 0.90 × 102 1.00 ± 0.03 0.998 
5 5.37 ± 1.45 × 102 -0.107 ± 0.008 0.993 
Hepta-am-
β-CD 
2 1.53 ± 0.69 × 103 0.675 ± 0.051 0.986 
3 5.32 ± 2.28 × 103 0.851 ± 0.030 0.994 
5 2.34 ± 1.03 × 103 0.112 ± 0.006 0.990 
QACD 
2 8.37 ± 1.33 × 102 1.65 ± 0.06 0.998 
3 6.76 ± 0.86 × 102 1.46 ± 0.05 0.998 
5 5.62 ± 2.49 × 102 0.0271 ± 0.0033 0.979 
SBECD 
2 
No significant association 3 
5 
 
 
Table A27: Regression Analysis Results for PFMOBA with Mono-am-β-CD, Hepta-am-β-CD, 
QACD, and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 1.97 ± 1.07 × 103 1.08 ± 0.08 0.984 
3 1.97 ± 1.06 × 103 2.23 ± 0.17 0.984 
4 1.82 ± 0.99 × 103 1.20 ± 0.10 0.983 
6 1.30 ± 0.96 × 103 -0.0155 ± 0.0008 0.966 
Hepta-am-
β-CD 
2 2.99 ± 0.67 × 103 0.835 ± 0.054 0.986 
3 4.94 ± 1.20 × 103 2.11 ± 0.08 0.994 
4 6.97 ± 1.24 × 10
3
 1.24 ± 0.04 0.994 
6 3.36 ± 1.77 × 103 0.227 ± 0.013 0.989 
QACD 
2 2.72 ± 0.61 × 103 1.61 ± 0.11 0.984 
3 2.59 ± 0.58 × 103 2.37 ± 0.18 0.983 
4 2.51 ± 0.58 × 103 1.21 ± 0.10 0.981 
6 5.35 ± 0.74 × 103 -0.0638 ± 0.0021 0.990 
SBECD 
2 1.15 ± 0.24 × 102 2.49 ± 0.29 0.997 
3 1.19 ± 0.25 × 102 3.71 ± 0.42 0.997 
4 1.13 ± 0.24 × 102 1.82 ± 0.21 0.997 
6 3.98 ± 1.81 × 101 0.0876 ± 0.0293 0.995 
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Table A28: Regression Analysis Results for PFPrOPrA with Mono-am-β-CD, Hepta-am-β-CD, 
QACD, and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 1.20 ± 0.49 × 104 2.08 ± 0.04 0.997 
3 1.09 ± 0.42 × 104 0.340 ± 0.007 0.997 
5a 1.13 ± 0.50 × 104 
3.56 ± 1.22 × 104 
-1.35 ± 0.57 
2.89 ± 0.16 
0.993 
0.956 5b 
6a,b 8.58 ± 0.51 × 103 -0.282 ± 0.010 0.992 
7 1.47 ± 1.02 × 104 -0.217 ± 0.007 0.993 
Hepta-am-
β-CD 
2 1.94 ± 1.37 × 103 2.97 ± 0.31 0.973 
3 2.34 ± 0.96 × 103 0.660 ± 0.036 0.991 
5a 
5b 
1.42 ± 1.03 × 103 
1.94 ± 1.49 × 103 
-1.27 ± 0.16 
3.21 ± 0.24 
0.967 
0.969 
6a,b 3.28 ± 1.82 × 103 -0.154 ± 0.009 0.983 
7 2.52 ± 1.02 × 102 0.244 ± 0.039 0.986 
QACD 
2 4.94 ± 1.71 × 102 2.53 ± 0.25 0.990 
3 5.88 ± 2.14 × 102 0.511 ± 0.049 0.989 
5a 4.38 ± 1.68 × 102 
4.44 ± 1.67 × 102 
-1.96 ± 0.23 
4.49 ± 0.51 
0.987 
0.988 5b 
6a,b 1.61 ± 0.56 × 102 0.351 ± 0.160 0.994 
7 5.36 ± 2.22 × 102 0.289 ± 0.033 0.986 
SBECD 
2 1.23 ± 0.31 × 102 3.56 ± 0.47 0.996 
3 1.13 ± 0.33 × 102 0.649 ± 0.104 0.995 
5a 
5b 
2.84 ± 1.13 × 102 
2.41 ± 1.10 × 102 
-2.09 ± 0.59 
4.98 ± 0.92 
0.951 
0.983 
6a,b 9.08 ± 3.43 × 101 0.274 ± 0.061 0.993 
7 1.37 ± 1.07 × 10
3
 -0.0126 ± 0.0017 0.942 
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Table A29: Regression Analysis Results for PFDMMOBA with Mono-am-β-CD, Hepta-am-β-
CD, QACD, and SBECD 
CD Fluorine K1:1, M
-1 Δδcd-F, ppm R
2 
Mono-am-
β-CD 
2 1.18 ± 0.72 × 104 0.669 ± 0.021 0.993 
3 2.63 ± 0.40 × 104 2.09 ± 0.04 0.997 
4 9.29 ± 0.63 × 104 1.64 ± 0.05 0.974 
6 4.51 ± 1.22 × 102 -1.31 ± 0.11 0.993 
7 5.87 ± 1.99 × 103 0.154 ± 0.029 0.999 
Hepta-am-
β-CD 
2 1.67 ± 0.32 × 105 0.614 ± 0.016 0.992 
3 3.70 ± 0.97 × 105 1.81 ± 0.13 0.931 
4 3.68 ± 0.84 × 105 1.45 ± 0.057 0.972 
6 6.91 ± 1.79 × 104 -0.591 ± 0.050 0.962 
7 8.52 ± 1.59 × 104 -0.217 ± 0.008 0.984 
QACD 
2 1.33 ± 0.21 × 105 1.15 ± 0.03 0.994 
3 2.74 ± 0.60 × 105 2.29 ± 0.05 0.994 
4 2.17 ± 0.36 × 105 2.03 ± 0.05 0.994 
6 6.57 ± 0.39 × 104 -0.220 ± 0.009 0.991 
7 3.21 ± 1.63 × 105 0.345 ± 0.005 0.997 
SBECD 
2 7.35 ± 1.62 × 103 1.11 ± 0.05 0.989 
3 5.88 ± 1.67 × 103 2.42 ± 0.17 0.978 
4 6.38 ± 1.40 × 103 2.10 ± 0.10 0.989 
6 1.93 ± 0.56 × 103 -0.163 ± 0.014 0.978 
7 1.09 ± 0.87 × 104 0.380 ± 0.017 0.986 
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Appendix 4: Chapter 5 
 
Representative Absorbance Spectra of HSA in the Presence and Absence of PFOA and β-
CD and Equation for Correcting Fluorescence Emission Spectra 
 
Figure A33: Representative absorbance spectra of 10 μM HSA with no PFOA, 10 μM 
PFOA, and 100 μM PFOA.  
 
 
 
Figure A34: Representative absorbance spectra of 10 μM HSA and 100 μM PFOA with 
no β-CD, 100 μM β-CD, 200 μM β-CD, and 500 μM β-CD. 
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To correct for the inner filter effect, the following equation (Bolattin et al. 2016) is used: 
 
 
 
𝐹𝑐𝑜𝑟𝑟 = 𝐹𝑜𝑏𝑠𝑒
(𝐴𝑒𝑥+𝐴𝑒𝑚)/2                                              (S16) 
 
 
where Fcorr is the corrected fluorescence intensity, Fobs is the observed fluorescence 
intensity, Aex is the absorbance at the excitation wavelength (295 nm), and Aem is the 
absorbance at the emission wavelength (335 nm). The absorbance at 295 nm and 335 nm 
was low; although the fluorescence data was corrected, this correction did not 
significantly alter the results and did not affect the trends observed in the fluorescence 
data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
180 
 
19F NMR Spectra of β-CD:PFOA Interactions in the Presence and Absence of HSA 
 
Figure A35: 
19
F NMR spectra of 2.42 mM PFOA with β-CD in 50% D2O/50% 100 mM 
phosphate buffer in H2O, 400 MHz NMR (F8 peak not pictured). 
 
 
Figure A36: 
19F NMR spectra of 2.42 mM PFOA with β-CD in the presence of 35 μM 
HSA in 50% D2O/50% 100 mM phosphate buffer in H2O, 400 MHz NMR (F8 peak not 
pictured). 
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NMR Individual Association Constants of β-CD:PFOA Interactions 
 
Table A30: Regression Analysis Results for Perfluorooctanoic Acid and β-Cyclodextrin in 50 
mM Phosphate Buffer 
Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
2 1.29 ± 0.24 × 103 Not observed 0.244 ± 0.008 Not observed 0.990 
3 7.57 ± 1.29 × 102 Not observed 0.493 ± 0.020 Not observed 0.990 
4 5.91 ± 1.88 × 105 4.35 ± 1.13 × 102 0.592 ± 0.023 -31.9 ± 12.4 0.983 
5 8.55 ± 0.91 × 105 5.91 ± 2.74 × 102 0.644 ± 0.027 -30.0 ± 7.5 0.990 
6 8.55 ± 2.17 × 105 4.56 ± 2.58 × 102 0.898 ± 0.037 -37.1 ± 2.8 0.974 
7 2.82 ± 0.79 × 105 9.15 ± 1.01 × 102 0.201 ± 0.095 -16.3 ± 2.1 0.998 
8 3.23 ± 0.42 × 105 8.14 ± 1.44 × 102 0.218 ± 0.009 -18.6 ± 4.4 0.998 
 
Table A31: Regression Analysis Results for Perfluorooctanoic Acid and β-Cyclodextrin in 50 
mM Phosphate Buffer in the Presence of 35 μM HSA 
Fluorine K1:1, M
-1 K2:1, M
-1 Δδcd-F, ppm Δδ2cd-F, ppm R
2 
2 2.60 ± 1.13 × 102 Not observed 0.182 ± 0.031 Not observed 0.925 
3 8.59 ± 1.29 × 102 Not observed 0.498 ± 0.017 Not observed 0.992 
4 4.58 ± 0.84 × 104 1.34 ± 0.50 × 102 0.599 ± 0.052 -99.6 ± 45.8 0.985 
5 3.43 ± 0.46 × 104 7.47 ± 2.05 × 102 0.731 ± 0.076 -27.3 ± 7.4 0.988 
6 3.58 ± 1.61 × 104 1.17 ± 0.11 × 103 0.979 ± 0.133 -20.3 ± 13.3 0.973 
7 5.28 ± 0.31 × 105 1.24 ± 0.21 × 103 0.174 ± 0.159 -12.2 ± 1.9 0.986 
8 5.28 ± 1.67 × 105 1.26 ± 0.17 × 103 0.234 ± 0.038 -12.9 ± 2.2 0.991 
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Representative Steady State Fluorescence Emission Spectra of HSA in the Presence and 
Absence of PFOA 
 
 
Figure A37: Representative fluorescence emission spectra of 10 μM HSA: with no 
PFOA, 10 μM PFOA, and 100 μM PFOA. 
 
 
 
Representative Circular Dichroism Spectra of HSA in the Presence and Absence of 
PFOA 
 
Figure A38: Representative circular dichroism spectra of 10 μM HSA: with no PFOA, 10 
μM PFOA, and 100 μM PFOA. 
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Change in α-Helical Content of HSA with Increasing PFOA Concentration and Equation 
to Calculate α-Helical Content from Circular Dichroism Data 
 
 
Figure A39: Change in α-helical content of 10 μM HSA upon addition of PFOA 
calculated from the circular dichroism ellipticity measured at 208 nm. 
 
 
 
To calculate the α-helical content of the protein, first the ellipticity at 208 nm measured 
in the circular dichroism spectra is converted to the mean residue ellipticity (MRE) by 
using the following equation: 
 
𝑀𝑅𝐸 = 
𝐸𝑙𝑙𝑖𝑝𝑡𝑖𝑐𝑖𝑡𝑦 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑎𝑡 208 𝑛𝑚
𝐶𝑝𝑛𝑙
                                         (S17) 
 
where Cp is the molar concentration of the protein, n is the number of amino acid residues 
in the protein (585 for HSA), and l is the path length in mm. The MRE is then converted 
to the α-helical content by the following equation: 
 
𝛼 − ℎ𝑒𝑙𝑖𝑥 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (%) =  
−𝑀𝑅𝐸−4000
33000−4000
 𝑥 100 %                             (S18) 
 
where 4000 is the MRE of the β-form or random coil conformations at 208 nm, and 
33000 is the MRE of a pure α-helical conformation at 208 nm (Bolattin et al. 2016). 
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Double Logarithm Plot and Equation to Calculate the Binding Constant 
 
 
 
Figure A40: Double logarithm plot of fluorescence emission intensity of HSA with 
PFOA to calculate the binding constant (Ka,2) of PFOA to the low affinity binding site on 
HSA. R
2
 = 0.987. 
 
 
 
 
The binding constant (Ka) and number of binding sites (n) can be calculated from the 
double logarithm plot (Wei et al. 2010) of the quencher concentration and fluorescence 
emission intensities: 
 
𝑙𝑜𝑔
(𝐹0−𝐹)
𝐹
= 𝑙𝑜𝑔𝐾𝑎 + 𝑛𝑙𝑜𝑔[𝑄]                                               (S19) 
 
 
where F0 is the fluorescence intensity in the absence of the quencher. 
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Modified Scatchard Plot and Equation to Calculate the Number of Binding Sites 
 
 
 
Figure A41: Modified Scatchard plot of fluorescence emission intensity of HSA with 
PFOA to calculate the number of low affinity binding sites on HSA for PFOA. R
2
 = 
0.920.  
 
 
 
 
The binding constant (Ka) and number of binding sites (n) can be calculated from the 
modified Scatchard plot (Wei et al. 2010) of the quencher concentration and fluorescence 
emission intensities: 
 
(𝐹𝑚𝑎𝑥−𝐹0)
(𝐹𝑚𝑎𝑥−𝐹)
= 𝐾𝑎[𝑄]
(𝐹𝑚𝑎𝑥−𝐹0)
(𝐹−𝐹0)
− 𝑛𝐾𝑎[𝑃]                                               (S20) 
 
 
where F0 is the fluorescence intensity at the 1:1 PFOA:HSA ratio, Fmax is the 
fluorescence intensity at the 20:1 PFOA:HSA ratio, and [P] is the concentration of HSA. 
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Average Lifetime of Trp Residue in HSA with PFOA and β-CD 
 
 
 
 
Figure A42: Average fluorescent lifetime of 10 μM HSA titrated with increasing 
concentrations of PFOA. 
 
 
 
 
Figure A43: Average fluorescent lifetime of 10 μM HSA with 500 μM PFOA titrated 
with increasing concentrations of β-CD. 
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